1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_1	[p1l926t81r1233b100],

1	thrombosis	NN	O	thrombosis	nsubjpass	3	SENT_2	[p1l11t295r506b374],
2	was	VBD	O	be	auxpass	3	SENT_2	[p1l551t322r715b374],
3	increased	VBN	O	increase	_	0	SENT_2	[p1l763t295r1174b374],
4	among	IN	O	among	_	0	SENT_2	[p1l1220t321r1522b396],
5	patients	NNS	O	patient	prep_among	3	SENT_2	[p1l1564t296r1908b396],
6	with	IN	O	with	_	0	SENT_2	[p1l1952t295r2149b375],
7	advanced	JJ	O	advanced	amod	9	SENT_2	[p1l10t423r408b502],
8	polycythemia	NN	O	polycythemia	nn	9	SENT_2	[p1l437t423r1020b524],
9	Vera	NNP	PERSON	Vera	prep_with	5	SENT_2	[p1l1044t449r1220b503],
10	and	CC	O	and	_	0	SENT_2	[p1l1248t423r1407b502],
11	essential	JJ	O	essential	amod	12	SENT_2	[p1l1438t423r1816b502],
12	thrombocythemia	NN	O	thrombocythemia	conj_and	5	SENT_2	[p1l1846t423r2148b502, p1l11t551r521b652],
13	who	WP	O	who	nsubj	14	SENT_2	[p1l549t551r734b631],
14	received	VBD	O	receive	rcmod	12	SENT_2	[p1l769t551r1118b630],
15	CEP	NNP	O	CEP	iobj	14	SENT_2	[p1l1152t557r1525b647],
16	—	CD	NUMBER	—	number	17	SENT_2	[p1l1152t557r1525b647],
17	701	CD	NUMBER	701	dobj	14	SENT_2	[p1l1152t557r1525b647],
18	,	,	O	,	_	0	SENT_2	[p1l1152t557r1525b647],
19	another	DT	O	another	det	21	SENT_2	[p1l1565t551r1903b630],
20	JAK2	NN	O	jak2	nn	21	SENT_2	[p1l1924t557r2149b643],
21	inhibitorz	NN	O	inhibitorz	appos	12	SENT_2	[p1l10t679r463b775],
22	;	:	O	;	_	0	SENT_2	[p1l10t679r463b775],
23	levels	NNS	O	level	dep	21	SENT_2	[p1l526t679r764b759],
24	of	IN	O	of	_	0	SENT_2	[p1l828t679r929b758],
25	White	JJ	O	white	amod	26	SENT_2	[p1l967t679r1212b758],
26	cells	NNS	O	cell	prep_of	23	SENT_2	[p1l1274t679r1466b758],
27	and	CC	O	and	_	0	SENT_2	[p1l1528t679r1690b758],
28	platelets	NNS	O	platelet	prep_of	23	SENT_2	[p1l1748t679r2144b780],
29	,	,	O	,	_	0	SENT_2	[p1l1748t679r2144b780],
30	which	WDT	O	which	nsubjpass	32	SENT_2	[p1l6t807r270b887],
31	are	VBP	O	be	auxpass	32	SENT_2	[p1l299t833r429b886],
32	associated	VBN	O	associate	rcmod	26	SENT_2	[p1l458t807r906b886],
33	with	IN	O	with	_	0	SENT_2	[p1l931t807r1127b887],
34	the	DT	O	the	det	35	SENT_2	[p1l1158t807r1291b886],
35	risk	NN	O	risk	prep_with	32	SENT_2	[p1l1321t807r1486b887],
36	of	IN	O	of	_	0	SENT_2	[p1l1511t807r1612b886],
37	thrombosis	NN	O	thrombosis	prep_of	35	SENT_2	[p1l1623t807r2144b903],
38	,	,	O	,	_	0	SENT_2	[p1l1623t807r2144b903],
39	increased	VBN	O	increase	partmod	12	SENT_2	[p1l10t936r421b1015],
40	in	IN	O	in	_	0	SENT_2	[p1l449t937r533b1014],
41	these	DT	O	these	det	42	SENT_2	[p1l562t936r788b1015],
42	patients	NNS	O	patient	prep_in	39	SENT_2	[p1l816t937r1184b1037],
43	.	.	O	.	_	0	SENT_2	[p1l816t937r1184b1037],

1	In	IN	O	in	_	0	SENT_3	[p1l1218t944r1307b1014],
2	contrast	NN	O	contrast	prep_in	8	SENT_3	[p1l1336t953r1712b1032],
3	,	,	O	,	_	0	SENT_3	[p1l1336t953r1712b1032],
4	these	DT	O	these	det	5	SENT_3	[p1l1747t936r1972b1015],
5	levels	NNS	O	level	nsubjpass	8	SENT_3	[p1l2000t936r2148b1016, p1l11t1064r123b1143],
6	Were	VBD	O	be	auxpass	8	SENT_3	[p1l171t1090r374b1143],
7	effectively	RB	O	effectively	advmod	8	SENT_3	[p1l426t1064r863b1165],
8	controlled	VBN	O	control	_	0	SENT_3	[p1l910t1064r1351b1143],
9	by	IN	O	by	_	0	SENT_3	[p1l1401t1064r1499b1165],
10	INCBO18424	NN	O	incbo18424	agent	8	SENT_3	[p1l1544t1070r2149b1143],
11	?	.	O	?	_	0	SENT_3	[p1l1544t1070r2149b1143],

1	CEP	NN	O	cep	nn	2	SENT_4	[p1l10t1199r360b1272],
2	—	NN	O	—	nsubjpass	6	SENT_4	[p1l10t1199r360b1272],
3	701	CD	NUMBER	701	dep	2	SENT_4	[p1l10t1199r360b1272],
4	was	VBD	O	be	auxpass	6	SENT_4	[p1l387t1220r551b1272],
5	not	RB	O	not	neg	6	SENT_4	[p1l584t1210r728b1272],
6	associated	VBN	O	associate	_	0	SENT_4	[p1l754t1193r1202b1272],
7	with	IN	O	with	_	0	SENT_4	[p1l1228t1193r1425b1272],
8	an	DT	O	a	det	10	SENT_4	[p1l1456t1219r1560b1272],
9	increased	VBN	O	increase	amod	10	SENT_4	[p1l1591t1193r2002b1272],
10	incidence	NN	O	incidence	prep_with	6	SENT_4	[p1l2033t1194r2148b1271, p1l11t1321r330b1400],
11	of	IN	O	of	_	0	SENT_4	[p1l366t1321r467b1400],
12	thrombosis	NN	O	thrombosis	prep_of	10	SENT_4	[p1l483t1321r979b1400],
13	in	IN	O	in	_	0	SENT_4	[p1l1015t1322r1098b1399],
14	two	CD	NUMBER	two	num	15	SENT_4	[p1l1134t1338r1292b1400],
15	trials	NNS	O	trial	prep_in	12	SENT_4	[p1l1329t1321r1550b1400],
16	involving	VBG	O	involve	partmod	15	SENT_4	[p1l1586t1321r1985b1422],
17	patients	NNS	O	patient	dobj	16	SENT_4	[p1l2016t1347r2148b1422, p1l11t1450r254b1528],
18	with	IN	O	with	_	0	SENT_4	[p1l306t1449r506b1529],
19	myelofibrosis	NN	O	myelofibrosis	prep_with	16	SENT_4	[p1l561t1449r1186b1550],
20	.	.	O	.	_	0	SENT_4	[p1l561t1449r1186b1550],

1	At	IN	O	at	quantmod	3	SENT_5	[p1l1242t1457r1344b1528],
2	least	JJS	O	least	mwe	1	SENT_5	[p1l1392t1449r1596b1528],
3	eight	CD	NUMBER	eight	num	5	SENT_5	[p1l1647t1449r1869b1550],
4	other	JJ	O	other	amod	5	SENT_5	[p1l1919t1449r2153b1528],
5	studies	NNS	O	study	nsubj	10	SENT_5	[p1l12t1578r314b1657],
6	of	IN	O	of	_	0	SENT_5	[p1l352t1578r453b1657],
7	various	JJ	O	various	amod	9	SENT_5	[p1l465t1579r777b1657],
8	JAK2	NN	O	jak2	nn	9	SENT_5	[p1l805t1584r1029b1670],
9	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_5	[p1l1065t1578r1490b1657],
10	showed	VBD	O	show	_	0	SENT_5	[p1l1530t1578r1855b1658],
11	no	DT	O	no	det	12	SENT_5	[p1l1890t1604r1997b1657],
12	increase	NN	O	increase	dep	17	SENT_5	[p1l2033t1579r2148b1656, p1l11t1732r277b1785],
13	in	IN	O	in	_	0	SENT_5	[p1l327t1707r411b1784],
14	thrombosis	NN	O	thrombosis	nn	15	SENT_5	[p1l462t1706r1022b1785],
15	.3	NN	NUMBER	.3	prep_in	12	SENT_5	[p1l462t1706r1022b1785],
16	My	PRP$	O	my	poss	17	SENT_5	[p1l1049t1714r1181b1807],
17	colleagues	NNS	O	colleague	dep	10	SENT_5	[p1l1228t1706r1679b1807],
18	and	CC	O	and	_	0	SENT_5	[p1l1731t1706r1890b1785],
19	I	PRP	O	I	nsubj	21	SENT_5	[p1l1939t1714r1970b1784],
20	are	VBP	O	be	cop	21	SENT_5	[p1l2020t1732r2149b1785],
21	confident	JJ	O	confident	dep	10	SENT_5	[p1l11t1834r430b1913],
22	to	TO	O	to	aux	23	SENT_5	[p1l453t1851r536b1913],
23	say	VB	O	say	xcomp	21	SENT_5	[p1l567t1861r701b1935],
24	that	IN	O	that	complm	32	SENT_5	[p1l725t1834r899b1913],
25	JAK2	NN	O	jak2	nn	26	SENT_5	[p1l912t1840r1136b1926],
26	inhibitors	NNS	O	inhibitor	nsubj	32	SENT_5	[p1l1166t1834r1590b1913],
27	as	IN	O	as	_	0	SENT_5	[p1l1620t1861r1707b1913],
28	a	DT	O	a	det	29	SENT_5	[p1l1736t1861r1781b1913],
29	class	NN	O	class	prep_as	26	SENT_5	[p1l1809t1834r2014b1913],
30	do	VBP	O	do	aux	32	SENT_5	[p1l2045t1834r2148b1913],
31	not	RB	O	not	neg	32	SENT_5	[p1l10t1980r154b2043],
32	increase	VB	O	increase	ccomp	23	SENT_5	[p1l186t1964r541b2043],
33	the	DT	O	the	det	34	SENT_5	[p1l580t1963r714b2043],
34	risk	NN	O	risk	dobj	32	SENT_5	[p1l752t1963r917b2044],
35	of	IN	O	of	_	0	SENT_5	[p1l951t1963r1052b2043],
36	thrombosis	NN	O	thrombosis	prep_of	34	SENT_5	[p1l1072t1963r1593b2043],
37	.	.	O	.	_	0	SENT_5	[p1l1072t1963r1593b2043],

1	The	DT	O	the	det	2	SENT_6	[p1l1633t1963r1795b2043],
2	characteristics	NNS	O	characteristic	nsubj	15	SENT_6	[p1l1834t1963r2148b2043, p1l11t2093r349b2171],
3	of	IN	O	of	_	0	SENT_6	[p1l384t2092r486b2171],
4	four	CD	NUMBER	four	num	5	SENT_6	[p1l500t2092r681b2171],
5	patients	NNS	O	patient	prep_of	2	SENT_6	[p1l709t2093r1053b2193],
6	in	IN	O	in	_	0	SENT_6	[p1l1088t2093r1171b2170],
7	our	PRP$	O	we	poss	8	SENT_6	[p1l1205t2118r1352b2171],
8	study	NN	O	study	prep_in	5	SENT_6	[p1l1383t2092r1614b2193],
9	Who	WP	O	who	nsubj	10	SENT_6	[p1l1638t2092r1822b2171],
10	had	VBD	O	have	rcmod	5	SENT_6	[p1l1856t2092r2014b2171],
11	an	DT	O	a	det	13	SENT_6	[p1l2046t2118r2149b2171],
12	MPL	NN	ORGANIZATION	mpl	nn	13	SENT_6	[p1l9t2227r192b2299],
13	mutation	NN	O	mutation	dobj	10	SENT_6	[p1l220t2221r616b2299],
14	were	VBD	O	be	cop	15	SENT_6	[p1l644t2246r847b2300],
15	similar	JJ	O	similar	_	0	SENT_6	[p1l882t2220r1190b2299],
16	to	TO	O	to	_	0	SENT_6	[p1l1220t2237r1301b2299],
17	those	DT	O	those	prep_to	15	SENT_6	[p1l1336t2220r1569b2299],
18	of	IN	O	of	_	0	SENT_6	[p1l1603t2220r1703b2299],
19	other	JJ	O	other	amod	20	SENT_6	[p1l1718t2220r1947b2299],
20	participants	NNS	O	participant	prep_of	17	SENT_6	[p1l1975t2246r2148b2321, p1l11t2349r407b2449],
21	;	:	O	;	_	0	SENT_6	[p1l1975t2246r2148b2321, p1l11t2349r407b2449],
22	three	CD	NUMBER	three	nsubj	28	SENT_6	[p1l441t2348r663b2427],
23	had	VBD	O	have	parataxis	15	SENT_6	[p1l693t2348r850b2427],
24	splenomegaly	NN	O	splenomegaly	dobj	23	SENT_6	[p1l882t2348r1477b2449],
25	at	IN	O	at	_	0	SENT_6	[p1l1501t2365r1581b2427],
26	baseline	NN	O	baseline	prep_at	24	SENT_6	[p1l1606t2348r1961b2427],
27	and	CC	O	and	_	0	SENT_6	[p1l1991t2348r2150b2427],
28	had	VBD	O	have	conj_and	23	SENT_6	[p1l10t2476r166b2555],
29	durable	JJ	O	durable	amod	30	SENT_6	[p1l196t2476r511b2555],
30	responses	NNS	O	response	iobj	28	SENT_6	[p1l539t2502r958b2577],
31	to	TO	O	to	_	0	SENT_6	[p1l989t2493r1070b2555],
32	IN	IN	O	in	amod	34	SENT_6	[p1l1099t2484r1208b2555],
33	CBO18424	NN	O	cbo18424	nn	34	SENT_6	[p1l1209t2482r1632b2555],
34	therapy	NN	O	therapy	prep_to	30	SENT_6	[p1l1661t2476r1979b2577],
35	(	CD	NUMBER	(	num	36	SENT_6	[p1l2008t2483r2148b2567, p1l11t2604r379b2683],
36	reductions	NNS	O	reduction	dobj	28	SENT_6	[p1l2008t2483r2148b2567, p1l11t2604r379b2683],
37	in	IN	O	in	_	0	SENT_6	[p1l410t2605r494b2682],
38	palpable	JJ	O	palpable	amod	39	SENT_6	[p1l522t2604r887b2705],
39	splenomegaly	NN	O	splenomegaly	prep_in	28	SENT_6	[p1l918t2604r1513b2705],
40	from	IN	O	from	_	0	SENT_6	[p1l1538t2604r1750b2683],
41	16	CD	NUMBER	16	num	42	SENT_6	[p1l1783t2610r1877b2683],
42	cm	NN	O	cm	prep_from	39	SENT_6	[p1l1908t2630r2036b2683],
43	to	TO	O	to	_	0	SENT_6	[p1l2067t2621r2149b2683],
44	o	NN	O	o	nn	45	SENT_6	[p1l10t2738r58b2811],
45	cm	NN	O	cm	prep_to	42	SENT_6	[p1l94t2758r245b2828],
46	,	,	O	,	_	0	SENT_6	[p1l94t2758r245b2828],
47	21	CD	NUMBER	21	num	48	SENT_6	[p1l286t2738r386b2810],
48	cm	NN	O	cm	prep_from	39	SENT_6	[p1l422t2758r551b2811],
49	to	TO	O	to	_	0	SENT_6	[p1l586t2749r668b2811],
50	3	CD	NUMBER	3	num	51	SENT_6	[p1l705t2738r750b2811],
51	cm	NN	O	cm	prep_to	48	SENT_6	[p1l789t2758r940b2828],
52	,	,	O	,	_	0	SENT_6	[p1l789t2758r940b2828],
53	and	CC	O	and	_	0	SENT_6	[p1l980t2732r1139b2811],
54	11	CD	NUMBER	11	num	55	SENT_6	[p1l1177t2738r1274b2810],
55	cm	NN	O	cm	prep_from	39	SENT_6	[p1l1310t2758r1438b2811],
56	to	TO	O	to	_	0	SENT_6	[p1l1474t2749r1556b2811],
57	o	NN	O	o	nn	59	SENT_6	[p1l1592t2738r1639b2811],
58	cm	NN	O	cm	nn	59	SENT_6	[p1l1676t2739r1855b2824],
59	)	NN	O	)	prep_to	55	SENT_6	[p1l1676t2739r1855b2824],
60	.	.	O	.	_	0	SENT_6	[p1l1676t2739r1855b2824],

1	Srdan	NNP	PERSON	Srdan	nn	3	SENT_7	[p1l12t2866r261b2946],
2	Verstovse	NNP	PERSON	Verstovse	nn	3	SENT_7	[p1l297t2866r802b2961],
3	|	NN	O	|	_	0	SENT_7	[p1l297t2866r802b2961],
4	<	JJR	O	<	dep	3	SENT_7	[p1l297t2866r802b2961],
5	,	,	O	,	_	0	SENT_7	[p1l297t2866r802b2961],
6	M.D.	NNP	O	M.D.	nn	8	SENT_7	[p1l847t2873r1080b2961],
7	,	,	O	,	_	0	SENT_7	[p1l847t2873r1080b2961],
8	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_7	[p1l1125t2866r1356b2946],
9	.	.	O	.	_	0	SENT_7	[p1l1125t2866r1356b2946],

1	M.D.	NNP	ORGANIZATION	M.D.	nn	5	SENT_8	[p1l15t3015r172b3070],
2	Anderson	NNP	ORGANIZATION	Anderson	nn	5	SENT_8	[p1l197t3009r524b3070],
3	Cancer	NNP	ORGANIZATION	Cancer	nn	5	SENT_8	[p1l553t3014r788b3070],
4	Center	NNP	ORGANIZATION	Center	nn	5	SENT_8	[p1l811t3014r1033b3070],
5	Houston	NNP	ORGANIZATION	Houston	_	0	SENT_8	[p1l15t3097r326b3162],
6	,	,	O	,	_	0	SENT_8	[p1l15t3097r326b3162],
7	TX	NNP	LOCATION	TX	nn	8	SENT_8	[p1l351t3097r444b3150],
8	sverstov@mdanderson.org	NN	O	sverstov@mdanderson.org	appos	5	SENT_8	[p1l11t3171r945b3252],

1	Since	IN	O	since	_	0	SENT_9	[p1l97t3273r269b3332],
2	publication	NN	O	publication	prep_since	9	SENT_9	[p1l295t3272r672b3349],
3	of	IN	O	of	_	0	SENT_9	[p1l700t3272r776b3332],
4	his	PRP$	O	he	poss	5	SENT_9	[p1l789t3273r885b3332],
5	article	NN	O	article	prep_of	2	SENT_9	[p1l913t3272r1139b3345],
6	,	,	O	,	_	0	SENT_9	[p1l913t3272r1139b3345],
7	the	DT	O	the	det	8	SENT_9	[p1l1170t3273r1272b3332],
8	author	NN	O	author	nsubj	9	SENT_9	[p1l1298t3273r1517b3332],
9	reports	VBZ	O	report	_	0	SENT_9	[p1l1541t3285r1778b3349],
10	no	DT	O	no	det	13	SENT_9	[p1l1807t3292r1887b3332],
11	further	JJ	O	further	amod	13	SENT_9	[p1l1915t3272r2153b3332],
12	potential	JJ	O	potential	amod	13	SENT_9	[p1l8t3359r308b3435],
13	conflict	NN	O	conflict	dobj	9	SENT_9	[p1l334t3358r594b3418],
14	of	IN	O	of	_	0	SENT_9	[p1l616t3358r693b3418],
15	interest	NN	O	interest	prep_of	13	SENT_9	[p1l704t3359r972b3418],
16	.	.	O	.	_	0	SENT_9	[p1l704t3359r972b3418],

1	1	LS	NUMBER	1	_	0	SENT_10	[p1l12t3469r61b3521],
2	.	.	O	.	_	0	SENT_10	[p1l12t3469r61b3521],

1	Barbui	JJ	ORGANIZATION	barbui	amod	2	SENT_11	[p1l138t3462r359b3521],
2	T	NN	ORGANIZATION	t	_	0	SENT_11	[p1l382t3466r441b3534],
3	,	,	O	,	_	0	SENT_11	[p1l382t3466r441b3534],
4	Carobbio	NNP	O	Carobbio	nn	5	SENT_11	[p1l471t3462r773b3521],
5	A	NNP	O	A	appos	2	SENT_11	[p1l798t3467r865b3534],
6	,	,	O	,	_	0	SENT_11	[p1l798t3467r865b3534],
7	Cervantes	NNP	PERSON	Cervantes	nn	8	SENT_11	[p1l895t3466r1220b3521],
8	F	NN	O	f	appos	2	SENT_11	[p1l1247t3467r1299b3534],
9	,	,	O	,	_	0	SENT_11	[p1l1247t3467r1299b3534],
10	et	FW	O	et	nn	11	SENT_11	[p1l1330t3474r1389b3521],
11	al.	FW	O	al.	appos	2	SENT_11	[p1l1411t3462r1487b3521],
12	.	.	O	.	_	0	SENT_11	[p1l1411t3462r1487b3521],

1	Thrombosis	NN	O	thrombosis	_	0	SENT_12	[p1l1514t3461r1915b3521],
2	in	IN	O	in	_	0	SENT_12	[p1l1943t3462r2007b3520],
3	primary	JJ	O	primary	amod	4	SENT_12	[p1l2033t3462r2149b3538, p1l9t3567r180b3624],
4	myelofibrosis	NN	O	myelofibrosis	prep_in	1	SENT_12	[p1l204t3547r673b3624],
5	:	:	O	:	_	0	SENT_12	[p1l204t3547r673b3624],
6	incidence	NN	O	incidence	dep	1	SENT_12	[p1l703t3547r1016b3607],
7	and	CC	O	and	_	0	SENT_12	[p1l1043t3547r1164b3607],
8	risk	NN	O	risk	nn	9	SENT_12	[p1l1190t3547r1317b3608],
9	factors	NNS	O	factor	dep	1	SENT_12	[p1l1340t3547r1585b3607],
10	.	.	O	.	_	0	SENT_12	[p1l1340t3547r1585b3607],

1	Blood	NN	O	blood	_	0	SENT_13	[p1l1614t3548r1807b3607],
2	2010	CD	DATE	2010	num	1	SENT_13	[p1l1833t3552r2147b3620],
3	;	:	O	;	_	0	SENT_13	[p1l1833t3552r2147b3620],
4	115	CD	NUMBER	115	num	6	SENT_13	[p1l1833t3552r2147b3620],
5	:	:	O	:	_	0	SENT_13	[p1l1833t3552r2147b3620],
6	778-82	CD	NUMBER	778-82	dep	1	SENT_13	[p1l10t3650r251b3705],
7	.	.	O	.	_	0	SENT_13	[p1l10t3650r251b3705],

1	2	LS	NUMBER	2	_	0	SENT_14	[p1l8t3739r62b3791],
2	.	.	O	.	_	0	SENT_14	[p1l8t3739r62b3791],

1	Moliterno	NNP	PERSON	Moliterno	nn	2	SENT_15	[p1l137t3732r459b3791],
2	AR	NNS	O	ar	_	0	SENT_15	[p1l480t3736r599b3804],
3	,	,	O	,	_	0	SENT_15	[p1l480t3736r599b3804],
4	Hexner	NNP	PERSON	Hexner	nn	5	SENT_15	[p1l626t3737r863b3791],
5	E	NNP	PERSON	E	appos	2	SENT_15	[p1l883t3737r941b3804],
6	,	,	O	,	_	0	SENT_15	[p1l883t3737r941b3804],
7	Roboz	NNP	O	Roboz	nn	9	SENT_15	[p1l968t3732r1176b3795],
8	G	NNP	O	G	nn	9	SENT_15	[p1l1201t3736r1291b3804],
9	]	NNS	O	]	appos	2	SENT_15	[p1l1201t3736r1291b3804],
10	,	,	O	,	_	0	SENT_15	[p1l1201t3736r1291b3804],
11	et	FW	O	et	nn	12	SENT_15	[p1l1319t3744r1378b3791],
12	al.	FW	O	al.	appos	2	SENT_15	[p1l1397t3731r1470b3791],
13	.	.	O	.	_	0	SENT_15	[p1l1397t3731r1470b3791],

1	An	DT	O	a	det	5	SENT_16	[p1l1496t3737r1589b3790],
2	open	JJ	O	open	amod	5	SENT_16	[p1l1613t3732r1952b3808],
3	—	NN	O	—	nn	5	SENT_16	[p1l1613t3732r1952b3808],
4	label	NN	O	label	nn	5	SENT_16	[p1l1613t3732r1952b3808],
5	study	NN	O	study	_	0	SENT_16	[p1l1976t3731r2153b3808],
6	of	IN	O	of	_	0	SENT_16	[p2l10t17r86b77],
7	CEP	NN	O	cep	nn	8	SENT_16	[p2l97t22r365b77],
8	—	NN	O	—	prep_of	5	SENT_16	[p2l97t22r365b77],
9	701	CD	NUMBER	701	num	8	SENT_16	[p2l97t22r365b77],
10	in	IN	O	in	_	0	SENT_16	[p2l391t18r454b76],
11	patients	NNS	O	patient	prep_in	5	SENT_16	[p2l478t18r742b94],
12	with	IN	O	with	_	0	SENT_16	[p2l765t18r916b78],
13	JAK2	NN	O	jak2	nn	14	SENT_16	[p2l933t22r1104b86],
14	V617F	NN	O	v617f	prep_with	11	SENT_16	[p2l1127t22r1442b77],
15	.	.	O	.	_	0	SENT_16	[p2l1127t22r1442b77],

1	—	NN	O	—	_	0	SENT_17	[p2l1127t22r1442b77],
2	.	.	O	.	_	0	SENT_17	[p2l1127t22r1442b77],

1	PV	NN	O	pv	nsubj	5	SENT_18	[p2l1127t22r1442b77],
2	and	CC	O	and	_	0	SENT_18	[p2l1463t17r1585b77],
3	ET	NNP	O	ET	conj_and	1	SENT_18	[p2l1608t22r1711b77],
4	:	:	O	:	_	0	SENT_18	[p2l1608t22r1711b77],
5	update	VB	O	update	_	0	SENT_18	[p2l1739t17r1961b94],
6	of	IN	O	of	_	0	SENT_18	[p2l1987t17r2063b77],
7	39	CD	NUMBER	39	num	9	SENT_18	[p2l2076t22r2149b77],
8	enrolled	VBN	O	enrol	amod	9	SENT_18	[p2l10t103r282b163],
9	patients	NNS	O	patient	prep_of	5	SENT_18	[p2l306t104r590b180],
10	.	.	O	.	_	0	SENT_18	[p2l306t104r590b180],

1	Blood	NN	O	blood	_	0	SENT_19	[p2l619t103r811b163],
2	2009	CD	DATE	2009	num	1	SENT_19	[p2l837t108r1289b176],
3	;	:	O	;	_	0	SENT_19	[p2l837t108r1289b176],
4	114:753	CD	NUMBER	114:753	dep	1	SENT_19	[p2l837t108r1289b176],
5	.	.	O	.	_	0	SENT_19	[p2l837t108r1289b176],

1	abstract	JJ	O	abstract	_	0	SENT_20	[p2l1319t103r1602b163],
2	.	.	O	.	_	0	SENT_20	[p2l1319t103r1602b163],

1	3	LS	NUMBER	3	_	0	SENT_21	[p2l9t197r60b249],
2	.	.	O	.	_	0	SENT_21	[p2l9t197r60b249],

1	Verstovsek	NNP	O	Verstovsek	nn	4	SENT_22	[p2l136t189r494b249],
2	S.	NNP	O	S.	nn	4	SENT_22	[p2l535t194r587b249],
3	Therapeutic	JJ	O	therapeutic	amod	4	SENT_22	[p2l633t190r1029b266],
4	potential	NN	O	potential	nsubj	8	SENT_22	[p2l1072t190r1371b266],
5	of	IN	O	of	_	0	SENT_22	[p2l1415t189r1491b249],
6	Janus	NN	O	janus	nn	7	SENT_22	[p2l1513t189r2020b258],
7	—	NN	O	—	prep_of	4	SENT_22	[p2l1513t189r2020b258],
8	activated	VBD	O	activate	_	0	SENT_22	[p2l1513t189r2020b258],
9	kinase-2	NN	O	kinase-2	nn	10	SENT_22	[p2l2063t190r2149b250, p2l9t280r219b335],
10	inhibitors	NNS	O	inhibitor	dobj	8	SENT_22	[p2l262t275r589b335],
11	for	IN	O	for	_	0	SENT_22	[p2l634t275r728b335],
12	the	DT	O	the	det	13	SENT_22	[p2l769t276r872b335],
13	management	NN	O	management	prep_for	8	SENT_22	[p2l915t288r1351b352],
14	of	IN	O	of	_	0	SENT_22	[p2l1391t275r1468b335],
15	myelofibrosis	NN	O	myelofibrosis	prep_of	13	SENT_22	[p2l1497t275r1967b352],
16	.	.	O	.	_	0	SENT_22	[p2l1497t275r1967b352],

1	Clin	NNP	O	Clin	nn	3	SENT_23	[p2l2013t276r2150b335],
2	Cancer	NNP	O	Cancer	nn	3	SENT_23	[p2l9t363r239b418],
3	Res	NNP	O	Res	_	0	SENT_23	[p2l262t363r378b422],
4	2010	CD	DATE	2010	num	3	SENT_23	[p2l406t363r967b431],
5	;	:	O	;	_	0	SENT_23	[p2l406t363r967b431],
6	16:1988	CD	NUMBER	16:1988	number	7	SENT_23	[p2l406t363r967b431],
7	—	CD	NUMBER	—	dep	3	SENT_23	[p2l406t363r967b431],
8	96	CD	NUMBER	96	dep	7	SENT_23	[p2l406t363r967b431],
9	.	.	O	.	_	0	SENT_23	[p2l406t363r967b431],

1	THE	DT	O	the	det	3	SENT_24	[p2l8t650r173b704],
2	EDITORIALIST	NNP	O	EDITORIALIST	nn	3	SENT_24	[p2l210t649r793b704],
3	REPL	NNP	O	REPL	nsubj	4	SENT_24	[p2l825t626r1850b727],
4	|	VBD	O	|	_	0	SENT_24	[p2l825t626r1850b727],
5	ES2HydrOXyl11	NN	O	es2hydroxyl11	dobj	4	SENT_24	[p2l825t626r1850b727],
6	'	''	O	'	_	0	SENT_24	[p2l825t626r1850b727],
7	eaiS	NNP	O	eaiS	nsubj	9	SENT_24	[p2l825t626r1850b727],
8	Widely	RB	O	widely	advmod	9	SENT_24	[p2l1876t626r2154b727],
9	used	VBD	O	use	rcmod	5	SENT_24	[p2l10t754r209b833],
10	for	IN	O	for	_	0	SENT_24	[p2l241t754r365b833],
11	palliative	JJ	O	palliative	amod	12	SENT_24	[p2l394t754r790b855],
12	treatment	NN	O	treatment	prep_for	9	SENT_24	[p2l823t771r1250b833],
13	of	IN	O	of	_	0	SENT_24	[p2l1279t754r1379b833],
14	myelofibrosis	NN	O	myelofibrosis	prep_of	12	SENT_24	[p2l1393t754r2005b855],
15	,	,	O	,	_	0	SENT_24	[p2l1393t754r2005b855],
16	although	IN	O	although	mark	22	SENT_24	[p2l2042t754r2148b833, p2l11t882r321b983],
17	data	NNS	O	datum	nsubj	22	SENT_24	[p2l352t882r536b961],
18	from	IN	O	from	_	0	SENT_24	[p2l564t882r776b961],
19	controlled	JJ	O	controlled	amod	20	SENT_24	[p2l807t882r1247b961],
20	studies	NNS	O	study	prep_from	17	SENT_24	[p2l1278t882r1580b961],
21	are	VBP	O	be	aux	22	SENT_24	[p2l1612t908r1741b961],
22	lacking	VBG	O	lack	advcl	9	SENT_24	[p2l1770t882r2150b983],
23	}	CD	NUMBER	}	dobj	22	SENT_24	[p2l1770t882r2150b983],
24	The	DT	O	the	det	25	SENT_24	[p2l7t1010r168b1089],
25	data	NNS	O	datum	nsubj	26	SENT_24	[p2l210t1010r395b1089],
26	described	VBN	O	describe	rcmod	23	SENT_24	[p2l435t1010r849b1089],
27	by	IN	O	by	_	0	SENT_24	[p2l890t1010r988b1111],
28	Arellano	NNP	PERSON	Arellano	prep_by	26	SENT_24	[p2l1021t1010r1784b1111],
29	.	.	O	.	_	0	SENT_24	[p2l1021t1010r1784b1111],

1	—	NN	O	—	_	0	SENT_25	[p2l1021t1010r1784b1111],
2	.	.	O	.	_	0	SENT_25	[p2l1021t1010r1784b1111],

1	Rodrigo	NNP	PERSON	Rodrigo	_	0	SENT_26	[p2l1021t1010r1784b1111],
2	and	CC	O	and	_	0	SENT_26	[p2l1825t1010r1985b1089],
3	Alvarez	NNP	PERSON	Alvarez	conj_and	1	SENT_26	[p2l2021t1010r2148b1088, p2l6t1136r556b1218],
4	.	.	O	.	_	0	SENT_26	[p2l2021t1010r2148b1088, p2l6t1136r556b1218],

1	—	NN	O	—	_	0	SENT_27	[p2l2021t1010r2148b1088, p2l6t1136r556b1218],
2	.	.	O	.	_	0	SENT_27	[p2l2021t1010r2148b1088, p2l6t1136r556b1218],

1	Larran	NNP	MISC	Larran	nsubjpass	3	SENT_28	[p2l2021t1010r2148b1088, p2l6t1136r556b1218],
2	were	VBD	O	be	auxpass	3	SENT_28	[p2l592t1165r795b1219],
3	obtained	VBN	O	obtain	_	0	SENT_28	[p2l837t1139r1218b1218],
4	from	IN	O	from	_	0	SENT_28	[p2l1258t1138r1470b1218],
5	a	DT	O	a	det	7	SENT_28	[p2l1509t1166r1554b1218],
6	retrospective	JJ	O	retrospective	amod	7	SENT_28	[p2l1592t1140r2149b1240],
7	study	NN	O	study	prep_from	3	SENT_28	[p2l12t1267r239b1368],
8	involving	VBG	O	involve	_	0	SENT_28	[p2l267t1267r658b1368],
9	40	CD	NUMBER	40	num	10	SENT_28	[p2l686t1273r788b1346],
10	patients	NNS	O	patient	prep_involving	7	SENT_28	[p2l821t1268r1157b1368],
11	who	WP	O	who	nsubj	12	SENT_28	[p2l1188t1267r1370b1346],
12	received	VBD	O	receive	rcmod	10	SENT_28	[p2l1405t1267r1745b1346],
13	hydroxy	NN	O	hydroxy	nn	15	SENT_28	[p2l1778t1267r2148b1368],
14	—	CD	NUMBER	—	num	15	SENT_28	[p2l1778t1267r2148b1368],
15	urea	NN	O	urea	dobj	12	SENT_28	[p2l10t1421r198b1474],
16	for	IN	O	for	_	0	SENT_28	[p2l229t1395r353b1474],
17	hyperproliferative	JJ	O	hyperproliferative	amod	18	SENT_28	[p2l382t1395r1156b1496],
18	manifestations	NNS	O	manifestation	prep_for	12	SENT_28	[p2l1188t1395r1840b1474],
19	of	IN	O	of	_	0	SENT_28	[p2l1875t1395r1976b1474],
20	myelofibrosis	NN	O	myelofibrosis	prep_of	18	SENT_28	[p2l1990t1421r2148b1496, p2l11t1523r491b1619],
21	,	,	O	,	_	0	SENT_28	[p2l1990t1421r2148b1496, p2l11t1523r491b1619],
22	including	VBG	O	include	_	0	SENT_28	[p2l525t1523r940b1624],
23	symptomatic	JJ	O	symptomatic	amod	24	SENT_28	[p2l967t1524r1529b1624],
24	splenomegaly	NN	O	splenomegaly	prep_including	12	SENT_28	[p2l1560t1523r2154b1624],
25	in	IN	O	in	_	0	SENT_28	[p2l10t1652r93b1729],
26	18	CD	NUMBER	18	num	27	SENT_28	[p2l131t1657r225b1730],
27	patients	NNS	O	patient	prep_in	24	SENT_28	[p2l260t1652r671b1752],
28	?	.	O	?	_	0	SENT_28	[p2l260t1652r671b1752],

1	These	DT	O	these	det	2	SENT_29	[p2l702t1651r955b1730],
2	patients	NNS	O	patient	nsubj	3	SENT_29	[p2l988t1652r1332b1752],
3	had	VBD	O	have	_	0	SENT_29	[p2l1368t1651r1526b1730],
4	less	RBR	O	less	advmod	5	SENT_29	[p2l1558t1651r1715b1730],
5	advanced	JJ	O	advanced	amod	7	SENT_29	[p2l1751t1651r2149b1730],
6	disease	NN	O	disease	nn	7	SENT_29	[p2l11t1779r323b1858],
7	(	NN	O	(	dobj	3	SENT_29	[p2l368t1779r720b1871],
8	median	JJ	O	median	amod	9	SENT_29	[p2l368t1779r720b1871],
9	time	NN	O	time	tmod	7	SENT_29	[p2l760t1780r954b1858],
10	from	IN	O	from	_	0	SENT_29	[p2l994t1779r1206b1858],
11	diagnosis	NN	O	diagnosis	prep_from	7	SENT_29	[p2l1246t1779r1685b1880],
12	,	,	O	,	_	0	SENT_29	[p2l1246t1779r1685b1880],
13	6	CD	DURATION	6	num	14	SENT_29	[p2l1730t1785r1777b1858],
14	months	NNS	NUMBER	month	conj_vs.	11	SENT_29	[p2l1817t1779r2147b1858],
15	vs.	CC	O	vs.	_	0	SENT_29	[p2l6t1934r115b1986],
16	6	CD	DURATION	6	num	17	SENT_29	[p2l153t1913r200b1986],
17	years	NNS	NUMBER	year	conj_vs.	11	SENT_29	[p2l228t1914r500b2008],
18	)	RB	O	)	advmod	3	SENT_29	[p2l228t1914r500b2008],
19	,	,	O	,	_	0	SENT_29	[p2l228t1914r500b2008],
20	and	CC	O	and	_	0	SENT_29	[p2l537t1907r696b1986],
21	only	RB	O	only	quantmod	22	SENT_29	[p2l728t1907r913b2008],
22	35	CD	PERCENT	35	num	23	SENT_29	[p2l941t1912r1123b1986],
23	%	NN	PERCENT	%	nsubj	26	SENT_29	[p2l941t1912r1123b1986],
24	of	IN	O	of	_	0	SENT_29	[p2l1155t1907r1256b1986],
25	patients	NNS	O	patient	prep_of	23	SENT_29	[p2l1267t1908r1611b2008],
26	had	VBD	O	have	conj_and	3	SENT_29	[p2l1645t1907r1803b1986],
27	splenomegaly	NN	O	splenomegaly	dobj	26	SENT_29	[p2l1835t1907r2148b2008, p2l10t2035r322b2136],
28	that	WDT	O	that	nsubj	30	SENT_29	[p2l361t2035r535b2114],
29	was	VBD	O	be	cop	30	SENT_29	[p2l569t2062r733b2114],
30	palpable	JJ	O	palpable	rcmod	27	SENT_29	[p2l777t2035r1141b2136],
31	10	CD	NUMBER	10	num	32	SENT_29	[p2l1188t2041r1282b2114],
32	cm	NN	O	cm	dep	30	SENT_29	[p2l1327t2061r1455b2114],
33	or	CC	O	or	cc	34	SENT_29	[p2l1500t2061r1589b2114],
34	more	JJR	O	more	npadvmod	30	SENT_29	[p2l1630t2061r1850b2114],
35	below	IN	O	below	_	0	SENT_29	[p2l1895t2035r2154b2115],
36	the	DT	O	the	det	38	SENT_29	[p2l11t2163r144b2242],
37	costal	JJ	O	costal	amod	38	SENT_29	[p2l180t2163r435b2242],
38	margin	NN	O	margin	prep_below	30	SENT_29	[p2l469t2164r811b2264],
39	,	,	O	,	_	0	SENT_29	[p2l469t2164r811b2264],
40	as	IN	O	as	_	0	SENT_29	[p2l851t2190r937b2242],
41	compared	VBN	O	compare	prepc_as	30	SENT_29	[p2l975t2163r1405b2264],
42	with	IN	O	with	pcomp	41	SENT_29	[p2l1435t2163r1632b2242],
43	91	CD	PERCENT	91	num	44	SENT_29	[p2l1667t2169r1846b2242],
44	%	NN	PERCENT	%	pobj	42	SENT_29	[p2l1667t2169r1846b2242],
45	of	IN	O	of	_	0	SENT_29	[p2l1882t2163r1982b2242],
46	140	CD	NUMBER	140	num	47	SENT_29	[p2l2002t2169r2149b2242],
47	patients	NNS	O	patient	prep_of	44	SENT_29	[p2l9t2292r345b2392],
48	in	IN	O	in	_	0	SENT_29	[p2l374t2292r456b2369],
49	the	DT	O	the	det	50	SENT_29	[p2l484t2291r615b2370],
50	study	NN	O	study	prep_in	47	SENT_29	[p2l644t2291r871b2392],
51	by	IN	O	by	_	0	SENT_29	[p2l894t2291r991b2392],
52	Verstovsek	NNP	PERSON	Verstovsek	prep_by	26	SENT_29	[p2l1010t2291r1465b2371],
53	and	CC	O	and	_	0	SENT_29	[p2l1487t2291r1643b2370],
54	colleagues	NNS	O	colleague	conj_and	52	SENT_29	[p2l1671t2291r2144b2392],
55	.	.	O	.	_	0	SENT_29	[p2l1671t2291r2144b2392],

1	Therefore	RB	O	therefore	advmod	8	SENT_30	[p2l7t2419r440b2515],
2	,	,	O	,	_	0	SENT_30	[p2l7t2419r440b2515],
3	these	DT	O	these	det	5	SENT_30	[p2l484t2419r705b2498],
4	two	CD	NUMBER	two	num	5	SENT_30	[p2l743t2436r900b2498],
5	studies	NNS	O	study	nsubj	8	SENT_30	[p2l941t2419r1236b2498],
6	are	VBP	O	be	cop	8	SENT_30	[p2l1275t2445r1403b2498],
7	hardly	RB	O	hardly	advmod	8	SENT_30	[p2l1441t2419r1712b2520],
8	comparable	JJ	O	comparable	_	0	SENT_30	[p2l1747t2445r2148b2520, p2l11t2547r157b2643],
9	,	,	O	,	_	0	SENT_30	[p2l1747t2445r2148b2520, p2l11t2547r157b2643],
10	and	CC	O	and	_	0	SENT_30	[p2l192t2547r351b2626],
11	the	DT	O	the	det	12	SENT_30	[p2l381t2547r515b2626],
12	value	NN	O	value	nsubj	21	SENT_30	[p2l540t2547r762b2626],
13	of	IN	O	of	_	0	SENT_30	[p2l792t2547r893b2626],
14	hydroxyurea	NN	O	hydroxyurea	prep_of	12	SENT_30	[p2l904t2547r1441b2648],
15	in	IN	O	in	_	0	SENT_30	[p2l1469t2548r1552b2625],
16	patients	NNS	O	patient	prep_in	14	SENT_30	[p2l1581t2548r1925b2648],
17	with	IN	O	with	_	0	SENT_30	[p2l1952t2547r2149b2626],
18	severe	JJ	O	severe	amod	19	SENT_30	[p2l12t2702r277b2754],
19	splenomegaly	NN	O	splenomegaly	prep_with	16	SENT_30	[p2l332t2675r940b2776],
20	remains	VBZ	O	remain	cop	21	SENT_30	[p2l989t2676r1345b2754],
21	unclear	JJ	O	unclear	conj_and	8	SENT_30	[p2l1401t2675r1750b2754],
22	.	.	O	.	_	0	SENT_30	[p2l1401t2675r1750b2754],

1	Anemia	NN	O	anemia	nsubj	2	SENT_31	[p2l1805t2676r2150b2754],
2	occurred	VBD	O	occur	_	0	SENT_31	[p2l11t2803r400b2882],
3	in	IN	O	in	_	0	SENT_31	[p2l453t2804r538b2881],
4	35	CD	PERCENT	35	num	5	SENT_31	[p2l592t2808r776b2882],
5	%	NN	PERCENT	%	prep_in	2	SENT_31	[p2l592t2808r776b2882],
6	of	IN	O	of	_	0	SENT_31	[p2l830t2803r932b2882],
7	patients	NNS	O	patient	prep_of	5	SENT_31	[p2l965t2804r1317b2904],
8	who	WP	O	who	nsubj	9	SENT_31	[p2l1367t2803r1554b2882],
9	received	VBD	O	receive	rcmod	7	SENT_31	[p2l1609t2803r1964b2883],
10	hydroxyurea	NN	O	hydroxyurea	dobj	9	SENT_31	[p2l2017t2803r2148b2904, p2l11t2931r447b3032],
11	as	IN	O	as	prep	9	SENT_31	[p2l480t2958r566b3010],
12	compared	VBN	O	compare	_	0	SENT_31	[p2l605t2931r1035b3032],
13	with	IN	O	with	prepc_compared_with	9	SENT_31	[p2l1066t2931r1262b3010],
14	8	CD	PERCENT	8	num	15	SENT_31	[p2l1299t2936r1434b3010],
15	%	NN	PERCENT	%	pobj	9	SENT_31	[p2l1299t2936r1434b3010],
16	of	IN	O	of	_	0	SENT_31	[p2l1470t2931r1570b3010],
17	patients	NNS	O	patient	prep_of	15	SENT_31	[p2l1587t2932r1930b3032],
18	who	WP	O	who	nsubj	19	SENT_31	[p2l1964t2931r2148b3011],
19	received	VBD	O	receive	rcmod	17	SENT_31	[p2l10t3059r368b3138],
20	the	DT	O	the	det	29	SENT_31	[p2l425t3059r561b3138],
21	most	RBS	O	most	advmod	22	SENT_31	[p2l618t3076r841b3138],
22	effective	JJ	O	effective	amod	29	SENT_31	[p2l894t3059r1265b3138],
23	15	CD	NUMBER	15	number	24	SENT_31	[p2l1326t3065r1607b3160],
24	—	CD	NUMBER	—	num	25	SENT_31	[p2l1326t3065r1607b3160],
25	mg	NN	O	mg	npadvmod	26	SENT_31	[p2l1326t3065r1607b3160],
26	twice	RB	O	twice	dep	22	SENT_31	[p2l1661t3059r2154b3160],
27	—	RB	O	—	dep	26	SENT_31	[p2l1661t3059r2154b3160],
28	daily	JJ	SET	daily	amod	29	SENT_31	[p2l1661t3059r2154b3160],
29	dose	NN	O	dose	dobj	19	SENT_31	[p2l11t3187r206b3266],
30	of	IN	O	of	_	0	SENT_31	[p2l243t3187r344b3266],
31	INCBO18424	NN	O	incbo18424	prep_of	29	SENT_31	[p2l359t3193r924b3266],
32	.	.	O	.	_	0	SENT_31	[p2l359t3193r924b3266],

1	The	DT	O	the	det	5	SENT_32	[p2l962t3187r1123b3266],
2	second	JJ	ORDINAL	second	amod	5	SENT_32	[p2l1161t3187r1460b3266],
3	Controlled	NNP	O	Controlled	nn	5	SENT_32	[p2l1495t3187r1956b3266],
4	Myelofibrosis	NNP	O	Myelofibrosis	nn	5	SENT_32	[p2l1989t3195r2148b3288, p2l11t3315r466b3394],
5	Study	NNP	O	Study	nsubj	10	SENT_32	[p2l516t3315r755b3416],
6	with	IN	O	with	_	0	SENT_32	[p2l791t3315r988b3395],
7	Oral	JJ	O	oral	amod	9	SENT_32	[p2l1033t3315r1221b3394],
8	JAK	NN	O	jak	nn	9	SENT_32	[p2l1255t3323r1429b3407],
9	Inhibitor	NN	O	inhibitor	prep_with	5	SENT_32	[p2l1469t3315r1859b3394],
10	Treatment	NN	O	treatment	_	0	SENT_32	[p2l1898t3321r2148b3394, p2l10t3460r236b3522],
11	(	CD	NUMBER	(	num	12	SENT_32	[p2l280t3449r903b3539],
12	COMFORT	NN	O	comfort	dobj	10	SENT_32	[p2l280t3449r903b3539],
13	.	.	O	.	_	0	SENT_32	[p2l280t3449r903b3539],

1	—	NN	O	—	_	0	SENT_33	[p2l280t3449r903b3539],
2	.	.	O	.	_	0	SENT_33	[p2l280t3449r903b3539],

1	II	CD	NUMBER	ii	_	0	SENT_34	[p2l280t3449r903b3539],
2	;	:	O	;	_	0	SENT_34	[p2l280t3449r903b3539],
3	ClinicalTrials	NNS	O	clinicaltrial	dep	1	SENT_34	[p2l952t3443r1738b3544],
4	.	.	O	.	_	0	SENT_34	[p2l952t3443r1738b3544],

1	gov	NN	O	gov	nn	2	SENT_35	[p2l952t3443r1738b3544],
2	number	NN	O	number	nsubj	13	SENT_35	[p2l1778t3443r2144b3539],
3	,	,	O	,	_	0	SENT_35	[p2l1778t3443r2144b3539],
4	NCTO0934544	NN	O	ncto0934544	nn	5	SENT_35	[p2l8t3578r659b3663],
5	)	NN	O	)	appos	2	SENT_35	[p2l8t3578r659b3663],
6	is	VBZ	O	be	cop	13	SENT_35	[p2l711t3573r777b3651],
7	an	DT	O	a	det	13	SENT_35	[p2l825t3598r929b3651],
8	ongoing	JJ	O	ongoing	amod	13	SENT_35	[p2l976t3573r1354b3673],
9	,	,	O	,	_	0	SENT_35	[p2l976t3573r1354b3673],
10	prospective	JJ	O	prospective	amod	13	SENT_35	[p2l1405t3573r1921b3673],
11	,	,	O	,	_	0	SENT_35	[p2l1405t3573r1921b3673],
12	randomized	JJ	O	randomized	amod	13	SENT_35	[p2l1974t3598r2148b3651, p2l11t3700r388b3779],
13	trial	NN	O	trial	_	0	SENT_35	[p2l430t3700r609b3779],
14	of	IN	O	of	_	0	SENT_35	[p2l651t3700r751b3779],
15	INCBO18424	NN	O	incbo18424	prep_of	13	SENT_35	[p2l773t3706r1315b3779],
16	as	IN	O	as	_	0	SENT_35	[p2l1356t3727r1442b3779],
17	compared	VBN	O	compare	prepc_as	13	SENT_35	[p2l1486t3700r1916b3801],
18	with	IN	O	with	pcomp	17	SENT_35	[p2l1952t3700r2149b3780],

1	“	RB	O	“	advmod	2	SENT_36	[p3l14t20r638b99],
2	best	JJS	O	best	amod	3	SENT_36	[p3l14t20r638b99],
3	—	NN	O	—	_	0	SENT_36	[p3l14t20r638b99],
4	available	JJ	O	available	amod	6	SENT_36	[p3l14t20r638b99],
5	therapy	NN	O	therapy	nn	6	SENT_36	[p3l674t20r1037b121],
6	”	NN	O	”	dep	3	SENT_36	[p3l674t20r1037b121],
7	in	IN	O	in	_	0	SENT_36	[p3l1076t21r1160b98],
8	219	CD	NUMBER	219	num	9	SENT_36	[p3l1195t26r1347b99],
9	patients	NNS	O	patient	prep_in	6	SENT_36	[p3l1381t21r1725b121],
10	with	IN	O	with	_	0	SENT_36	[p3l1758t20r1955b99],
11	myelofibrosis	NN	O	myelofibrosis	prep_with	9	SENT_36	[p3l1990t46r2148b121, p3l11t148r491b227],
12	.	.	O	.	_	0	SENT_36	[p3l1990t46r2148b121, p3l11t148r491b227],

1	It	PRP	O	it	nsubj	3	SENT_37	[p3l539t156r604b227],
2	is	VBZ	O	be	cop	3	SENT_37	[p3l643t149r710b227],
3	likely	JJ	O	likely	_	0	SENT_37	[p3l755t148r988b249],
4	that	IN	O	that	complm	12	SENT_37	[p3l1029t148r1202b227],
5	most	JJS	O	most	amod	6	SENT_37	[p3l1241t165r1460b227],
6	patients	NNS	O	patient	nsubj	12	SENT_37	[p3l1497t149r1841b249],
7	in	IN	O	in	_	0	SENT_37	[p3l1887t149r1971b226],
8	the	DT	O	the	det	10	SENT_37	[p3l2016t148r2149b227],
9	control	NN	O	control	nn	10	SENT_37	[p3l11t276r313b355],
10	group	NN	O	group	prep_in	6	SENT_37	[p3l347t302r597b377],
11	will	MD	O	will	aux	12	SENT_37	[p3l629t276r792b355],
12	receive	VB	O	receive	ccomp	3	SENT_37	[p3l826t277r1111b355],
13	hydroxyurea	NN	O	hydroxyurea	dobj	12	SENT_37	[p3l1146t276r1694b377],
14	;	:	O	;	_	0	SENT_37	[p3l1146t276r1694b377],
15	therefore	RB	O	therefore	advmod	20	SENT_37	[p3l1734t276r2144b372],
16	,	,	O	,	_	0	SENT_37	[p3l1734t276r2144b372],
17	this	DT	O	this	det	18	SENT_37	[p3l11t404r171b483],
18	trial	NN	O	trial	nsubj	20	SENT_37	[p3l219t404r399b483],
19	could	MD	O	could	aux	20	SENT_37	[p3l444t404r680b483],
20	generate	VB	O	generate	parataxis	3	SENT_37	[p3l725t421r1092b505],
21	controlled	VBN	O	control	amod	22	SENT_37	[p3l1137t404r1578b483],
22	information	NN	O	information	dobj	20	SENT_37	[p3l1622t404r2150b483],
23	about	IN	O	about	_	0	SENT_37	[p3l10t532r256b611],
24	the	DT	O	the	det	25	SENT_37	[p3l305t532r438b611],
25	efficacy	NN	O	efficacy	prep_about	22	SENT_37	[p3l493t532r832b633],
26	of	IN	O	of	_	0	SENT_37	[p3l882t532r983b611],
27	hydroxyurea	NN	O	hydroxyurea	prep_of	25	SENT_37	[p3l1019t532r1555b633],
28	and	CC	O	and	_	0	SENT_37	[p3l1607t532r1766b611],
29	allow	VB	O	allow	parataxis	3	SENT_37	[p3l1819t532r2057b612],
30	a	DT	O	a	det	31	SENT_37	[p3l2106t559r2150b611],
31	comparison	NN	O	comparison	dobj	29	SENT_37	[p3l11t661r525b761],
32	with	IN	O	with	_	0	SENT_37	[p3l555t660r751b739],
33	the	DT	O	the	det	37	SENT_37	[p3l787t660r921b739],
34	JAK1	NN	O	jak1	nn	37	SENT_37	[p3l946t666r1169b752],
35	and	CC	O	and	_	0	SENT_37	[p3l1204t660r1363b739],
36	JAK2	NN	O	jak2	conj_and	34	SENT_37	[p3l1388t666r1612b751],
37	inhibitors	NNS	O	inhibitor	prep_with	29	SENT_37	[p3l1647t660r2097b739],
38	.	.	O	.	_	0	SENT_37	[p3l1647t660r2097b739],

1	Alessandro	NNP	PERSON	Alessandro	nn	3	SENT_38	[p3l8t799r504b879],
2	M.	NNP	PERSON	M.	nn	3	SENT_38	[p3l545t806r648b879],
3	Vannucchi	NNP	PERSON	Vannucchi	_	0	SENT_38	[p3l682t799r1172b894],
4	,	,	O	,	_	0	SENT_38	[p3l682t799r1172b894],
5	M.D.	NNP	O	M.D.	appos	3	SENT_38	[p3l1218t806r1425b879],

1	University	NNP	ORGANIZATION	University	_	0	SENT_39	[p3l14t948r353b1023],
2	of	IN	ORGANIZATION	of	_	0	SENT_39	[p3l376t942r448b1004],
3	Florence	NNP	ORGANIZATION	Florence	nn	4	SENT_39	[p3l466t942r751b1004],
4	Florence	NNP	ORGANIZATION	Florence	prep_of	1	SENT_39	[p3l15t1029r318b1101],
5	,	,	O	,	_	0	SENT_39	[p3l15t1029r318b1101],
6	Italy	NNP	LOCATION	Italy	appos	4	SENT_39	[p3l351t1029r487b1110],

1	Since	IN	O	since	_	0	SENT_40	[p3l97t1129r269b1188],
2	publication	NN	O	publication	prep_since	9	SENT_40	[p3l295t1128r672b1205],
3	of	IN	O	of	_	0	SENT_40	[p3l700t1128r776b1188],
4	his	PRP$	O	he	poss	5	SENT_40	[p3l789t1129r885b1188],
5	article	NN	O	article	prep_of	2	SENT_40	[p3l913t1128r1139b1201],
6	,	,	O	,	_	0	SENT_40	[p3l913t1128r1139b1201],
7	the	DT	O	the	det	8	SENT_40	[p3l1170t1129r1272b1188],
8	author	NN	O	author	nsubj	9	SENT_40	[p3l1298t1129r1517b1188],
9	reports	VBZ	O	report	_	0	SENT_40	[p3l1541t1141r1778b1205],
10	no	DT	O	no	det	13	SENT_40	[p3l1807t1148r1887b1188],
11	further	JJ	O	further	amod	13	SENT_40	[p3l1915t1128r2153b1188],
12	potential	JJ	O	potential	amod	13	SENT_40	[p3l8t1215r308b1291],
13	conflict	NN	O	conflict	dobj	9	SENT_40	[p3l334t1214r594b1274],
14	of	IN	O	of	_	0	SENT_40	[p3l616t1214r693b1274],
15	interest	NN	O	interest	prep_of	13	SENT_40	[p3l704t1215r972b1274],
16	.	.	O	.	_	0	SENT_40	[p3l704t1215r972b1274],

1	1	LS	NUMBER	1	_	0	SENT_41	[p3l12t1324r62b1375],
2	.	.	O	.	_	0	SENT_41	[p3l12t1324r62b1375],

1	Mesa	NNP	LOCATION	Mesa	nn	2	SENT_42	[p3l137t1321r312b1375],
2	RA	NN	LOCATION	ra	_	0	SENT_42	[p3l335t1321r455b1387],
3	,	,	O	,	_	0	SENT_42	[p3l335t1321r455b1387],
4	Barosi	NN	O	barosus	nn	5	SENT_42	[p3l482t1317r696b1375],
5	G	NN	O	g	appos	2	SENT_42	[p3l720t1320r792b1388],
6	,	,	O	,	_	0	SENT_42	[p3l720t1320r792b1388],
7	Cervantes	NNP	PERSON	Cervantes	nn	8	SENT_42	[p3l821t1320r1151b1376],
8	F	NN	O	f	appos	2	SENT_42	[p3l1176t1321r1229b1388],
9	,	,	O	,	_	0	SENT_42	[p3l1176t1321r1229b1388],
10	Reilly	NNP	PERSON	Reilly	nn	11	SENT_42	[p3l1257t1316r1451b1391],
11	JT	NNP	O	JT	appos	2	SENT_42	[p3l1464t1321r1555b1388],
12	,	,	O	,	_	0	SENT_42	[p3l1464t1321r1555b1388],
13	Tefferi	NNP	LOCATION	Tefferi	nn	15	SENT_42	[p3l1581t1316r1806b1375],
14	A.	NNP	O	A.	nn	15	SENT_42	[p3l1827t1321r1895b1375],
15	Myelo	NNP	O	Myelo	appos	2	SENT_42	[p3l1922t1316r2149b1391],
16	—	CD	NUMBER	—	num	17	SENT_42	[p3l1922t1316r2149b1391],
17	fibrosis	NN	O	fibrosis	dep	15	SENT_42	[p3l9t1401r266b1461],
18	with	IN	O	with	_	0	SENT_42	[p3l302t1401r454b1462],
19	myeloid	JJ	O	myeloid	amod	20	SENT_42	[p3l492t1401r756b1477],
20	metaplasia	NN	O	metaplasium	prep_with	2	SENT_42	[p3l794t1401r1179b1477],
21	:	:	O	:	_	0	SENT_42	[p3l794t1401r1179b1477],
22	disease	NN	O	disease	nn	23	SENT_42	[p3l1221t1401r1465b1461],
23	overview	NN	O	overview	dep	2	SENT_42	[p3l1504t1402r1802b1461],
24	and	CC	O	and	_	0	SENT_42	[p3l1837t1401r1959b1461],
25	nontransplant	JJ	O	nontransplant	amod	26	SENT_42	[p3l1997t1421r2149b1461, p3l10t1486r362b1561],
26	options	NNS	O	option	conj_and	23	SENT_42	[p3l385t1487r658b1561],
27	.	.	O	.	_	0	SENT_42	[p3l385t1487r658b1561],

1	Best	JJS	O	best	amod	2	SENT_43	[p3l687t1491r832b1545],
2	Pract	NN	O	pract	_	0	SENT_43	[p3l853t1491r1026b1545],
3	Res	NNP	O	Res	nn	5	SENT_43	[p3l1047t1491r1165b1548],
4	Clin	NNP	O	Clin	nn	5	SENT_43	[p3l1193t1486r1331b1545],
5	Haematol	NNP	O	Haematol	dep	2	SENT_43	[p3l1358t1486r1686b1545],
6	2006	CD	DATE	2006	num	8	SENT_43	[p3l1712t1490r2149b1557, p3l11t1587r135b1642],
7	;	:	O	;	_	0	SENT_43	[p3l1712t1490r2149b1557, p3l11t1587r135b1642],
8	19:495517	CD	NUMBER	19:495517	dep	5	SENT_43	[p3l1712t1490r2149b1557, p3l11t1587r135b1642],
9	.	.	O	.	_	0	SENT_43	[p3l1712t1490r2149b1557, p3l11t1587r135b1642],

1	2	LS	NUMBER	2	_	0	SENT_44	[p3l8t1677r62b1728],
2	.	.	O	.	_	0	SENT_44	[p3l8t1677r62b1728],

1	Martinez-Trillos	NNP	O	Martinez-Trillos	nn	2	SENT_45	[p3l137t1668r678b1729],
2	A	NNP	O	A	_	0	SENT_45	[p3l710t1675r777b1742],
3	,	,	O	,	_	0	SENT_45	[p3l710t1675r777b1742],
4	Gaya	NNP	LOCATION	Gaya	nn	5	SENT_45	[p3l815t1674r976b1745],
5	A	NNP	O	A	appos	2	SENT_45	[p3l1005t1675r1072b1742],
6	,	,	O	,	_	0	SENT_45	[p3l1005t1675r1072b1742],
7	Maffioli	NNP	O	Maffioli	nn	8	SENT_45	[p3l1107t1669r1381b1729],
8	M	NNP	O	M	appos	2	SENT_45	[p3l1411t1675r1494b1741],
9	,	,	O	,	_	0	SENT_45	[p3l1411t1675r1494b1741],
10	et	FW	O	et	nn	11	SENT_45	[p3l1531t1682r1591b1728],
11	al.	FW	O	al.	appos	2	SENT_45	[p3l1620t1669r1695b1729],
12	.	.	O	.	_	0	SENT_45	[p3l1620t1669r1695b1729],

1	Efficacy	NN	O	efficacy	_	0	SENT_46	[p3l1731t1669r2000b1745],
2	and	CC	O	and	_	0	SENT_46	[p3l2029t1669r2150b1729],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_46	[p3l10t1757r373b1833],
4	of	IN	O	of	_	0	SENT_46	[p3l402t1757r478b1817],
5	hydroxyurea	NN	O	hydroxyurea	prep_of	1	SENT_46	[p3l496t1757r907b1833],
6	in	IN	O	in	_	0	SENT_46	[p3l938t1758r1002b1816],
7	the	DT	O	the	det	8	SENT_46	[p3l1034t1757r1136b1816],
8	treatment	NN	O	treatment	prep_in	5	SENT_46	[p3l1168t1770r1496b1816],
9	of	IN	O	of	_	0	SENT_46	[p3l1524t1757r1600b1817],
10	the	DT	O	the	det	12	SENT_46	[p3l1619t1757r1721b1816],
11	hyperproliferative	JJ	O	hyperproliferative	amod	12	SENT_46	[p3l1753t1757r2149b1833, p3l10t1846r226b1905],
12	manifestations	NNS	O	manifestation	prep_of	8	SENT_46	[p3l259t1845r759b1904],
13	of	IN	O	of	_	0	SENT_46	[p3l795t1845r872b1904],
14	myelofibrosis	NN	O	myelofibrosis	prep_of	12	SENT_46	[p3l892t1845r1362b1920],
15	:	:	O	:	_	0	SENT_46	[p3l892t1845r1362b1920],
16	results	NNS	O	result	dep	1	SENT_46	[p3l1399t1845r1618b1905],
17	in	IN	O	in	_	0	SENT_46	[p3l1653t1846r1717b1903],
18	40	CD	NUMBER	40	num	19	SENT_46	[p3l1749t1850r1829b1904],
19	patients	NNS	O	patient	prep_in	16	SENT_46	[p3l1862t1846r2145b1920],
20	.	.	O	.	_	0	SENT_46	[p3l1862t1846r2145b1920],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_47	[p3l6t1936r147b1989],
2	Hematol	NNP	PERSON	Hematol	_	0	SENT_47	[p3l172t1931r456b1990],
3	2010	CD	DATE	2010	num	2	SENT_47	[p3l482t1935r636b1990],
4	June	NNP	DATE	June	tmod	2	SENT_47	[p3l655t1936r803b2000],
5	22	CD	DATE	22	num	4	SENT_47	[p3l830t1935r907b1989],
6	(	CD	NUMBER	(	num	7	SENT_47	[p3l937t1931r1126b2006],
7	Epub	NN	O	epub	npadvmod	2	SENT_47	[p3l937t1931r1126b2006],
8	ahead	RB	O	ahead	_	0	SENT_47	[p3l1153t1931r1348b1990],
9	of	IN	O	of	_	0	SENT_47	[p3l1374t1931r1451b1990],
10	print	NN	O	print	nn	11	SENT_47	[p3l1461t1932r1664b2006],
11	)	NN	O	)	prep_ahead_of	2	SENT_47	[p3l1461t1932r1664b2006],
12	.	.	O	.	_	0	SENT_47	[p3l1461t1932r1664b2006],

1	Dosing	NN	O	dosing	nn	4	SENT_48	[p3l246t2083r430b2145],
2	ofC	NN	O	ofc	nn	4	SENT_48	[p3l449t2081r815b2145],
3	|	NN	O	|	nn	4	SENT_48	[p3l449t2081r815b2145],
4	opidogre	NN	O	opidogre	_	0	SENT_48	[p3l449t2081r815b2145],
5	|	NN	O	|	dep	4	SENT_48	[p3l449t2081r815b2145],
6	and	CC	O	and	_	0	SENT_48	[p3l838t2081r931b2130],
7	Aspirin	NN	O	aspirin	dep	4	SENT_48	[p3l953t2083r1136b2144],
8	in	IN	O	in	_	0	SENT_48	[p3l1161t2083r1204b2129],
9	Acute	JJ	O	acute	amod	10	SENT_48	[p3l1226t2086r1375b2130],
10	Coronary	JJ	O	coronary	prep_in	5	SENT_48	[p3l1395t2085r1633b2145],

1	Syndromes	NNS	O	syndrome	_	0	SENT_49	[p3l792t2156r1082b2220],

1	To	TO	O	to	_	0	SENT_50	[p3l94t2279r137b2300],
2	THE	DT	O	the	det	3	SENT_50	[p3l151t2279r214b2300],
3	EDITOR	NN	O	editor	pobj	1	SENT_50	[p3l231t2279r362b2300],
4	:	:	O	:	_	0	SENT_50	[p3l231t2279r362b2300],
5	In	IN	O	in	_	0	SENT_50	[p3l377t2273r412b2300],
6	reporting	VBG	O	report	prepc_in	3	SENT_50	[p3l427t2270r586b2309],
7	on	IN	O	on	_	0	SENT_50	[p3l600t2280r641b2301],
8	the	DT	O	the	det	10	SENT_50	[p3l656t2270r708b2300],
9	Clopidogrel	NNP	MISC	Clopidogrel	nn	10	SENT_50	[p3l723t2270r918b2309],
10	fit	NN	O	fit	prep_on	6	SENT_50	[p3l957t2270r997b2300],
11	from	IN	O	from	_	0	SENT_50	[p3l1013t2270r1096b2301],
12	double	JJ	O	double	amod	13	SENT_50	[p3l1114t2270r1227b2301],
13	doses	NNS	O	dose	prep_from	10	SENT_50	[p3l1246t2270r1339b2301],
14	of	IN	O	of	_	0	SENT_50	[p3l1358t2270r1398b2301],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_50	[p3l1409t2270r1600b2309],
16	or	CC	O	or	_	0	SENT_50	[p3l1618t2280r1653b2301],
17	higher	JJR	O	higher	conj_or	13	SENT_50	[p3l1670t2270r1781b2309],
18	and	CC	O	and	_	0	SENT_50	[p3l94t2319r154b2350],
19	Aspirin	NNP	O	Aspirin	nn	22	SENT_50	[p3l164t2319r283b2358],
20	Optimal	JJ	O	optimal	amod	22	SENT_50	[p3l294t2319r428b2358],
21	Dose	NN	O	dose	nn	22	SENT_50	[p3l439t2322r519b2350],
22	Usage	NN	O	usage	conj_or	13	SENT_50	[p3l531t2322r627b2358],
23	to	TO	O	to	aux	24	SENT_50	[p3l639t2326r670b2350],
24	Reduce	VB	O	reduce	xcomp	6	SENT_50	[p3l681t2319r797b2351],
25	Recur	NNP	O	Recur	nn	27	SENT_50	[p3l808t2322r917b2351],
26	—	CD	NUMBER	—	num	27	SENT_50	[p3l808t2322r917b2351],
27	doses	NNS	O	dose	dobj	24	SENT_50	[p3l958t2319r1049b2350],
28	of	IN	O	of	_	0	SENT_50	[p3l1062t2319r1101b2350],
29	aspirin	NN	O	aspirin	prep_of	27	SENT_50	[p3l1105t2319r1221b2358],
30	instead	RB	O	instead	_	0	SENT_50	[p3l1232t2319r1352b2350],
31	of	IN	O	of	_	0	SENT_50	[p3l1364t2319r1403b2350],
32	lower	JJR	O	lower	amod	33	SENT_50	[p3l1406t2319r1499b2350],
33	doses	NNS	O	dose	prep_instead_of	3	SENT_50	[p3l1509t2319r1611b2350],
34	.	.	O	.	_	0	SENT_50	[p3l1509t2319r1611b2350],

1	This	DT	O	this	_	0	SENT_51	[p3l1623t2319r1695b2349],
2	negrent	JJ	O	negrent	amod	3	SENT_51	[p3l1708t2329r1780b2358, p3l94t2374r160b2398],
3	Events	NNS	O	event	dep	1	SENT_51	[p3l168t2368r426b2399],
4	.	.	O	.	_	0	SENT_51	[p3l168t2368r426b2399],

1	—	NN	O	—	_	0	SENT_52	[p3l168t2368r426b2399],
2	.	.	O	.	_	0	SENT_52	[p3l168t2368r426b2399],

1	Seventh	NNP	ORDINAL	Seventh	nn	2	SENT_53	[p3l168t2368r426b2399],
2	Organization	NNP	O	Organization	nsubj	19	SENT_53	[p3l437t2368r655b2407],
3	to	TO	O	to	aux	4	SENT_53	[p3l666t2374r697b2399],
4	Assess	VB	O	assess	infmod	2	SENT_53	[p3l707t2371r815b2398],
5	Strat	NNP	O	Strat	dobj	4	SENT_53	[p3l827t2370r917b2399],
6	—	CD	NUMBER	—	num	8	SENT_53	[p3l827t2370r917b2399],
7	ative	JJ	O	ative	amod	8	SENT_53	[p3l957t2368r1031b2399],
8	message	NN	O	message	nsubjpass	11	SENT_53	[p3l1041t2378r1181b2407],
9	was	VBD	O	be	auxpass	11	SENT_53	[p3l1189t2378r1252b2399],
10	partly	RB	O	partly	advmod	11	SENT_53	[p3l1262t2368r1359b2407],
11	attenuated	VBN	O	attenuate	rcmod	5	SENT_53	[p3l1367t2368r1539b2399],
12	by	IN	O	by	_	0	SENT_53	[p3l1550t2368r1587b2407],
13	the	DT	O	the	det	15	SENT_53	[p3l1596t2368r1647b2398],
14	finding	NN	O	finding	nn	15	SENT_53	[p3l1657t2368r1782b2407],
15	egies	NNS	O	egy	agent	11	SENT_53	[p3l95t2417r174b2456],
16	in	IN	O	in	_	0	SENT_53	[p3l184t2417r216b2447],
17	Ischemic	JJ	O	ischemic	amod	18	SENT_53	[p3l225t2417r368b2447],
18	Syndromes	NNS	O	syndrome	prep_in	15	SENT_53	[p3l378t2417r555b2456],
19	(	VBP	O	(	_	0	SENT_53	[p3l567t2419r875b2452],
20	CURRENT-OASIS	NN	O	current-oasis	dobj	19	SENT_53	[p3l567t2419r875b2452],
21	7	CD	NUMBER	7	num	22	SENT_53	[p3l886t2420r915b2452],
22	)	NN	O	)	npadvmod	23	SENT_53	[p3l886t2420r915b2452],
23	that	IN	O	that	advmod	19	SENT_53	[p3l957t2417r1032b2454],
24	,	,	O	,	_	0	SENT_53	[p3l957t2417r1032b2454],
25	in	IN	O	in	_	0	SENT_53	[p3l1051t2417r1083b2447],
26	the	DT	O	the	det	28	SENT_53	[p3l1100t2417r1151b2447],
27	large	JJ	O	large	amod	28	SENT_53	[p3l1167t2417r1250b2456],
28	subgroup	NN	O	subgroup	prep_in	19	SENT_53	[p3l1267t2417r1424b2456],
29	of	IN	O	of	_	0	SENT_53	[p3l1441t2417r1480b2448],
30	patients	NNS	O	patient	prep_of	28	SENT_53	[p3l1489t2418r1621b2456],
31	who	WP	O	who	dep	34	SENT_53	[p3l1637t2417r1708b2448],
32	untrial	JJ	O	untrial	amod	34	SENT_53	[p3l1725t2427r1780b2448, p3l95t2466r164b2496],
33	(	NN	O	(	nn	34	SENT_53	[p3l183t2466r488b2505],
34	ClinicalTrials	NNS	O	clinicaltrial	rcmod	28	SENT_53	[p3l183t2466r488b2505],
35	.	.	O	.	_	0	SENT_53	[p3l183t2466r488b2505],

1	gov	NN	O	gov	nn	2	SENT_54	[p3l183t2466r488b2505],
2	number	NN	O	number	_	0	SENT_54	[p3l504t2466r642b2503],
3	,	,	O	,	_	0	SENT_54	[p3l504t2466r642b2503],
4	NCT00335452	NN	O	nct00335452	nn	5	SENT_54	[p3l660t2468r915b2503],
5	)	NN	O	)	appos	2	SENT_54	[p3l660t2468r915b2503],
6	,	,	O	,	_	0	SENT_54	[p3l660t2468r915b2503],
7	derwent	NN	O	derwent	nn	13	SENT_54	[p3l958t2466r1088b2497],
8	percutaneous	JJ	O	percutaneous	amod	13	SENT_54	[p3l1098t2473r1313b2505],
9	coronary	JJ	O	coronary	amod	13	SENT_54	[p3l1326t2476r1469b2505],
10	intervention	NN	O	intervention	nn	13	SENT_54	[p3l1479t2466r1674b2497],
11	(	CD	NUMBER	(	num	13	SENT_54	[p3l1687t2468r1778b2503],
12	PCI	NN	O	pcus	nn	13	SENT_54	[p3l1687t2468r1778b2503],
13	)	NN	O	)	appos	2	SENT_54	[p3l1687t2468r1778b2503],
14	,	,	O	,	_	0	SENT_54	[p3l1687t2468r1778b2503],
15	Mehta	NNP	PERSON	Mehta	appos	2	SENT_54	[p3l93t2515r200b2545],
16	et	FW	O	et	nn	17	SENT_54	[p3l218t2522r248b2545],
17	al.	FW	O	al.	dep	15	SENT_54	[p3l264t2515r303b2546],
18	(	FW	O	(	dep	19	SENT_54	[p3l324t2517r416b2554],
19	Sept.	NNP	DATE	Sept.	rcmod	17	SENT_54	[p3l324t2517r416b2554],
20	2	CD	DATE	2	num	19	SENT_54	[p3l436t2517r455b2545],
21	issue	NN	O	issue	nn	22	SENT_54	[p3l473t2515r583b2550],
22	)	NN	O	)	dep	17	SENT_54	[p3l473t2515r583b2550],
23	1	CD	NUMBER	1	num	24	SENT_54	[p3l473t2515r583b2550],
24	state	NN	O	state	dep	22	SENT_54	[p3l601t2521r680b2545],
25	that	WDT	O	that	dobj	38	SENT_54	[p3l698t2515r766b2545],
26	patients	NNS	O	patient	nsubj	38	SENT_54	[p3l781t2515r917b2554],
27	doubling	VBG	O	double	partmod	26	SENT_54	[p3l958t2515r1108b2554],
28	the	DT	O	the	det	29	SENT_54	[p3l1122t2515r1173b2545],
29	dose	NN	O	dose	nsubjpass	33	SENT_54	[p3l1189t2515r1265b2546],
30	of	IN	O	of	_	0	SENT_54	[p3l1280t2515r1319b2546],
31	clopidogrel	NN	O	clopidogrel	prep_of	29	SENT_54	[p3l1328t2515r1515b2554],
32	was	VBD	O	be	auxpass	33	SENT_54	[p3l1529t2525r1592b2546],
33	associated	VBN	O	associate	ccomp	27	SENT_54	[p3l1608t2515r1780b2546],
34	with	IN	O	with	_	0	SENT_54	[p3l93t2564r169b2595],
35	acute	JJ	O	acute	amod	37	SENT_54	[p3l183t2570r269b2595],
36	coronary	JJ	O	coronary	amod	37	SENT_54	[p3l284t2574r434b2603],
37	syndromes	NNS	O	syndrome	prep_with	33	SENT_54	[p3l447t2564r627b2603],
38	gained	VBD	O	gain	dep	2	SENT_54	[p3l643t2564r755b2603],
39	no	DT	O	no	det	41	SENT_54	[p3l770t2574r811b2595],
40	bene	NN	O	bene	nn	41	SENT_54	[p3l826t2564r917b2595],
41	—	NN	O	—	dobj	38	SENT_54	[p3l826t2564r917b2595],
42	with	IN	O	with	_	0	SENT_54	[p3l955t2564r1031b2595],
43	a	DT	O	a	det	45	SENT_54	[p3l1048t2574r1065b2594],
44	significant	JJ	O	significant	amod	45	SENT_54	[p3l1082t2564r1263b2603],
45	reduction	NN	O	reduction	prep_with	38	SENT_54	[p3l1278t2564r1437b2595],
46	in	IN	O	in	_	0	SENT_54	[p3l1453t2564r1485b2594],
47	the	DT	O	the	det	49	SENT_54	[p3l1502t2564r1554b2594],
48	primary	JJ	O	primary	amod	49	SENT_54	[p3l1570t2564r1706b2603],
49	end	NN	O	end	prep_in	38	SENT_54	[p3l1721t2564r1780b2595],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_55	[p3l588t2689r695b2711],
2	MEo363	NN	O	meo363	_	0	SENT_55	[p3l710t2683r848b2711],
3	;	:	O	;	_	0	SENT_55	[p3l710t2683r848b2711],
4	25	CD	NUMBER	25	num	6	SENT_55	[p3l710t2683r848b2711],
5	NEjM.ORG	NN	O	nejm.org	nn	6	SENT_55	[p3l884t2689r1008b2711],
6	DEcEMBER16	NN	O	december16	dep	2	SENT_55	[p3l1045t2683r1289b2709],
7	,2	CD	NUMBER	,2	number	8	SENT_55	[p3l1045t2683r1289b2709],
8	o1o	CD	NUMBER	o1o	num	9	SENT_55	[p3l1045t2683r1289b2709],
9	2455	CD	DATE	2455	dep	6	SENT_55	[p3l1991t2678r2066b2702],

1	The	DT	O	the	det	4	SENT_56	[p3l753t2746r804b2770],
2	New	NNP	O	New	nn	4	SENT_56	[p3l813t2747r875b2770],
3	England	NNP	O	England	nn	4	SENT_56	[p3l884t2746r995b2777],
4	Journal	NNP	O	Journal	_	0	SENT_56	[p3l1004t2746r1101b2770],
5	of	IN	O	of	_	0	SENT_56	[p3l1111t2746r1140b2770],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_56	[p3l1146t2746r1271b2770],

1	The	DT	O	the	det	4	SENT_57	[p3l673t2934r718b2955],
2	NEW	NNP	O	NEW	nn	4	SENT_57	[p3l737t2936r822b2955],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_57	[p3l841t2936r1029b2955],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_57	[p3l1048t2936r1227b2962],
5	of	IN	O	of	_	0	SENT_57	[p3l1247t2934r1275b2961],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_57	[p3l1287t2936r1486b2955],

1	point	NN	O	point	_	0	SENT_58	[p3l15t3157r254b3257],
2	.	.	O	.	_	0	SENT_58	[p3l15t3157r254b3257],

1	However	RB	O	however	advmod	11	SENT_59	[p3l292t3164r671b3252],
2	,	,	O	,	_	0	SENT_59	[p3l292t3164r671b3252],
3	for	IN	O	for	_	0	SENT_59	[p3l709t3156r828b3235],
4	statistical	JJ	O	statistical	amod	5	SENT_59	[p3l858t3156r1252b3235],
5	reasons	NNS	O	reason	prep_for	11	SENT_59	[p3l1284t3182r1620b3252],
6	,	,	O	,	_	0	SENT_59	[p3l1284t3182r1620b3252],
7	the	DT	O	the	det	8	SENT_59	[p3l1658t3156r1786b3235],
8	authors	NNS	O	author	nsubj	11	SENT_59	[p3l1818t3156r2136b3235],
9	could	MD	O	could	aux	11	SENT_59	[p3l16t3275r251b3354],
10	not	RB	O	not	neg	11	SENT_59	[p3l280t3292r423b3354],
11	rule	VB	O	rule	_	0	SENT_59	[p3l447t3275r613b3354],
12	out	RP	O	out	prt	11	SENT_59	[p3l644t3292r783b3354],
13	the	DT	O	the	det	14	SENT_59	[p3l808t3275r940b3354],
14	possibility	NN	O	possibility	dobj	11	SENT_59	[p3l969t3275r1418b3376],
15	that	IN	O	that	complm	20	SENT_59	[p3l1444t3275r1616b3354],
16	these	DT	O	these	det	18	SENT_59	[p3l1641t3275r1865b3354],
17	favorable	JJ	O	favorable	amod	18	SENT_59	[p3l1894t3275r2137b3354, p3l15t3394r185b3473],
18	results	NNS	O	result	nsubj	20	SENT_59	[p3l224t3394r506b3473],
19	were	VBD	O	be	cop	20	SENT_59	[p3l542t3421r744b3473],
20	due	JJ	O	due	ccomp	11	SENT_59	[p3l782t3394r931b3473],
21	to	TO	O	to	_	0	SENT_59	[p3l970t3411r1052b3473],
22	chance	NN	O	chance	prep_to	20	SENT_59	[p3l1091t3394r1411b3473],
23	.	.	O	.	_	0	SENT_59	[p3l1091t3394r1411b3473],

1	Specific	JJ	O	specific	amod	3	SENT_60	[p3l1457t3394r1794b3495],
2	genetic	JJ	O	genetic	amod	3	SENT_60	[p3l1831t3395r2139b3495],
3	factors2	NN	O	factors2	nsubj	15	SENT_60	[p3l16t3513r344b3592],
4	and	CC	O	and	_	0	SENT_60	[p3l386t3513r544b3592],
5	drug	NN	O	drug	nn	6	SENT_60	[p3l586t3513r790b3614],
6	interactions3	NN	O	interactions3	nsubj	8	SENT_60	[p3l829t3514r1375b3592],
7	can	MD	O	can	aux	8	SENT_60	[p3l1420t3539r1569b3592],
8	limit	VB	O	limit	_	0	SENT_60	[p3l1610t3513r1819b3592],
9	the	DT	O	the	det	10	SENT_60	[p3l1857t3513r1990b3592],
10	efficacy	NN	O	efficacy	dobj	8	SENT_60	[p3l2033t3513r2137b3592, p3l16t3632r268b3733],
11	of	IN	O	of	_	0	SENT_60	[p3l313t3632r413b3711],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_60	[p3l444t3632r927b3733],
13	and	CC	O	and	_	0	SENT_60	[p3l974t3632r1155b3728],
14	,	,	O	,	_	0	SENT_60	[p3l974t3632r1155b3728],
15	according	VBG	O	accord	conj_and	8	SENT_60	[p3l1209t3632r1635b3733],
16	to	TO	O	to	pcomp	15	SENT_60	[p3l1681t3649r1762b3711],
17	in	FW	O	in	nn	18	SENT_60	[p3l1811t3633r1894b3710],
18	vitro	FW	O	vitro	advmod	32	SENT_60	[p3l1939t3633r2137b3711],
19	laboratory	NN	O	laboratory	nn	20	SENT_60	[p4l15t16r461b117],
20	tests	NNS	O	test	nsubj	32	SENT_60	[p4l500t33r718b112],
21	,	,	O	,	_	0	SENT_60	[p4l500t33r718b112],
22	the	DT	O	the	det	23	SENT_60	[p4l767t16r899b95],
23	prevalence	NN	O	prevalence	appos	20	SENT_60	[p4l940t16r1394b117],
24	of	IN	O	of	_	0	SENT_60	[p4l1437t16r1537b95],
25	a	DT	O	a	det	27	SENT_60	[p4l1560t43r1604b95],
26	reduced	VBN	O	reduce	amod	27	SENT_60	[p4l1645t16r1982b95],
27	response	NN	O	response	prep_of	23	SENT_60	[p4l2024t42r2137b95, p4l17t161r317b236],
28	to	TO	O	to	_	0	SENT_60	[p4l356t152r439b214],
29	clopidogrel	NN	O	clopidogrel	prep_to	27	SENT_60	[p4l479t135r973b236],
30	is	VBZ	O	be	cop	32	SENT_60	[p4l1010t136r1077b214],
31	21	CD	NUMBER	21	number	32	SENT_60	[p4l1117t140r1368b214],
32	°	CD	NUMBER	°	dep	40	SENT_60	[p4l1117t140r1368b214],
33	/	:	O	/	punct	34	SENT_60	[p4l1117t140r1368b214],
34	o.	NN	O	o.	dep	32	SENT_60	[p4l1117t140r1368b214],
35	4	CD	NUMBER	4	num	34	SENT_60	[p4l1117t140r1368b214],
36	Thus	RB	O	thus	advmod	32	SENT_60	[p4l1402t135r1642b231],
37	,	,	O	,	_	0	SENT_60	[p4l1402t135r1642b231],
38	one	NN	NUMBER	one	nsubj	40	SENT_60	[p4l1687t161r1840b214],
39	might	MD	O	might	aux	40	SENT_60	[p4l1879t135r2143b236],
40	anticipate	VB	O	anticipate	pobj	16	SENT_60	[p4l15t255r434b355],
41	that	DT	O	that	det	43	SENT_60	[p4l480t254r652b333],
42	high	JJ	O	high	amod	43	SENT_60	[p4l691t254r886b355],
43	doses	NNS	O	dose	nsubj	47	SENT_60	[p4l931t254r1168b333],
44	could	MD	O	could	aux	47	SENT_60	[p4l1215t254r1449b333],
45	be	VB	O	be	cop	47	SENT_60	[p4l1494t254r1590b333],
46	more	RBR	O	more	advmod	47	SENT_60	[p4l1635t280r1854b333],
47	effective	JJ	O	effective	ccomp	40	SENT_60	[p4l1899t254r2137b333, p4l16t374r163b452],
48	than	IN	O	than	_	0	SENT_60	[p4l204t373r401b452],
49	lower	JJR	O	lower	amod	50	SENT_60	[p4l440t373r678b452],
50	doses	NNS	O	dose	prep_than	47	SENT_60	[p4l716t373r953b452],
51	in	IN	O	in	_	0	SENT_60	[p4l995t374r1078b451],
52	this	DT	O	this	det	54	SENT_60	[p4l1119t373r1278b452],
53	limited	JJ	O	limited	amod	54	SENT_60	[p4l1320t373r1628b452],
54	population	NN	O	population	prep_in	50	SENT_60	[p4l1667t373r2138b474],
55	of	IN	O	of	_	0	SENT_60	[p4l16t492r117b571],
56	patients	NNS	O	patient	prep_of	54	SENT_60	[p4l129t493r471b593],
57	who	WP	O	who	nsubj	60	SENT_60	[p4l502t492r684b571],
58	do	VBP	O	do	aux	60	SENT_60	[p4l720t492r822b571],
59	not	RB	O	not	neg	60	SENT_60	[p4l857t509r1000b571],
60	have	VB	O	have	rcmod	56	SENT_60	[p4l1027t492r1217b571],
61	a	DT	O	a	det	62	SENT_60	[p4l1250t519r1294b571],
62	response	NN	O	response	dobj	60	SENT_60	[p4l1326t518r1731b593],
63	;	:	O	;	_	0	SENT_60	[p4l1326t518r1731b593],
64	this	DT	DATE	this	nsubj	66	SENT_60	[p4l1769t492r1928b571],
65	may	MD	DATE	may	aux	66	SENT_60	[p4l1963t518r2142b593],
66	explain	VB	O	explain	parataxis	40	SENT_60	[p4l16t611r336b712],
67	the	DT	O	the	det	69	SENT_60	[p4l382t611r517b690],
68	negative	JJ	O	negative	amod	69	SENT_60	[p4l563t612r923b712],
69	results	NNS	O	result	dobj	66	SENT_60	[p4l970t611r1259b690],
70	in	IN	O	in	_	0	SENT_60	[p4l1307t612r1391b689],
71	the	DT	O	the	det	74	SENT_60	[p4l1437t611r1572b690],
72	overall	JJ	O	overall	amod	74	SENT_60	[p4l1619t611r1911b691],
73	trial	NN	O	trial	nn	74	SENT_60	[p4l1956t611r2138b690],
74	population	NN	O	population	prep_in	69	SENT_60	[p4l15t730r486b831],
75	and	CC	O	and	_	0	SENT_60	[p4l530t730r688b809],
76	the	DT	O	the	det	80	SENT_60	[p4l733t730r866b809],
77	positive	JJ	O	positive	amod	80	SENT_60	[p4l910t731r1241b831],
78	but	CC	O	but	_	0	SENT_60	[p4l1287t730r1427b809],
79	uncertain	JJ	O	uncertain	conj_but	77	SENT_60	[p4l1467t731r1882b809],
80	findings	NNS	O	finding	pobj	16	SENT_60	[p4l1927t730r2137b809, p4l15t850r194b950],
81	in	IN	O	in	_	0	SENT_60	[p4l226t850r310b927],
82	the	DT	O	the	det	84	SENT_60	[p4l341t849r473b928],
83	PCI	NN	O	pcus	nn	84	SENT_60	[p4l503t855r652b928],
84	subgroup	NN	O	subgroup	prep_in	80	SENT_60	[p4l684t849r1110b950],
85	.	.	O	.	_	0	SENT_60	[p4l684t849r1110b950],

1	We	PRP	O	we	nsubj	2	SENT_61	[p4l1142t857r1275b928],
2	think	VBP	O	think	_	0	SENT_61	[p4l1306t849r1543b929],
3	that	IN	O	that	complm	8	SENT_61	[p4l1570t849r1742b928],
4	this	DT	O	this	det	5	SENT_61	[p4l1769t849r1928b928],
5	trial	NN	O	trial	nsubj	8	SENT_61	[p4l1961t849r2139b928],
6	should	MD	O	should	aux	8	SENT_61	[p4l17t968r299b1047],
7	not	RB	O	not	neg	8	SENT_61	[p4l331t985r471b1047],
8	discourage	VB	O	discourage	ccomp	2	SENT_61	[p4l498t968r956b1069],
9	cardiologists	NNS	O	cardiologist	dobj	8	SENT_61	[p4l988t968r1529b1069],
10	from	IN	O	from	_	0	SENT_61	[p4l1563t968r1770b1047],
11	increasing	VBG	O	increase	amod	12	SENT_61	[p4l1801t969r2137b1047, p4l15t1088r154b1188],
12	doses	NNS	O	dose	prep_from	8	SENT_61	[p4l185t1087r421b1166],
13	of	IN	O	of	_	0	SENT_61	[p4l457t1087r557b1166],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_61	[p4l572t1087r1055b1188],
15	in	IN	O	in	_	0	SENT_61	[p4l1086t1088r1170b1165],
16	patients	NNS	O	patient	prep_in	14	SENT_61	[p4l1201t1088r1543b1188],
17	who	WP	O	who	nsubj	18	SENT_61	[p4l1574t1087r1756b1166],
18	prove	VBP	O	prove	rcmod	16	SENT_61	[p4l1789t1113r2022b1188],
19	to	TO	O	to	aux	20	SENT_61	[p4l2055t1104r2137b1166],
20	have	VB	O	have	xcomp	18	SENT_61	[p4l16t1206r206b1285],
21	resistance	NN	O	resistance	dobj	20	SENT_61	[p4l240t1207r669b1285],
22	to	TO	O	to	aux	26	SENT_61	[p4l704t1223r785b1285],
23	in	FW	O	in	nn	24	SENT_61	[p4l821t1207r904b1284],
24	vitro	FW	O	vitro	advmod	26	SENT_61	[p4l934t1207r1132b1285],
25	aggregation	NN	O	aggregation	nn	26	SENT_61	[p4l1168t1207r1684b1307],
26	tests	NNS	O	test	infmod	21	SENT_61	[p4l1720t1223r1938b1285],
27	.	.	O	.	_	0	SENT_61	[p4l1720t1223r1938b1285],

1	Roberto	NNP	PERSON	Roberto	nn	2	SENT_62	[p4l24t1325r362b1404],
2	Padrini	NNP	PERSON	Padrini	_	0	SENT_62	[p4l403t1325r727b1419],
3	,	,	O	,	_	0	SENT_62	[p4l403t1325r727b1419],
4	M.D.	NNP	PERSON	M.D.	nn	6	SENT_62	[p4l772t1332r977b1404],
5	Vittorio	NNP	PERSON	Vittorio	nn	6	SENT_62	[p4l14t1450r341b1523],
6	Pengo	NNP	PERSON	Pengo	appos	2	SENT_62	[p4l382t1450r670b1548],
7	,	,	O	,	_	0	SENT_62	[p4l382t1450r670b1548],
8	M.D.	NNP	ORGANIZATION	M.D.	nn	9	SENT_62	[p4l715t1450r920b1522],
9	University	NNP	ORGANIZATION	University	appos	2	SENT_62	[p4l20t1587r356b1661],
10	of	IN	ORGANIZATION	of	_	0	SENT_62	[p4l378t1581r451b1642],
11	Padua	NNP	ORGANIZATION	Padua	nn	14	SENT_62	[p4l469t1581r668b1642],
12	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_62	[p4l699t1581r957b1642],
13	School	NNP	ORGANIZATION	School	nn	14	SENT_62	[p4l986t1581r1208b1642],
14	Padua	NNP	ORGANIZATION	Padua	prep_of	9	SENT_62	[p4l21t1677r239b1748],
15	,	,	O	,	_	0	SENT_62	[p4l21t1677r239b1748],
16	Italy	NNP	LOCATION	Italy	nn	17	SENT_62	[p4l273t1677r407b1757],
17	roberto.padrini@unipd.it	NN	O	roberto.padrini@unipd.it	appos	2	SENT_62	[p4l19t1757r873b1836],

1	No	DT	O	no	det	3	SENT_63	[p4l99t1882r194b1935],
2	potential	JJ	O	potential	amod	3	SENT_63	[p4l220t1876r517b1952],
3	conflict	NN	O	conflict	nsubjpass	11	SENT_63	[p4l543t1876r802b1935],
4	of	IN	O	of	_	0	SENT_63	[p4l824t1876r900b1935],
5	interest	NN	O	interest	prep_of	3	SENT_63	[p4l912t1877r1162b1935],
6	relevant	JJ	O	relevant	amod	5	SENT_63	[p4l1184t1877r1446b1936],
7	to	TO	O	to	_	0	SENT_63	[p4l1468t1889r1530b1935],
8	this	DT	O	this	det	9	SENT_63	[p4l1558t1877r1680b1935],
9	letter	NN	O	letter	prep_to	6	SENT_63	[p4l1707t1877r1880b1935],
10	was	VBD	O	be	auxpass	11	SENT_63	[p4l1900t1896r2023b1936],
11	reported	VBN	O	report	_	0	SENT_63	[p4l2051t1896r2138b1935, p4l13t1972r249b2048],
12	.	.	O	.	_	0	SENT_63	[p4l2051t1896r2138b1935, p4l13t1972r249b2048],

1	1	LS	NUMBER	1	_	0	SENT_64	[p4l17t2099r67b2150],
2	.	.	O	.	_	0	SENT_64	[p4l17t2099r67b2150],

1	The	DT	O	the	det	2	SENT_65	[p4l141t2092r264b2150],
2	CURRENT	NNP	DATE	CURRENT	_	0	SENT_65	[p4l287t2096r885b2154],
3	.	.	O	.	_	0	SENT_65	[p4l287t2096r885b2154],

1	—	NN	O	—	_	0	SENT_66	[p4l287t2096r885b2154],
2	.	.	O	.	_	0	SENT_66	[p4l287t2096r885b2154],

1	OASIS	NN	ORGANIZATION	oasis	_	0	SENT_67	[p4l287t2096r885b2154],
2	7	CD	NUMBER	7	num	3	SENT_67	[p4l912t2097r946b2150],
3	Investigators	NNS	O	investigator	dep	1	SENT_67	[p4l969t2092r1414b2167],
4	.	.	O	.	_	0	SENT_67	[p4l969t2092r1414b2167],

1	Dose	NN	O	dose	nn	2	SENT_68	[p4l1441t2096r1604b2150],
2	comparisons	NNS	O	comparison	_	0	SENT_68	[p4l1628t2092r2050b2167],
3	of	IN	O	of	_	0	SENT_68	[p4l2077t2091r2152b2150],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_68	[p4l16t2188r386b2263],
5	and	CC	O	and	_	0	SENT_68	[p4l417t2188r536b2246],
6	aspirin	NN	O	aspirin	conj_and	4	SENT_68	[p4l567t2188r797b2263],
7	in	IN	O	in	_	0	SENT_68	[p4l827t2188r891b2245],
8	acute	JJ	O	acute	amod	10	SENT_68	[p4l921t2200r1092b2247],
9	coronary	JJ	O	coronary	amod	10	SENT_68	[p4l1124t2206r1418b2263],
10	syndromes	NNS	O	syndrome	prep_in	2	SENT_68	[p4l1446t2188r1822b2263],
11	.	.	O	.	_	0	SENT_68	[p4l1446t2188r1822b2263],

1	N	NN	O	n	nn	2	SENT_69	[p4l1855t2193r1912b2247],
2	EnglJ	NN	O	englj	nsubj	3	SENT_69	[p4l1941t2188r2141b2263],
3	Med	VBD	O	med	_	0	SENT_69	[p4l12t2283r154b2342],
4	2010	CD	DATE	2010	dobj	3	SENT_69	[p4l180t2288r738b2354],
5	;	:	O	;	_	0	SENT_69	[p4l180t2288r738b2354],
6	363:930	CD	NUMBER	363:930	number	7	SENT_69	[p4l180t2288r738b2354],
7	—	CD	NUMBER	—	dep	4	SENT_69	[p4l180t2288r738b2354],
8	42	CD	NUMBER	42	dep	7	SENT_69	[p4l180t2288r738b2354],
9	.	.	O	.	_	0	SENT_69	[p4l180t2288r738b2354],

1	[	NN	O	[	nn	2	SENT_70	[p4l776t2288r1089b2355],
2	Erratum	NN	O	erratum	_	0	SENT_70	[p4l776t2288r1089b2355],
3	,	,	O	,	_	0	SENT_70	[p4l776t2288r1089b2355],
4	N	NN	O	n	appos	2	SENT_70	[p4l1117t2289r1173b2342],
5	EnglJ	NNP	O	EnglJ	nn	6	SENT_70	[p4l1197t2284r1391b2359],
6	Med	NNP	O	Med	dep	2	SENT_70	[p4l1413t2284r1555b2342],
7	2010	CD	DATE	2010	rcmod	6	SENT_70	[p4l1581t2288r2089b2355],
8	;	:	O	;	_	0	SENT_70	[p4l1581t2288r2089b2355],
9	363:1585	CD	NUMBER	363:1585	dep	7	SENT_70	[p4l1581t2288r2089b2355],
10	.	.	O	.	_	0	SENT_70	[p4l1581t2288r2089b2355],
11	]	SYM	O	]	dep	7	SENT_70	[p4l1581t2288r2089b2355],

1	2	LS	NUMBER	2	_	0	SENT_71	[p4l14t2387r68b2438],
2	.	.	O	.	_	0	SENT_71	[p4l14t2387r68b2438],

1	Ellis	NNP	PERSON	Ellis	nn	3	SENT_72	[p4l142t2380r284b2438],
2	K	NNP	O	K	nn	3	SENT_72	[p4l307t2385r398b2451],
3	]	NNP	O	]	_	0	SENT_72	[p4l307t2385r398b2451],
4	,	,	O	,	_	0	SENT_72	[p4l307t2385r398b2451],
5	Stouffer	NNP	ORGANIZATION	Stouffer	nn	6	SENT_72	[p4l426t2379r692b2439],
6	GA	NNP	ORGANIZATION	GA	appos	3	SENT_72	[p4l712t2384r833b2451],
7	,	,	O	,	_	0	SENT_72	[p4l712t2384r833b2451],
8	McLeod	NNP	PERSON	McLeod	nn	9	SENT_72	[p4l858t2380r1119b2438],
9	HL	NNS	O	hl	appos	3	SENT_72	[p4l1141t2385r1257b2451],
10	,	,	O	,	_	0	SENT_72	[p4l1141t2385r1257b2451],
11	Lee	NNP	PERSON	Lee	nn	12	SENT_72	[p4l1283t2385r1393b2438],
12	CR	NN	O	cr	appos	3	SENT_72	[p4l1415t2384r1529b2442],
13	.	.	O	.	_	0	SENT_72	[p4l1415t2384r1529b2442],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_73	[p4l1556t2379r1942b2455],
2	pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_73	[p4l1962t2380r2138b2455, p4l15t2476r510b2551],
3	and	CC	O	and	_	0	SENT_73	[p4l551t2475r671b2534],
4	risk	NN	O	risk	conj_and	2	SENT_73	[p4l711t2476r837b2535],
5	of	IN	O	of	_	0	SENT_73	[p4l875t2475r951b2534],
6	inadequate	JJ	O	inadequate	amod	8	SENT_73	[p4l977t2476r1338b2551],
7	platelet	NN	O	platelet	nn	8	SENT_73	[p4l1378t2476r1622b2551],
8	inhibition	NN	O	inhibition	prep_of	4	SENT_73	[p4l1658t2476r2006b2534],
9	:	:	O	:	_	0	SENT_73	[p4l1658t2476r2006b2534],
10	US	NNP	LOCATION	US	nn	11	SENT_73	[p4l2050t2480r2137b2534],
11	FDA	NNP	ORGANIZATION	FDA	dep	2	SENT_73	[p4l13t2576r154b2630],
12	recommendations	NNS	O	recommendation	dep	11	SENT_73	[p4l177t2572r794b2630],
13	.	.	O	.	_	0	SENT_73	[p4l177t2572r794b2630],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_74	[p4l822t2572r1472b2647],
2	2009	CD	DATE	2009	num	1	SENT_74	[p4l1500t2576r2090b2642],
3	;	:	O	;	_	0	SENT_74	[p4l1500t2576r2090b2642],
4	10:1799	CD	NUMBER	10:1799	num	5	SENT_74	[p4l1500t2576r2090b2642],
5	—	NN	O	—	dep	1	SENT_74	[p4l1500t2576r2090b2642],
6	817	CD	NUMBER	817	dep	5	SENT_74	[p4l1500t2576r2090b2642],
7	.	.	O	.	_	0	SENT_74	[p4l1500t2576r2090b2642],

1	3	LS	NUMBER	3	_	0	SENT_75	[p4l15t2675r65b2726],
2	.	.	O	.	_	0	SENT_75	[p4l15t2675r65b2726],

1	Ho	NNP	O	Ho	nn	2	SENT_76	[p4l143t2673r238b2726],
2	PM	NNP	O	PM	_	0	SENT_76	[p4l260t2672r380b2739],
3	,	,	O	,	_	0	SENT_76	[p4l260t2672r380b2739],
4	Maddox	NNP	PERSON	Maddox	nn	5	SENT_76	[p4l404t2667r669b2726],
5	TM	NNP	O	TM	appos	2	SENT_76	[p4l686t2672r813b2739],
6	,	,	O	,	_	0	SENT_76	[p4l686t2672r813b2739],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_76	[p4l837t2673r1028b2743],
8	L	NNP	PERSON	L	appos	2	SENT_76	[p4l1046t2673r1104b2739],
9	,	,	O	,	_	0	SENT_76	[p4l1046t2673r1104b2739],
10	et	FW	O	et	nn	11	SENT_76	[p4l1131t2680r1190b2726],
11	al.	FW	O	al.	appos	2	SENT_76	[p4l1208t2667r1282b2726],
12	.	.	O	.	_	0	SENT_76	[p4l1208t2667r1282b2726],

1	Risk	NN	O	risk	_	0	SENT_77	[p4l1307t2667r1456b2730],
2	of	IN	O	of	_	0	SENT_77	[p4l1475t2667r1551b2726],
3	adverse	JJ	O	adverse	amod	4	SENT_77	[p4l1558t2667r1800b2727],
4	outcomes	NNS	O	outcome	prep_of	1	SENT_77	[p4l1823t2680r2137b2727],
5	associated	VBN	O	associate	partmod	4	SENT_77	[p4l15t2764r348b2822],
6	with	IN	O	with	_	0	SENT_77	[p4l368t2764r515b2823],
7	concomitant	JJ	O	concomitant	amod	8	SENT_77	[p4l538t2764r949b2822],
8	use	NN	O	use	prep_with	5	SENT_77	[p4l968t2783r1074b2823],
9	of	IN	O	of	_	0	SENT_77	[p4l1097t2763r1173b2822],
10	clopidogrel	NN	O	clopidogrel	nn	14	SENT_77	[p4l1183t2763r1546b2839],
11	and	CC	O	and	_	0	SENT_77	[p4l1568t2763r1686b2822],
12	proton	NN	O	proton	nn	14	SENT_77	[p4l1708t2776r1925b2839],
13	pump	NN	O	pump	nn	14	SENT_77	[p4l1948t2783r2138b2839],
14	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_77	[p4l14t2859r338b2918],
15	following	VBG	O	follow	_	0	SENT_77	[p4l385t2859r704b2935],
16	acute	JJ	O	acute	amod	18	SENT_77	[p4l747t2872r917b2919],
17	coronary	JJ	O	coronary	amod	18	SENT_77	[p4l963t2878r1257b2935],
18	syndromes	NNS	O	syndrome	prep_following	1	SENT_77	[p4l1301t2860r1676b2935],
19	.	.	O	.	_	0	SENT_77	[p4l1301t2860r1676b2935],

1	JAMA	NNP	O	JAMA	_	0	SENT_78	[p4l1719t2865r1915b2928],
2	2009	CD	DATE	2009	num	1	SENT_78	[p4l1958t2864r2136b2931],
3	;	:	O	;	_	0	SENT_78	[p4l1958t2864r2136b2931],
4	301:937	CD	NUMBER	301:937	number	5	SENT_78	[p4l16t2960r390b3014],
5	—	CD	NUMBER	—	dep	1	SENT_78	[p4l16t2960r390b3014],
6	44	CD	NUMBER	44	dep	5	SENT_78	[p4l16t2960r390b3014],
7	.	.	O	.	_	0	SENT_78	[p4l16t2960r390b3014],

1	4	LS	NUMBER	4	_	0	SENT_79	[p4l13t3058r67b3109],
2	.	.	O	.	_	0	SENT_79	[p4l13t3058r67b3109],

1	Snoep	NNP	PERSON	Snoep	nn	2	SENT_80	[p4l145t3055r342b3126],
2	JD	NNP	O	JD	_	0	SENT_80	[p4l377t3055r477b3122],
3	,	,	O	,	_	0	SENT_80	[p4l377t3055r477b3122],
4	Hovens	NNP	ORGANIZATION	Hovens	nn	5	SENT_80	[p4l523t3056r763b3110],
5	MM	NN	ORGANIZATION	mm	appos	2	SENT_80	[p4l805t3056r955b3122],
6	,	,	O	,	_	0	SENT_80	[p4l805t3056r955b3122],
7	Eikenboom	NNP	ORGANIZATION	Eikenboom	nn	8	SENT_80	[p4l1000t3050r1377b3110],
8	JC	NNP	ORGANIZATION	JC	appos	5	SENT_80	[p4l1411t3055r1505b3122],
9	,	,	O	,	_	0	SENT_80	[p4l1411t3055r1505b3122],
10	van	NNP	O	van	nn	13	SENT_80	[p4l1548t3070r1662b3110],
11	der	NNP	O	der	nn	13	SENT_80	[p4l1705t3051r1809b3109],
12	Bom	NNP	O	Bom	nn	13	SENT_80	[p4l1849t3055r2000b3109],
13	JG	NNP	O	JG	appos	5	SENT_80	[p4l2034t3055r2135b3122],
14	,	,	O	,	_	0	SENT_80	[p4l2034t3055r2135b3122],
15	Jukema	NNP	O	Jukema	nn	16	SENT_80	[p4l7t3146r257b3215],
16	JW	NNP	O	JW	appos	5	SENT_80	[p4l274t3152r386b3218],
17	,	,	O	,	_	0	SENT_80	[p4l274t3152r386b3218],
18	Huisman	NNP	PERSON	Huisman	nn	19	SENT_80	[p4l415t3147r717b3206],
19	MV	NNP	O	MV	appos	5	SENT_80	[p4l740t3152r862b3205],
20	.	.	O	.	_	0	SENT_80	[p4l740t3152r862b3205],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_81	[p4l892t3146r1277b3222],
2	nonresponsiveness	NN	O	nonresponsiveness	_	0	SENT_81	[p4l1302t3147r1924b3222],
3	in	IN	O	in	_	0	SENT_81	[p4l1949t3147r2013b3204],
4	patients	NNS	O	patient	prep_in	2	SENT_81	[p4l2037t3166r2138b3222, p4l15t3243r193b3301],
5	undergoing	VBG	O	undergo	partmod	4	SENT_81	[p4l216t3242r593b3318],
6	percutaneous	JJ	O	percutaneous	amod	8	SENT_81	[p4l611t3255r1045b3318],
7	coronary	JJ	O	coronary	amod	8	SENT_81	[p4l1070t3261r1358b3318],
8	intervention	NN	O	intervention	dobj	5	SENT_81	[p4l1377t3243r1770b3302],
9	with	IN	O	with	_	0	SENT_81	[p4l1789t3242r1935b3302],
10	stent	NN	O	stent	nn	12	SENT_81	[p4l1958t3255r2138b3301],
11	—	CD	NUMBER	—	num	12	SENT_81	[p4l1958t3255r2138b3301],
12	ing	NN	O	ing	prep_with	5	SENT_81	[p4l14t3339r136b3414],
13	:	:	O	:	_	0	SENT_81	[p4l14t3339r136b3414],
14	a	DT	O	a	det	16	SENT_81	[p4l176t3358r209b3397],
15	systematic	JJ	O	systematic	amod	16	SENT_81	[p4l245t3339r590b3414],
16	review	NN	O	review	dep	2	SENT_81	[p4l626t3339r840b3398],
17	and	CC	O	and	_	0	SENT_81	[p4l873t3339r993b3397],
18	meta	NN	O	meta	nn	20	SENT_81	[p4l1030t3339r1500b3414],
19	—	NN	O	—	nn	20	SENT_81	[p4l1030t3339r1500b3414],
20	analysis	NN	O	analysis	dep	2	SENT_81	[p4l1030t3339r1500b3414],
21	.	.	O	.	_	0	SENT_81	[p4l1030t3339r1500b3414],

1	Am	VBP	O	be	dep	2	SENT_82	[p4l1538t3344r1653b3396],
2	Heart	NNP	O	Heart	_	0	SENT_82	[p4l1689t3344r1930b3407],
3	]	CD	NUMBER	]	number	4	SENT_82	[p4l1689t3344r1930b3407],
4	2007	CD	DATE	2007	amod	2	SENT_82	[p4l1966t3343r2136b3410],
5	;	:	O	;	_	0	SENT_82	[p4l1966t3343r2136b3410],
6	154:221	CD	NUMBER	154:221	dep	4	SENT_82	[p4l17t3439r389b3493],
7	—	CD	NUMBER	—	num	8	SENT_82	[p4l17t3439r389b3493],
8	31	CD	NUMBER	31	dep	6	SENT_82	[p4l17t3439r389b3493],
9	.	.	O	.	_	0	SENT_82	[p4l17t3439r389b3493],

1	TO	TO	O	to	aux	3	SENT_83	[p4l14t3710r126b3765],
2	THE	DT	O	the	det	3	SENT_83	[p4l197t3711r360b3765],
3	EDITOR	NN	O	editor	_	0	SENT_83	[p4l439t3710r775b3766],
4	:	:	O	:	_	0	SENT_83	[p4l439t3710r775b3766],
5	I	PRP	O	I	nsubj	6	SENT_83	[p4l858t3695r889b3765],
6	read	VBP	O	read	dep	3	SENT_83	[p4l973t3687r1159b3766],
7	the	DT	O	the	det	8	SENT_83	[p4l1244t3687r1379b3766],
8	article	NN	O	article	dobj	6	SENT_83	[p4l1463t3687r1738b3766],
9	by	IN	O	by	_	0	SENT_83	[p4l1824t3687r1922b3788],
10	the	DT	O	the	prep_by	3	SENT_83	[p4l2002t3687r2138b3766],

1	CURRENT	JJ	DATE	current	_	0	SENT_84	[p5l16t26r823b104],
2	.	.	O	.	_	0	SENT_84	[p5l16t26r823b104],

1	—	NN	O	—	_	0	SENT_85	[p5l16t26r823b104],
2	.	.	O	.	_	0	SENT_85	[p5l16t26r823b104],

1	OASIS	NN	O	oasis	nsubjpass	11	SENT_86	[p5l16t26r823b104],
2	7	CD	NUMBER	7	num	3	SENT_86	[p5l866t28r911b99],
3	investigators	NNS	O	investigator	dep	1	SENT_86	[p5l951t21r1498b121],
4	with	IN	O	with	_	0	SENT_86	[p5l1534t20r1729b99],
5	concern	NN	O	concern	prep_with	3	SENT_86	[p5l1769t46r2133b116],
6	,	,	O	,	_	0	SENT_86	[p5l1769t46r2133b116],
7	since	IN	O	since	_	0	SENT_86	[p5l17t149r232b227],
8	insufficient	JJ	O	insufficient	amod	9	SENT_86	[p5l270t148r772b227],
9	data	NNS	O	datum	prep_since	3	SENT_86	[p5l806t148r989b227],
10	were	VBD	O	be	auxpass	11	SENT_86	[p5l1021t174r1222b228],
11	collected	VBN	O	collect	_	0	SENT_86	[p5l1262t148r1642b227],
12	on	IN	O	on	_	0	SENT_86	[p5l1681t174r1787b227],
13	the	DT	O	the	det	14	SENT_86	[p5l1826t148r1958b227],
14	use	NN	O	use	prep_on	11	SENT_86	[p5l1997t175r2137b227],
15	of	IN	O	of	_	0	SENT_86	[p5l16t276r117b355],
16	proton	NN	O	proton	nn	19	SENT_86	[p5l139t293r711b377],
17	—	CD	NUMBER	—	num	19	SENT_86	[p5l139t293r711b377],
18	pump	NN	O	pump	nn	19	SENT_86	[p5l139t293r711b377],
19	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_86	[p5l754t276r1200b355],
20	.	.	O	.	_	0	SENT_86	[p5l754t276r1200b355],

1	Data	NNS	O	datum	nsubjpass	9	SENT_87	[p5l1246t283r1448b355],
2	on	IN	O	on	_	0	SENT_87	[p5l1489t302r1595b355],
3	only	JJ	O	only	quantmod	4	SENT_87	[p5l1637t276r1822b377],
4	18,430	CD	NUMBER	18,430	prep_on	1	SENT_87	[p5l1863t282r2137b372],
5	of	IN	O	of	_	0	SENT_87	[p5l16t404r117b483],
6	25,086	CD	NUMBER	25,086	num	7	SENT_87	[p5l127t410r409b500],
7	patients	NNS	O	patient	prep_of	4	SENT_87	[p5l437t405r778b505],
8	are	VBP	O	be	auxpass	9	SENT_87	[p5l809t430r937b483],
9	shown	VBN	O	show	_	0	SENT_87	[p5l968t404r1249b483],
10	(	IN	O	(	_	0	SENT_87	[p5l1283t409r1624b496],
11	73.5	CD	PERCENT	73.5	number	12	SENT_87	[p5l1283t409r1624b496],
12	%	NN	PERCENT	%	num	13	SENT_87	[p5l1283t409r1624b496],
13	)	CD	NUMBER	)	prep_(	9	SENT_87	[p5l1283t409r1624b496],
14	.	.	O	.	_	0	SENT_87	[p5l1283t409r1624b496],

1	This	DT	O	this	nsubj	3	SENT_88	[p5l1655t404r1842b483],
2	is	VBZ	O	be	cop	3	SENT_88	[p5l1872t405r1938b483],
3	crucial	JJ	O	crucial	_	0	SENT_88	[p5l1970t431r2137b483, p5l16t532r187b628],
4	,	,	O	,	_	0	SENT_88	[p5l1970t431r2137b483, p5l16t532r187b628],
5	since	IN	O	since	mark	8	SENT_88	[p5l227t533r442b611],
6	we	PRP	O	we	nsubj	8	SENT_88	[p5l470t559r588b611],
7	now	RB	DATE	now	advmod	8	SENT_88	[p5l621t558r805b611],
8	appreciate	VBP	O	appreciate	advcl	3	SENT_88	[p5l833t533r1271b633],
9	that	IN	O	that	complm	20	SENT_88	[p5l1305t532r1477b611],
10	the	DT	O	the	det	11	SENT_88	[p5l1505t532r1638b611],
11	interaction	NN	O	interaction	nsubj	20	SENT_88	[p5l1670t533r2138b611],
12	between	IN	O	between	_	0	SENT_88	[p5l16t660r374b739],
13	clopidogrel	NN	O	clopidogrel	prep_between	11	SENT_88	[p5l417t660r900b761],
14	and	CC	O	and	_	0	SENT_88	[p5l941t660r1098b739],
15	some	DT	O	some	det	16	SENT_88	[p5l1142t686r1365b739],
16	proton	NN	O	proton	nsubj	20	SENT_88	[p5l1407t677r1979b761],
17	—	CD	NUMBER	—	num	19	SENT_88	[p5l1407t677r1979b761],
18	pump	NN	O	pump	nn	19	SENT_88	[p5l1407t677r1979b761],
19	inhibitors	NNS	O	inhibitor	dep	16	SENT_88	[p5l2022t661r2137b738, p5l16t788r348b867],
20	(	VBP	O	(	ccomp	8	SENT_88	[p5l385t788r950b889],
21	omeprazolel	NN	O	omeprazolel	nn	24	SENT_88	[p5l385t788r950b889],
22	and	CC	O	and	_	0	SENT_88	[p5l979t788r1137b867],
23	esomeprazole	NN	O	esomeprazole	nn	24	SENT_88	[p5l1167t788r1824b889],
24	}	NN	O	}	nsubj	29	SENT_88	[p5l1167t788r1824b889],
25	in	IN	O	in	_	0	SENT_88	[p5l1854t789r1937b866],
26	particular	JJ	O	particular	amod	27	SENT_88	[p5l1965t814r2137b889, p5l16t916r313b1008],
27	)	NN	O	)	prep_in	24	SENT_88	[p5l1965t814r2137b889, p5l16t916r313b1008],
28	can	MD	O	can	aux	29	SENT_88	[p5l349t942r496b995],
29	interfere	VB	O	interfere	ccomp	20	SENT_88	[p5l526t916r883b995],
30	with	IN	O	with	_	0	SENT_88	[p5l909t916r1101b995],
31	clopidogrel	NN	O	clopidogrel	nn	32	SENT_88	[p5l1132t916r1604b1017],
32	metabolism	NN	O	metabolism	prep_with	29	SENT_88	[p5l1634t916r2138b995],
33	and	CC	O	and	_	0	SENT_88	[p5l15t1044r173b1123],
34	its	PRP$	O	its	poss	35	SENT_88	[p5l204t1045r302b1123],
35	efficacy	NN	O	efficacy	conj_and	32	SENT_88	[p5l337t1044r686b1145],
36	,	,	O	,	_	0	SENT_88	[p5l337t1044r686b1145],
37	possibly	RB	O	possibly	advmod	38	SENT_88	[p5l722t1044r1075b1145],
38	confounding	VBG	O	confound	xcomp	8	SENT_88	[p5l1103t1044r1659b1145],
39	the	DT	O	the	det	40	SENT_88	[p5l1689t1044r1821b1123],
40	results	NNS	O	result	dobj	38	SENT_88	[p5l1853t1044r2135b1123],
41	of	IN	O	of	_	0	SENT_88	[p5l16t1172r117b1251],
42	this	DT	O	this	det	43	SENT_88	[p5l143t1172r303b1251],
43	trial	NN	O	trial	prep_of	40	SENT_88	[p5l350t1172r550b1251],
44	.	.	O	.	_	0	SENT_88	[p5l350t1172r550b1251],

1	Such	JJ	O	such	nsubjpass	6	SENT_89	[p5l603t1172r805b1251],
2	decreased	VBN	O	decrease	partmod	1	SENT_89	[p5l850t1172r1272b1251],
3	efficacy	NN	O	efficacy	dobj	2	SENT_89	[p5l1318t1172r1654b1273],
4	is	VBZ	O	be	auxpass	6	SENT_89	[p5l1694t1173r1759b1251],
5	actually	RB	O	actually	advmod	6	SENT_89	[p5l1806t1172r2142b1273],
6	confirmed	VBN	O	confirm	_	0	SENT_89	[p5l16t1300r452b1379],
7	by	IN	O	by	_	0	SENT_89	[p5l479t1300r575b1401],
8	the	DT	O	the	det	9	SENT_89	[p5l596t1300r724b1379],
9	results	NNS	O	result	agent	6	SENT_89	[p5l751t1300r1021b1379],
10	of	IN	O	of	_	0	SENT_89	[p5l1050t1300r1148b1379],
11	this	DT	O	this	det	12	SENT_89	[p5l1156t1300r1309b1379],
12	trial	NN	O	trial	prep_of	9	SENT_89	[p5l1338t1300r1528b1379],
13	:	:	O	:	_	0	SENT_89	[p5l1338t1300r1528b1379],
14	after	IN	O	after	_	0	SENT_89	[p5l1558t1300r1751b1379],
15	random	JJ	O	random	amod	17	SENT_89	[p5l1774t1300r2137b1379],
16	—	NN	O	—	nn	17	SENT_89	[p5l1774t1300r2137b1379],
17	ization	NN	O	ization	prep_after	46	SENT_89	[p5l15t1429r335b1524],
18	,	,	O	,	_	0	SENT_89	[p5l15t1429r335b1524],
19	5.3	CD	PERCENT	5.3	num	20	SENT_89	[p5l396t1433r604b1507],
20	%	NN	PERCENT	%	nsubj	46	SENT_89	[p5l396t1433r604b1507],
21	of	IN	O	of	_	0	SENT_89	[p5l657t1428r758b1507],
22	patients	NNS	O	patient	prep_of	20	SENT_89	[p5l791t1429r1132b1529],
23	who	WP	O	who	nsubj	24	SENT_89	[p5l1182t1428r1365b1507],
24	received	VBD	O	receive	rcmod	22	SENT_89	[p5l1420t1428r1765b1507],
25	protonpump	NN	O	protonpump	nn	26	SENT_89	[p5l1817t1445r2137b1529, p5l15t1582r264b1657],
26	inhibitors	NNS	O	inhibitor	dobj	24	SENT_89	[p5l314t1556r735b1635],
27	and	CC	O	and	_	0	SENT_89	[p5l786t1556r944b1635],
28	standard	JJ	O	standard	amod	31	SENT_89	[p5l995t1556r1606b1635],
29	—	NN	O	—	nn	31	SENT_89	[p5l995t1556r1606b1635],
30	dose	NN	O	dose	nn	31	SENT_89	[p5l995t1556r1606b1635],
31	clopidogrel	NN	O	clopidogrel	dobj	24	SENT_89	[p5l1656t1556r2138b1657],
32	and	CC	O	and	_	0	SENT_89	[p5l15t1684r173b1763],
33	4.6	CD	PERCENT	4.6	num	34	SENT_89	[p5l218t1689r430b1763],
34	%	NN	PERCENT	%	dobj	24	SENT_89	[p5l218t1689r430b1763],
35	who	WP	O	who	nsubj	36	SENT_89	[p5l472t1684r655b1763],
36	received	VBD	O	receive	rcmod	34	SENT_89	[p5l703t1684r1048b1764],
37	proton	NN	O	proton	iobj	36	SENT_89	[p5l1094t1701r1667b1785],
38	—	CD	NUMBER	—	num	40	SENT_89	[p5l1094t1701r1667b1785],
39	pump	NN	O	pump	nn	40	SENT_89	[p5l1094t1701r1667b1785],
40	inhibitors	NNS	O	inhibitor	dobj	36	SENT_89	[p5l1714t1684r2136b1763],
41	and	CC	O	and	_	0	SENT_89	[p5l11t1802r170b1881],
42	double	JJ	O	double	amod	45	SENT_89	[p5l201t1802r725b1881],
43	—	JJ	O	—	amod	45	SENT_89	[p5l201t1802r725b1881],
44	dose	NN	O	dose	nn	45	SENT_89	[p5l201t1802r725b1881],
45	clopidogrel	NN	O	clopidogrel	dobj	36	SENT_89	[p5l757t1802r1243b1903],
46	reached	VBD	O	reach	parataxis	6	SENT_89	[p5l1273t1802r1607b1881],
47	the	DT	O	the	det	49	SENT_89	[p5l1637t1802r1771b1881],
48	primary	JJ	O	primary	amod	49	SENT_89	[p5l1800t1803r2152b1903],
49	outcome	NN	O	outcome	dobj	46	SENT_89	[p5l12t1937r415b2016],
50	;	:	O	;	_	0	SENT_89	[p5l12t1937r415b2016],
51	these	DT	O	these	det	52	SENT_89	[p5l469t1920r698b1999],
52	rates	NNS	O	rate	nsubj	55	SENT_89	[p5l747t1937r955b1999],
53	were	VBD	O	be	cop	55	SENT_89	[p5l1002t1946r1208b1999],
54	significantly	RB	O	significantly	advmod	55	SENT_89	[p5l1259t1920r1818b2021],
55	higher	JJR	O	higher	parataxis	6	SENT_89	[p5l1863t1920r2151b2021],
56	than	IN	O	than	_	0	SENT_89	[p5l12t2038r207b2117],
57	the	DT	O	the	det	63	SENT_89	[p5l235t2038r366b2117],
58	corresponding	JJ	O	corresponding	amod	63	SENT_89	[p5l395t2038r1016b2139],
59	3.9	CD	PERCENT	3.9	number	63	SENT_89	[p5l1041t2043r1251b2117],
60	%	NN	PERCENT	%	dep	63	SENT_89	[p5l1041t2043r1251b2117],
61	and	CC	O	and	_	0	SENT_89	[p5l1277t2038r1434b2117],
62	3.7	CD	PERCENT	3.7	conj_and	63	SENT_89	[p5l1462t2043r1670b2117],
63	%	NN	PERCENT	%	prep_than	55	SENT_89	[p5l1462t2043r1670b2117],
64	of	IN	O	of	_	0	SENT_89	[p5l1698t2038r1797b2117],
65	patients	NNS	O	patient	prep_of	63	SENT_89	[p5l1805t2039r2146b2139],
66	who	WP	O	who	nsubj	69	SENT_89	[p5l7t2156r192b2235],
67	did	VBD	O	do	aux	69	SENT_89	[p5l229t2156r364b2235],
68	not	RB	O	not	neg	69	SENT_89	[p5l399t2173r542b2235],
69	receive	VB	O	receive	rcmod	65	SENT_89	[p5l572t2157r863b2235],
70	a	DT	O	a	det	74	SENT_89	[p5l897t2183r942b2235],
71	proton	NN	O	proton	nn	74	SENT_89	[p5l974t2173r1550b2257],
72	—	CD	NUMBER	—	num	74	SENT_89	[p5l974t2173r1550b2257],
73	pump	NN	O	pump	nn	74	SENT_89	[p5l974t2173r1550b2257],
74	inhibitor	NN	O	inhibitor	dobj	69	SENT_89	[p5l1585t2156r1988b2235],
75	.	.	O	.	_	0	SENT_89	[p5l1585t2156r1988b2235],

1	Furthermore	RB	O	furthermore	advmod	23	SENT_90	[p5l140t2274r728b2370],
2	,	,	O	,	_	0	SENT_90	[p5l140t2274r728b2370],
3	since	IN	O	since	mark	14	SENT_90	[p5l787t2275r1007b2353],
4	42	CD	PERCENT	42	num	5	SENT_90	[p5l1057t2279r1247b2353],
5	%	NN	PERCENT	%	nsubj	14	SENT_90	[p5l1057t2279r1247b2353],
6	of	IN	O	of	_	0	SENT_90	[p5l1299t2274r1400b2353],
7	the	DT	O	the	det	8	SENT_90	[p5l1434t2274r1570b2353],
8	patients	NNS	O	patient	prep_of	5	SENT_90	[p5l1621t2275r1971b2375],
9	for	IN	O	for	_	0	SENT_90	[p5l2026t2274r2152b2353],
10	whom	WP	O	whom	dobj	13	SENT_90	[p5l7t2392r280b2471],
11	data	NNS	O	datum	nsubj	13	SENT_90	[p5l318t2392r503b2471],
12	were	VBD	O	be	cop	13	SENT_90	[p5l534t2418r737b2471],
13	available	JJ	O	available	prepc_for	8	SENT_90	[p5l775t2392r1148b2471],
14	received	VBN	O	receive	advcl	23	SENT_90	[p5l1187t2392r1534b2471],
15	proton	NN	O	proton	tmod	14	SENT_90	[p5l1570t2409r2147b2493],
16	—	CD	NUMBER	—	num	18	SENT_90	[p5l1570t2409r2147b2493],
17	pump	NN	O	pump	nn	18	SENT_90	[p5l1570t2409r2147b2493],
18	inhibitors	NNS	O	inhibitor	dep	15	SENT_90	[p5l12t2510r450b2606],
19	,	,	O	,	_	0	SENT_90	[p5l12t2510r450b2606],
20	it	PRP	O	it	nsubj	23	SENT_90	[p5l490t2511r549b2589],
21	would	MD	O	would	aux	23	SENT_90	[p5l575t2510r838b2589],
22	be	VB	O	be	cop	23	SENT_90	[p5l874t2510r969b2589],
23	interesting	JJ	O	interesting	_	0	SENT_90	[p5l1005t2511r1466b2611],
24	to	TO	O	to	aux	25	SENT_90	[p5l1499t2527r1580b2589],
25	know	VB	O	know	xcomp	23	SENT_90	[p5l1617t2510r1856b2590],
26	which	WDT	O	which	dobj	33	SENT_90	[p5l1883t2510r2148b2589],
27	specific	JJ	O	specific	amod	31	SENT_90	[p5l14t2628r345b2729],
28	proton	NN	O	proton	nn	31	SENT_90	[p5l377t2645r954b2729],
29	—	CD	NUMBER	—	num	31	SENT_90	[p5l377t2645r954b2729],
30	pump	NN	O	pump	nn	31	SENT_90	[p5l377t2645r954b2729],
31	inhibitors	NNS	O	inhibitor	nsubjpass	33	SENT_90	[p5l988t2628r1413b2707],
32	were	VBD	O	be	auxpass	33	SENT_90	[p5l1445t2655r1648b2708],
33	received	VBN	O	receive	ccomp	25	SENT_90	[p5l1683t2628r2031b2707],
34	in	IN	O	in	_	0	SENT_90	[p5l2064t2629r2148b2706],
35	both	CC	O	both	advmod	37	SENT_90	[p5l13t2746r208b2825],
36	the	DT	O	the	det	37	SENT_90	[p5l241t2746r372b2825],
37	group	NN	O	group	prep_in	33	SENT_90	[p5l404t2772r654b2847],
38	that	WDT	O	that	nsubj	39	SENT_90	[p5l687t2746r858b2825],
39	reached	VBD	O	reach	rcmod	37	SENT_90	[p5l884t2746r1212b2825],
40	the	DT	O	the	det	42	SENT_90	[p5l1244t2746r1376b2825],
41	primary	JJ	O	primary	amod	42	SENT_90	[p5l1406t2747r1752b2847],
42	outcome	NN	O	outcome	dobj	39	SENT_90	[p5l1780t2763r2148b2825],
43	and	CC	O	and	_	0	SENT_90	[p5l12t2864r168b2943],
44	the	DT	O	the	det	45	SENT_90	[p5l204t2864r336b2943],
45	group	NN	O	group	dobj	39	SENT_90	[p5l372t2890r621b2965],
46	that	WDT	O	that	nsubj	47	SENT_90	[p5l660t2864r829b2943],
47	did	VBD	O	do	rcmod	45	SENT_90	[p5l861t2864r994b2943],
48	not	RB	O	not	neg	47	SENT_90	[p5l1030t2881r1191b2943],
49	.	.	O	.	_	0	SENT_90	[p5l1030t2881r1191b2943],

1	A	DT	O	a	det	2	SENT_91	[p5l1230t2872r1296b2942],
2	surplus	NN	O	surplus	nsubj	20	SENT_91	[p5l1330t2864r1638b2965],
3	of	IN	O	of	_	0	SENT_91	[p5l1677t2864r1777b2943],
4	omepra	NN	O	omepra	nn	6	SENT_91	[p5l1795t2890r2147b2965],
5	—	CD	NUMBER	—	num	6	SENT_91	[p5l1795t2890r2147b2965],
6	zole	NN	O	zole	prep_of	2	SENT_91	[p5l12t2982r178b3061],
7	or	CC	O	or	_	0	SENT_91	[p5l214t3008r301b3061],
8	esomeprazole	NN	O	esomeprazole	nsubj	20	SENT_91	[p5l334t2982r907b3083],
9	in	IN	O	in	_	0	SENT_91	[p5l943t2983r1024b3060],
10	patients	NNS	O	patient	prep_in	8	SENT_91	[p5l1058t2983r1386b3083],
11	receiving	VBG	O	receive	partmod	10	SENT_91	[p5l1424t2983r1799b3083],
12	doubledose	JJ	O	doubledose	amod	13	SENT_91	[p5l1832t2982r2147b3061, p5l13t3100r205b3179],
13	clopidogrel	NN	O	clopidogrel	dobj	11	SENT_91	[p5l239t3100r713b3201],
14	in	IN	O	in	_	0	SENT_91	[p5l746t3101r829b3178],
15	the	DT	O	the	det	17	SENT_91	[p5l862t3100r994b3179],
16	former	JJ	O	former	amod	17	SENT_91	[p5l1027t3100r1320b3179],
17	group	NN	O	group	prep_in	11	SENT_91	[p5l1349t3126r1599b3201],
18	could	MD	O	could	aux	20	SENT_91	[p5l1634t3100r1865b3179],
19	partly	RB	O	partly	advmod	20	SENT_91	[p5l1897t3100r2153b3201],
20	explain	VB	O	explain	_	0	SENT_91	[p5l13t3218r328b3319],
21	the	DT	O	the	det	22	SENT_91	[p5l368t3218r502b3297],
22	lack	NN	O	lack	dobj	20	SENT_91	[p5l540t3218r717b3298],
23	of	IN	O	of	_	0	SENT_91	[p5l753t3218r854b3297],
24	superiority	NN	O	superiority	prep_of	22	SENT_91	[p5l877t3219r1345b3319],
25	seen	VBN	O	see	partmod	24	SENT_91	[p5l1382t3244r1594b3297],
26	.	.	O	.	_	0	SENT_91	[p5l1382t3244r1594b3297],

1	Vassilios	NNP	PERSON	Vassilios	nn	3	SENT_92	[p5l10t3336r399b3417],
2	S.	NNP	PERSON	S.	nn	3	SENT_92	[p5l436t3342r508b3416],
3	Vassiliou	NNP	PERSON	Vassiliou	_	0	SENT_92	[p5l542t3336r966b3431],
4	,	,	O	,	_	0	SENT_92	[p5l542t3336r966b3431],
5	M.B.	NNP	LOCATION	M.B.	nn	7	SENT_92	[p5l1012t3343r1232b3431],
6	,	,	O	,	_	0	SENT_92	[p5l1012t3343r1232b3431],
7	B.S.	NNP	O	B.S.	appos	3	SENT_92	[p5l1277t3342r1434b3416],

1	University	NNP	O	University	nn	3	SENT_93	[p5l16t3479r355b3553],
2	ofCambridge	NNP	O	ofCambridge	nn	3	SENT_93	[p5l377t3473r834b3553],
3	Cambridge	NNP	LOCATION	Cambridge	_	0	SENT_93	[p5l12t3569r402b3649],
4	,	,	O	,	_	0	SENT_93	[p5l12t3569r402b3649],
5	United	NNP	LOCATION	United	nn	6	SENT_93	[p5l433t3569r652b3631],
6	Kingdom	NNP	LOCATION	Kingdom	appos	3	SENT_93	[p5l686t3569r983b3649],
7	vassi	NN	O	vassus	nn	9	SENT_93	[p5l10t3649r887b3729],
8	|	NN	O	|	nn	9	SENT_93	[p5l10t3649r887b3729],
9	iou@doctors.org.uk	NN	O	iou@doctors.org.uk	dep	3	SENT_93	[p5l10t3649r887b3729],

1	No	DT	O	no	det	3	SENT_94	[p6l96t33r191b87],
2	potential	JJ	O	potential	amod	3	SENT_94	[p6l217t28r516b104],
3	conﬂict	NN	O	conﬂict	nsubjpass	11	SENT_94	[p6l543t27r803b87],
4	of	IN	O	of	_	0	SENT_94	[p6l826t27r902b87],
5	interest	NN	O	interest	prep_of	3	SENT_94	[p6l914t28r1165b87],
6	relevant	JJ	O	relevant	amod	5	SENT_94	[p6l1188t28r1451b87],
7	to	TO	O	to	_	0	SENT_94	[p6l1474t40r1536b87],
8	this	DT	O	this	det	9	SENT_94	[p6l1564t28r1687b87],
9	letter	NN	O	letter	prep_to	6	SENT_94	[p6l1714t27r1888b87],
10	was	VBD	O	be	auxpass	11	SENT_94	[p6l1909t48r2033b87],
11	reported	VBN	O	report	_	0	SENT_94	[p6l2061t48r2148b87, p6l10t124r247b201],
12	.	.	O	.	_	0	SENT_94	[p6l2061t48r2148b87, p6l10t124r247b201],

1	1	LS	NUMBER	1	_	0	SENT_95	[p6l13t251r63b303],
2	.	.	O	.	_	0	SENT_95	[p6l13t251r63b303],

1	Public	NNP	O	Public	nn	3	SENT_96	[p6l140t244r345b303],
2	health	NN	O	health	nn	3	SENT_96	[p6l376t243r585b303],
3	advisory	NN	O	advisory	_	0	SENT_96	[p6l616t244r908b320],
4	:	:	O	:	_	0	SENT_96	[p6l616t244r908b320],
5	updated	VBN	O	update	amod	7	SENT_96	[p6l944t243r1209b320],
6	safety	NN	O	safety	nn	7	SENT_96	[p6l1243t243r1438b320],
7	information	NN	O	information	dep	3	SENT_96	[p6l1466t243r1869b303],
8	about	IN	O	about	_	0	SENT_96	[p6l1901t243r2088b303],
9	a	DT	O	a	det	11	SENT_96	[p6l2116t264r2150b303],
10	drug	NN	O	drug	nn	11	SENT_96	[p6l12t341r163b417],
11	interaction	NN	O	interaction	prep_about	7	SENT_96	[p6l181t341r526b400],
12	between	IN	O	between	_	0	SENT_96	[p6l547t341r812b400],
13	clopidogrel	NN	O	clopidogrel	nn	15	SENT_96	[p6l833t340r1190b417],
14	bisulfate	NN	O	bisulfate	nn	15	SENT_96	[p6l1210t340r1482b400],
15	(	NN	O	(	prep_between	11	SENT_96	[p6l1506t341r1826b409],
16	marketed	VBN	O	market	partmod	15	SENT_96	[p6l1506t341r1826b409],
17	as	IN	O	as	_	0	SENT_96	[p6l1846t361r1909b400],
18	Plavix	NNP	O	Plavix	nn	19	SENT_96	[p6l1931t340r2145b409],
19	)	NN	O	)	prep_as	16	SENT_96	[p6l1931t340r2145b409],
20	and	CC	O	and	_	0	SENT_96	[p6l11t437r132b497],
21	omeprazole	NN	O	omeprazole	nn	22	SENT_96	[p6l157t438r544b514],
22	(	NN	O	(	prep_as	16	SENT_96	[p6l573t438r907b506],
23	marketed	VBN	O	market	partmod	19	SENT_96	[p6l573t438r907b506],
24	as	IN	O	as	_	0	SENT_96	[p6l931t458r996b497],
25	Prilosec	NNP	O	Prilosec	prep_as	23	SENT_96	[p6l1022t438r1285b497],
26	and	CC	O	and	_	0	SENT_96	[p6l1309t438r1430b497],
27	Prilosec	NNP	O	Prilosec	nn	28	SENT_96	[p6l1454t438r1717b497],
28	OTC	NNP	O	OTC	conj_and	25	SENT_96	[p6l1742t442r1932b506],
29	)	CD	NUMBER	)	num	28	SENT_96	[p6l1742t442r1932b506],
30	.	.	O	.	_	0	SENT_96	[p6l1742t442r1932b506],

1	Rockville	NNP	LOCATION	Rockville	nn	3	SENT_97	[p6l1961t437r2148b501, p6l8t535r164b607],
2	,	,	O	,	_	0	SENT_97	[p6l1961t437r2148b501, p6l8t535r164b607],
3	MD	NNP	O	MD	_	0	SENT_97	[p6l205t539r345b594],
4	:	:	O	:	_	0	SENT_97	[p6l205t539r345b594],
5	Food	NNP	O	Food	nn	8	SENT_97	[p6l386t535r550b594],
6	and	CC	O	and	_	0	SENT_97	[p6l589t534r710b594],
7	Drug	NNP	O	Drug	conj_and	5	SENT_97	[p6l748t539r917b611],
8	Administration	NNP	O	Administration	dep	3	SENT_97	[p6l952t534r1483b607],
9	,	,	O	,	_	0	SENT_97	[p6l952t534r1483b607],
10	2009	CD	DATE	2009	appos	8	SENT_97	[p6l1527t539r1702b594],
11	.	.	O	.	_	0	SENT_97	[p6l1527t539r1702b594],

1	(	NN	O	(	nn	2	SENT_98	[p6l1749t534r2152b611],
2	http	NN	O	http	_	0	SENT_98	[p6l1749t534r2152b611],
3	:	:	O	:	_	0	SENT_98	[p6l1749t534r2152b611],
4	/	:	O	/	punct	5	SENT_98	[p6l1749t534r2152b611],
5	[	CD	NUMBER	[	dep	2	SENT_98	[p6l1749t534r2152b611],
6	WWW	NNP	O	WWW	dep	5	SENT_98	[p6l1749t534r2152b611],
7	.	.	O	.	_	0	SENT_98	[p6l14t631r2143b708],

1	fda	NN	O	fda	_	0	SENT_99	[p6l14t631r2143b708],
2	.	.	O	.	_	0	SENT_99	[p6l14t631r2143b708],

1	gov/Drugs/DrugSafety	NN	O	gov/drugs/drugsafety	_	0	SENT_100	[p6l14t631r2143b708],
2	/	:	O	/	punct	1	SENT_100	[p6l14t631r2143b708],
3	PostmarketDrugSafetyInformation	NN	O	postmarketdrugsafetyinformation	dep	1	SENT_100	[p6l14t631r2143b708],
4	forPatientsandProviders/DrugSafetyInformationforHeathcare	NN	O	forpatientsandproviders/drugsafetyinformationforheathcare	nn	5	SENT_100	[p6l11t728r2112b805],
5	Professionals/PublicHealthAdvisorieslucm190825	NN	O	professionals/publichealthadvisorieslucm190825	dep	3	SENT_100	[p6l10t825r1866b894],
6	.	.	O	.	_	0	SENT_100	[p6l10t825r1866b894],

1	htm	NN	O	htm	_	0	SENT_101	[p6l10t825r1866b894],
2	.	.	O	.	_	0	SENT_101	[p6l10t825r1866b894],
3	)	SYM	O	)	dep	1	SENT_101	[p6l10t825r1866b894],

1	2	LS	NUMBER	2	_	0	SENT_102	[p6l10t930r64b982],
2	.	.	O	.	_	0	SENT_102	[p6l10t930r64b982],

1	Public	NNP	O	Public	nn	2	SENT_103	[p6l139t923r345b982],
2	statement	NN	O	statement	_	0	SENT_103	[p6l377t935r721b982],
3	:	:	O	:	_	0	SENT_103	[p6l377t935r721b982],
4	interaction	NN	O	interaction	dep	2	SENT_103	[p6l755t923r1116b982],
5	between	IN	O	between	_	0	SENT_103	[p6l1148t923r1424b982],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_103	[p6l1456t923r1829b999],
7	and	CC	O	and	_	0	SENT_103	[p6l1859t923r1980b982],
8	proton-pump	NN	O	proton-pump	nn	9	SENT_103	[p6l2010t942r2148b999, p6l11t1032r332b1096],
9	inhibitors	NNS	O	inhibitor	prep_between	4	SENT_103	[p6l355t1019r693b1079],
10	.	.	O	.	_	0	SENT_103	[p6l355t1019r693b1079],

1	London	NNP	LOCATION	London	_	0	SENT_104	[p6l719t1019r986b1079],
2	:	:	O	:	_	0	SENT_104	[p6l719t1019r986b1079],
3	European	JJ	ORGANIZATION	european	amod	5	SENT_104	[p6l1012t1025r1324b1096],
4	Medicines	NNP	ORGANIZATION	Medicines	nn	5	SENT_104	[p6l1344t1019r1674b1079],
5	Agency	NNP	ORGANIZATION	Agency	dep	1	SENT_104	[p6l1697t1025r1945b1096],
6	,	,	O	,	_	0	SENT_104	[p6l1697t1025r1945b1096],
7	2010	CD	DATE	2010	appos	5	SENT_104	[p6l1973t1024r2144b1079],
8	.	.	O	.	_	0	SENT_104	[p6l1973t1024r2144b1079],

1	(	NN	O	(	dep	5	SENT_105	[p6l15t1116r2038b1193],
2	http	NN	O	http	dep	1	SENT_105	[p6l15t1116r2038b1193],
3	:	:	O	:	_	0	SENT_105	[p6l15t1116r2038b1193],
4	/	:	O	/	punct	5	SENT_105	[p6l15t1116r2038b1193],
5	lwwW	NN	O	lwww	_	0	SENT_105	[p6l15t1116r2038b1193],
6	.	.	O	.	_	0	SENT_105	[p6l15t1116r2038b1193],

1	ema	NN	O	ema	_	0	SENT_106	[p6l15t1116r2038b1193],
2	.	.	O	.	_	0	SENT_106	[p6l15t1116r2038b1193],

1	europa	NN	O	europa	_	0	SENT_107	[p6l15t1116r2038b1193],
2	.	.	O	.	_	0	SENT_107	[p6l15t1116r2038b1193],

1	eu/docs/en	JJ	O	eu/docs/en	amod	3	SENT_108	[p6l15t1116r2038b1193],
2	_	NN	O	_	nn	3	SENT_108	[p6l15t1116r2038b1193],
3	GB/document	NN	O	gb/document	_	0	SENT_108	[p6l15t1116r2038b1193],
4	_	CD	NUMBER	_	num	5	SENT_108	[p6l15t1116r2038b1193],
5	library	NN	O	library	dep	3	SENT_108	[p6l15t1116r2038b1193],
6	/	:	O	/	punct	3	SENT_108	[p6l15t1116r2038b1193],
7	Public_statement	NN	O	public_statement	dep	3	SENT_108	[p6l10t1213r1546b1290],
8	/	:	O	/	punct	7	SENT_108	[p6l10t1213r1546b1290],
9	2010/03/WCSOO076346	NN	O	2010/03/wcsoo076346	dep	7	SENT_108	[p6l10t1213r1546b1290],
10	.	.	O	.	_	0	SENT_108	[p6l10t1213r1546b1290],

1	pd	NN	O	pd	_	0	SENT_109	[p6l10t1213r1546b1290],
2	£	CD	NUMBER	£	num	3	SENT_109	[p6l10t1213r1546b1290],
3	)	NN	O	)	dep	1	SENT_109	[p6l10t1213r1546b1290],

1	To	TO	O	to	dep	17	SENT_110	[p6l10t1508r123b1563],
2	THE	DT	O	the	det	3	SENT_110	[p6l164t1509r329b1563],
3	EDITOR	NN	O	editor	pobj	1	SENT_110	[p6l378t1508r716b1564],
4	:	:	O	:	_	0	SENT_110	[p6l378t1508r716b1564],
5	In	IN	O	in	_	0	SENT_110	[p6l764t1493r853b1563],
6	his	PRP$	O	he	poss	7	SENT_110	[p6l899t1485r1025b1564],
7	editoriall	NN	O	editoriall	nsubj	8	SENT_110	[p6l1074t1485r1475b1564],
8	accompanying	VBG	O	accompany	prepc_in	17	SENT_110	[p6l1521t1486r2152b1586],
9	the	DT	O	the	det	10	SENT_110	[p6l12t1613r146b1692],
10	article	NN	O	article	dobj	8	SENT_110	[p6l181t1613r450b1692],
11	by	IN	O	by	_	0	SENT_110	[p6l487t1613r585b1714],
12	Mehta	NNP	PERSON	Mehta	prep_by	8	SENT_110	[p6l613t1613r886b1692],
13	et	FW	O	et	nn	14	SENT_110	[p6l921t1630r999b1692],
14	al.	FW	O	al.	dep	12	SENT_110	[p6l1029t1613r1152b1709],
15	,	,	O	,	_	0	SENT_110	[p6l1029t1613r1152b1709],
16	Fuster	NNP	PERSON	Fuster	nsubj	17	SENT_110	[p6l1192t1621r1461b1692],
17	provides	VBZ	O	provide	_	0	SENT_110	[p6l1492t1613r1855b1714],
18	an	DT	O	a	det	20	SENT_110	[p6l1892t1639r1996b1692],
19	interesting	JJ	O	interesting	amod	20	SENT_110	[p6l2031t1614r2147b1691, p6l12t1742r388b1842],
20	algorithm	NN	O	algorithm	dobj	17	SENT_110	[p6l411t1741r834b1842],
21	for	IN	O	for	_	0	SENT_110	[p6l862t1741r984b1820],
22	the	DT	O	the	det	23	SENT_110	[p6l1009t1741r1140b1820],
23	use	NN	O	use	prep_for	20	SENT_110	[p6l1168t1768r1307b1820],
24	of	IN	O	of	_	0	SENT_110	[p6l1335t1741r1435b1820],
25	antiplatelet	JJ	O	antiplatelet	amod	26	SENT_110	[p6l1443t1741r1921b1842],
26	therapy	NN	O	therapy	prep_of	23	SENT_110	[p6l1944t1741r2147b1820, p6l11t1895r158b1970],
27	in	IN	O	in	_	0	SENT_110	[p6l200t1870r284b1947],
28	acute	JJ	O	acute	amod	30	SENT_110	[p6l331t1886r554b1948],
29	coronary	JJ	O	coronary	amod	30	SENT_110	[p6l603t1895r990b1970],
30	syndromes	NNS	O	syndrome	prep_in	26	SENT_110	[p6l1035t1869r1527b1970],
31	.	.	O	.	_	0	SENT_110	[p6l1035t1869r1527b1970],

1	Although	IN	O	although	mark	3	SENT_111	[p6l1577t1869r1987b1970],
2	We	PRP	O	we	nsubj	3	SENT_111	[p6l2030t1896r2148b1949],
3	agree	VBP	O	agree	advcl	25	SENT_111	[p6l11t2023r243b2098],
4	that	IN	O	that	complm	20	SENT_111	[p6l281t1997r455b2076],
5	data	NNS	O	datum	nsubj	20	SENT_111	[p6l487t1997r672b2076],
6	providing	VBG	O	provide	partmod	5	SENT_111	[p6l706t1997r1127b2098],
7	support	NN	O	support	dobj	6	SENT_111	[p6l1162t2014r1498b2098],
8	for	IN	O	for	_	0	SENT_111	[p6l1530t1997r1653b2076],
9	the	DT	O	the	det	11	SENT_111	[p6l1688t1997r1822b2076],
10	double	JJ	O	double	amod	11	SENT_111	[p6l1861t1997r2148b2076],
11	dose	NN	O	dose	prep_for	6	SENT_111	[p6l12t2125r208b2204],
12	of	IN	O	of	_	0	SENT_111	[p6l250t2125r351b2204],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_111	[p6l374t2125r860b2226],
14	for	IN	O	for	_	0	SENT_111	[p6l900t2125r1024b2204],
15	the	DT	DURATION	the	det	18	SENT_111	[p6l1063t2125r1196b2204],
16	first	JJ	DURATION	first	amod	18	SENT_111	[p6l1238t2125r1423b2204],
17	6	CD	DURATION	6	num	18	SENT_111	[p6l1460t2131r1507b2204],
18	days	NNS	NUMBER	day	prep_for	13	SENT_111	[p6l1549t2125r1735b2226],
19	are	VBP	O	be	aux	20	SENT_111	[p6l1778t2151r1907b2204],
20	lacking	VBG	O	lack	ccomp	3	SENT_111	[p6l1947t2125r2147b2205, p6l11t2254r171b2354],
21	,	,	O	,	_	0	SENT_111	[p6l1947t2125r2147b2205, p6l11t2254r171b2354],
22	We	PRP	O	we	nsubj	25	SENT_111	[p6l202t2280r320b2333],
23	do	VBP	O	do	aux	25	SENT_111	[p6l352t2253r455b2332],
24	not	RB	O	not	neg	25	SENT_111	[p6l486t2270r630b2332],
25	agree	VB	O	agree	_	0	SENT_111	[p6l655t2280r886b2354],
26	with	IN	O	with	_	0	SENT_111	[p6l912t2253r1108b2332],
27	the	DT	O	the	det	30	SENT_111	[p6l1139t2253r1273b2332],
28	proposed	VBN	O	propose	amod	30	SENT_111	[p6l1302t2253r1705b2354],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_111	[p6l1736t2253r2147b2354, p6l12t2382r115b2460],
30	strategy	NN	O	strategy	prep_with	25	SENT_111	[p6l155t2398r493b2482],
31	for	IN	O	for	_	0	SENT_111	[p6l528t2381r650b2460],
32	patients	NNS	O	patient	prep_for	30	SENT_111	[p6l685t2382r1020b2482],
33	with	IN	O	with	_	0	SENT_111	[p6l1057t2381r1251b2460],
34	non	JJ	O	non	prep_with	32	SENT_111	[p6l1289t2387r2011b2482],
35	.	.	O	.	_	0	SENT_111	[p6l1289t2387r2011b2482],

1	—	NN	O	—	_	0	SENT_112	[p6l1289t2387r2011b2482],
2	.	.	O	.	_	0	SENT_112	[p6l1289t2387r2011b2482],

1	ST-segment	JJ	O	st-segment	amod	4	SENT_113	[p6l1289t2387r2011b2482],
2	elevation	NN	O	elevation	nn	4	SENT_113	[p6l2046t2381r2147b2460, p6l13t2510r322b2589],
3	myocardial	JJ	O	myocardial	amod	4	SENT_113	[p6l355t2509r838b2610],
4	infarction	NN	O	infarction	nsubj	11	SENT_113	[p6l870t2509r1300b2588],
5	or	CC	O	or	_	0	SENT_113	[p6l1334t2535r1423b2588],
6	unstable	JJ	O	unstable	amod	7	SENT_113	[p6l1453t2509r1819b2588],
7	angina	NN	O	angina	conj_or	4	SENT_113	[p6l1852t2510r2149b2610],
8	who	WP	O	who	rcmod	7	SENT_113	[p6l8t2637r189b2716],
9	do	VBP	O	do	aux	11	SENT_113	[p6l218t2637r320b2716],
10	not	RB	O	not	neg	11	SENT_113	[p6l348t2654r489b2716],
11	undergo	VB	O	undergo	_	0	SENT_113	[p6l511t2637r863b2738],
12	PCI	NN	O	pcus	nn	15	SENT_113	[p6l889t2643r1037b2716],
13	or	CC	O	or	_	0	SENT_113	[p6l1064t2663r1152b2716],
14	coronary-artery	JJ	O	coronary-artery	nn	15	SENT_113	[p6l1176t2654r1837b2738],
15	bypass	NN	O	bypass	dobj	11	SENT_113	[p6l1860t2637r2146b2738],
16	grafting	VBG	O	graft	partmod	15	SENT_113	[p6l12t2765r371b2866],
17	(	CD	NUMBER	(	num	19	SENT_113	[p6l425t2771r767b2857],
18	CABG	NN	ORGANIZATION	cabg	nn	19	SENT_113	[p6l425t2771r767b2857],
19	)	NN	O	)	dobj	16	SENT_113	[p6l425t2771r767b2857],
20	.	.	O	.	_	0	SENT_113	[p6l425t2771r767b2857],

1	Treatment	NN	O	treatment	nsubj	11	SENT_114	[p6l821t2771r1273b2844],
2	with	IN	O	with	_	0	SENT_114	[p6l1316t2765r1512b2845],
3	aspirin	NN	O	aspirin	prep_with	1	SENT_114	[p6l1564t2766r1865b2866],
4	alone	RB	O	alone	advmod	11	SENT_114	[p6l1917t2765r2148b2844],
5	after	IN	O	after	_	0	SENT_114	[p6l12t2893r215b2972],
6	an	DT	O	a	det	10	SENT_114	[p6l253t2919r356b2972],
7	acute	JJ	O	acute	amod	10	SENT_114	[p6l398t2910r621b2972],
8	coronary	JJ	O	coronary	amod	10	SENT_114	[p6l665t2919r1052b2994],
9	ischemic	JJ	O	ischemic	amod	10	SENT_114	[p6l1088t2893r1470b2972],
10	event	NN	O	event	prep_after	4	SENT_114	[p6l1513t2910r1738b2972],
11	is	VBZ	O	be	_	0	SENT_114	[p6l1774t2894r1840b2972],
12	not	RB	O	not	neg	11	SENT_114	[p6l1884t2910r2028b2972],
13	in	IN	O	in	_	0	SENT_114	[p6l2064t2894r2148b2971],
14	accordance	NN	O	accordance	prep_in	11	SENT_114	[p6l12t3021r485b3100],
15	with	IN	O	with	_	0	SENT_114	[p6l508t3021r702b3100],
16	recommendations	NNS	O	recommendation	prep_with	11	SENT_114	[p6l727t3021r1497b3100],
17	made	VBN	O	make	partmod	16	SENT_114	[p6l1526t3021r1755b3100],
18	by	IN	O	by	_	0	SENT_114	[p6l1783t3021r1879b3122],
19	scientific	JJ	O	scientific	amod	20	SENT_114	[p6l1903t3022r2147b3100, p6l12t3149r188b3228],
20	societies	NNS	O	society	agent	17	SENT_114	[p6l218t3150r608b3228],
21	.	.	O	.	_	0	SENT_114	[p6l218t3150r608b3228],

1	Indeed	RB	O	indeed	dep	11	SENT_115	[p6l642t3149r960b3245],
2	,	,	O	,	_	0	SENT_115	[p6l642t3149r960b3245],
3	the	DT	O	the	dep	11	SENT_115	[p6l995t3149r1128b3228],
4	guidelines	NNS	O	guideline	nsubj	11	SENT_115	[p6l1157t3149r1605b3250],
5	of	IN	O	of	_	0	SENT_115	[p6l1637t3149r1738b3228],
6	the	DT	O	the	det	8	SENT_115	[p6l1748t3149r1882b3228],
7	European	JJ	ORGANIZATION	european	amod	8	SENT_115	[p6l1910t3157r2147b3228, p6l11t3303r220b3378],
8	Society	NNP	ORGANIZATION	Society	prep_of	4	SENT_115	[p6l261t3278r568b3378],
9	of	IN	ORGANIZATION	of	_	0	SENT_115	[p6l602t3277r703b3356],
10	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	8	SENT_115	[p6l722t3277r1200b3378],
11	recommend	VB	O	recommend	_	0	SENT_115	[p6l1234t3277r1751b3356],
12	the	DT	O	the	det	13	SENT_115	[p6l1789t3277r1923b3356],
13	continuation	NN	O	continuation	dobj	11	SENT_115	[p6l1962t3303r2147b3356, p6l12t3406r410b3484],
14	of	IN	O	of	_	0	SENT_115	[p6l449t3405r550b3484],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_115	[p6l570t3405r1056b3506],
16	therapy	NN	O	therapy	prep_of	13	SENT_115	[p6l1095t3405r1418b3506],
17	for	IN	O	for	_	0	SENT_115	[p6l1452t3405r1577b3484],
18	12	CD	DURATION	12	num	19	SENT_115	[p6l1615t3411r1713b3483],
19	months	NNS	NUMBER	month	prep_for	16	SENT_115	[p6l1753t3405r2148b3501],
20	}	CD	NUMBER	}	npadvmod	11	SENT_115	[p6l1753t3405r2148b3501],
21	Whereas	IN	O	whereas	_	0	SENT_115	[p6l7t3534r361b3613],
22	the	DT	O	the	det	25	SENT_115	[p6l396t3534r529b3613],
23	American	JJ	MISC	american	amod	25	SENT_115	[p6l558t3535r981b3613],
24	Heart	NNP	MISC	Heart	nn	25	SENT_115	[p6l1013t3542r1260b3613],
25	AssociationAmerican	NNP	MISC	AssociationAmerican	prep_whereas	11	SENT_115	[p6l1283t3535r2147b3613, p6l12t3688r163b3741],

1	College	NNP	O	College	_	0	SENT_116	[p6l191t3662r511b3763],
2	of	IN	O	of	_	0	SENT_116	[p6l540t3662r641b3741],
3	Cardiology	NNP	O	Cardiology	nn	4	SENT_116	[p6l651t3662r1129b3763],
4	guidelines	NNS	O	guideline	prep_of	1	SENT_116	[p6l1152t3662r1600b3763],
5	recommend	VB	O	recommend	dep	4	SENT_116	[p6l1631t3662r2148b3741],
6	at	IN	DURATION	at	quantmod	8	SENT_116	[p7l11t37r90b99],
7	least	JJS	DURATION	least	mwe	6	SENT_116	[p7l134t20r335b99],
8	1	CD	DURATION	1	num	9	SENT_116	[p7l383t26r428b98],
9	month	NN	NUMBER	month	dobj	5	SENT_116	[p7l478t20r765b99],
10	of	IN	O	of	_	0	SENT_116	[p7l817t20r917b99],
11	treatment	NN	O	treatment	prep_of	9	SENT_116	[p7l949t37r1375b99],
12	with	IN	O	with	_	0	SENT_116	[p7l1416t20r1612b99],
13	clopidogrel	NN	O	clopidogrel	prep_with	5	SENT_116	[p7l1663t20r2149b121],
14	and	CC	O	and	_	0	SENT_116	[p7l11t148r170b227],
15	ideally	RB	O	ideally	advmod	16	SENT_116	[p7l208t148r492b249],
16	up	RB	DURATION	up	dep	4	SENT_116	[p7l526t174r630b249],
17	to	TO	DURATION	to	_	0	SENT_116	[p7l671t165r753b227],
18	1	CD	DURATION	1	num	19	SENT_116	[p7l797t154r841b226],
19	year	NN	NUMBER	year	prep_to	16	SENT_116	[p7l876t174r1057b249],
20	of	IN	O	of	_	0	SENT_116	[p7l1093t148r1194b227],
21	treatment.-3	NN	O	treatment.-3	prep_of	19	SENT_116	[p7l1215t154r1701b227],
22	Although	IN	O	although	mark	24	SENT_116	[p7l1738t148r2148b249],
23	the	DT	O	the	det	24	SENT_116	[p7l12t276r146b355],
24	benefits	NNS	O	benefit	dep	16	SENT_116	[p7l197t276r543b355],
25	of	IN	O	of	_	0	SENT_116	[p7l596t276r697b355],
26	double	JJ	O	double	amod	31	SENT_116	[p7l729t276r1544b377],
27	—	JJ	O	—	amod	31	SENT_116	[p7l729t276r1544b377],
28	antiplatelet	JJ	O	antiplatelet	amod	31	SENT_116	[p7l729t276r1544b377],
29	therapy	NN	O	therapy	nn	31	SENT_116	[p7l1590t276r1914b377],
30	(	NN	O	(	nn	31	SENT_116	[p7l1964t276r2147b368, p7l11t404r363b505],
31	clopidogrel	NN	O	clopidogrel	prep_of	24	SENT_116	[p7l1964t276r2147b368, p7l11t404r363b505],
32	plus	CC	O	plus	prep	24	SENT_116	[p7l385t404r559b505],
33	aspirin	NN	O	aspirin	nn	34	SENT_116	[p7l584t405r903b505],
34	)	NN	O	)	dep	32	SENT_116	[p7l584t405r903b505],
35	in	IN	O	in	_	0	SENT_116	[p7l931t405r1014b482],
36	acute	JJ	O	acute	amod	38	SENT_116	[p7l1037t421r1256b483],
37	coronary	JJ	O	coronary	amod	38	SENT_116	[p7l1281t430r1660b505],
38	syndromes	NNS	O	syndrome	prep_in	16	SENT_116	[p7l1682t404r2146b505],

1	2466	CD	DATE	2466	num	4	SENT_117	[p7l149t580r226b603],
2	N	NN	O	n	nn	4	SENT_117	[p7l930t591r944b606],
3	ENGLJ	NN	O	englj	nn	4	SENT_117	[p7l958t591r1036b613],
4	MED	NN	O	med	_	0	SENT_117	[p7l1051t591r1103b606],
5	36	CD	NUMBER	36	dep	4	SENT_117	[p7l1113t585r1141b613],
6	;	:	O	;	_	0	SENT_117	[p7l1158t591r1177b611],
7	2	CD	NUMBER	2	num	9	SENT_117	[p7l1158t591r1177b611],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_117	[p7l1226t591r1350b613],
9	DECEMBER16	NN	O	december16	dep	5	SENT_117	[p7l1386t585r1630b611],
10	,2010	CD	NUMBER	,2010	dep	9	SENT_117	[p7l1386t585r1630b611],

1	The	DT	O	the	det	4	SENT_118	[p7l936t624r987b648],
2	New	NNP	O	New	nn	4	SENT_118	[p7l996t625r1058b648],
3	Englan	NNP	O	Englan	nn	4	SENT_118	[p7l1067t624r1161b655],
4	ournal	NN	O	ournal	_	0	SENT_118	[p7l1200t624r1284b648],
5	of	IN	O	of	_	0	SENT_118	[p7l1294t624r1323b648],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_118	[p7l1330t624r1455b648],

1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_119	[p7l926t812r1233b831],

1	are	VBP	O	be	cop	2	SENT_120	[p7l15t1052r144b1105],
2	greater	JJR	O	greater	ccomp	9	SENT_120	[p7l188t1043r495b1127],
3	in	IN	O	in	_	0	SENT_120	[p7l536t1027r619b1104],
4	patients	NNS	O	patient	prep_in	2	SENT_120	[p7l663t1027r1006b1127],
5	undergoing	VBG	O	undergo	partmod	4	SENT_120	[p7l1052t1026r1555b1127],
6	PCI	NNP	O	PCI	dobj	5	SENT_120	[p7l1595t1032r1768b1122],
7	,	,	O	,	_	0	SENT_120	[p7l1595t1032r1768b1122],
8	there	EX	O	there	expl	9	SENT_120	[p7l1818t1026r2035b1105],
9	is	VBZ	O	be	_	0	SENT_120	[p7l2080t1027r2146b1105],
10	clear	JJ	O	clear	amod	11	SENT_120	[p7l16t1155r222b1234],
11	evidence	NN	O	evidence	nsubj	9	SENT_120	[p7l269t1155r636b1234],
12	of	IN	O	of	_	0	SENT_120	[p7l685t1155r786b1234],
13	a	DT	O	a	det	15	SENT_120	[p7l816t1182r860b1234],
14	significant	JJ	O	significant	amod	15	SENT_120	[p7l909t1155r1379b1256],
15	reduction	NN	O	reduction	prep_of	11	SENT_120	[p7l1423t1155r1834b1234],
16	in	IN	O	in	_	0	SENT_120	[p7l1882t1156r1966b1233],
17	the	DT	O	the	det	18	SENT_120	[p7l2015t1155r2148b1234],
18	risk	NN	O	risk	prep_in	15	SENT_120	[p7l15t1294r182b1374],
19	of	IN	O	of	_	0	SENT_120	[p7l219t1294r320b1373],
20	the	DT	O	the	det	23	SENT_120	[p7l342t1294r478b1373],
21	composite	JJ	O	composite	amod	23	SENT_120	[p7l518t1295r970b1395],
22	end	NN	O	end	nn	23	SENT_120	[p7l1011t1294r1167b1373],
23	point	NN	O	point	prep_of	18	SENT_120	[p7l1205t1295r1441b1395],
24	(	CD	NUMBER	(	num	26	SENT_120	[p7l1480t1294r2152b1386],
25	cardiovascular	JJ	O	cardiovascular	amod	26	SENT_120	[p7l1480t1294r2152b1386],
26	death	NN	O	death	dep	23	SENT_120	[p7l16t1433r277b1529],
27	,	,	O	,	_	0	SENT_120	[p7l16t1433r277b1529],
28	myocardial	JJ	O	myocardial	amod	29	SENT_120	[p7l323t1433r806b1534],
29	infarction	NN	O	infarction	npadvmod	35	SENT_120	[p7l846t1433r1299b1529],
30	,	,	O	,	_	0	SENT_120	[p7l846t1433r1299b1529],
31	or	CC	O	or	_	0	SENT_120	[p7l1346t1459r1436b1512],
32	stroke	NN	O	stroke	nn	33	SENT_120	[p7l1475t1433r1788b1529],
33	)	NN	O	)	npadvmod	35	SENT_120	[p7l1475t1433r1788b1529],
34	,	,	O	,	_	0	SENT_120	[p7l1475t1433r1788b1529],
35	even	RB	O	even	advmod	23	SENT_120	[p7l1835t1459r2025b1512],
36	in	IN	O	in	_	0	SENT_120	[p7l2065t1434r2148b1511],
37	patients	NNS	O	patient	prep_in	35	SENT_120	[p7l13t1572r356b1672],
38	who	WP	O	who	nsubj	41	SENT_120	[p7l389t1571r573b1651],
39	are	VBP	O	be	aux	41	SENT_120	[p7l608t1597r738b1650],
40	not	RB	O	not	neg	41	SENT_120	[p7l773t1588r916b1650],
41	undergoing	VBG	O	undergo	rcmod	23	SENT_120	[p7l946t1571r1449b1672],
42	PCL4	NN	O	pcl4	nn	44	SENT_120	[p7l1480t1576r1696b1650],
43	Pierluigi	NNP	PERSON	Pierluigi	nn	44	SENT_120	[p7l24t1709r370b1814],
44	Merella	NNP	PERSON	Merella	dobj	41	SENT_120	[p7l414t1709r758b1803],
45	,	,	O	,	_	0	SENT_120	[p7l414t1709r758b1803],
46	M.D.	NNP	ORGANIZATION	M.D.	nn	50	SENT_120	[p7l803t1716r1009b1788],
47	Universita	NNP	ORGANIZATION	Universita	nn	50	SENT_120	[p7l19t1858r358b1914],
48	di	NNP	O	di	nn	50	SENT_120	[p7l384t1852r439b1913],
49	Sassari	NNP	LOCATION	Sassari	nn	50	SENT_120	[p7l467t1857r701b1913],
50	Sassari	NNP	LOCATION	Sassari	appos	44	SENT_120	[p7l16t1953r270b2019],
51	,	,	O	,	_	0	SENT_120	[p7l16t1953r270b2019],
52	Italy	NNP	LOCATION	Italy	nn	55	SENT_120	[p7l304t1948r439b2028],
53	pier	NN	O	pier	nn	55	SENT_120	[p7l18t2044r742b2124],
54	|	NN	O	|	nn	55	SENT_120	[p7l18t2044r742b2124],
55	uigi9@hotmai	NN	O	uigi9@hotmai	appos	44	SENT_120	[p7l18t2044r742b2124],
56	|	NN	O	|	dep	55	SENT_120	[p7l18t2044r742b2124],
57	.	.	O	.	_	0	SENT_120	[p7l18t2044r742b2124],

1	it	PRP	O	it	_	0	SENT_121	[p7l18t2044r742b2124],

1	Gavino	NNP	PERSON	Gavino	nn	2	SENT_122	[p7l17t2187r326b2261],
2	Casu	NNP	PERSON	Casu	_	0	SENT_122	[p7l361t2187r598b2275],
3	,	,	O	,	_	0	SENT_122	[p7l361t2187r598b2275],
4	M.D.	NNP	PERSON	M.D.	nn	6	SENT_122	[p7l644t2188r850b2261],
5	Ivan	NNP	PERSON	Ivan	nn	6	SENT_122	[p7l24t2321r194b2394],
6	Meloni	NNP	PERSON	Meloni	appos	2	SENT_122	[p7l239t2313r561b2408],
7	,	,	O	,	_	0	SENT_122	[p7l239t2313r561b2408],
8	M.D.	NNP	ORGANIZATION	M.D.	nn	14	SENT_122	[p7l606t2321r813b2394],
9	Cardiologia	NNP	ORGANIZATION	Cardiologia	nn	14	SENT_122	[p7l16t2457r399b2537],
10	Ospedale	NNP	ORGANIZATION	Ospedale	nn	14	SENT_122	[p7l426t2457r746b2536],
11	San	NNP	ORGANIZATION	San	nn	14	SENT_122	[p7l772t2462r889b2518],
12	Francesco	NNP	ORGANIZATION	Francesco	nn	14	SENT_122	[p7l922t2463r1256b2518],
13	N	NNP	ORGANIZATION	N	nn	14	SENT_122	[p7l20t2559r64b2614],
14	uoro	NN	O	uoro	appos	2	SENT_122	[p7l80t2575r248b2624],
15	,	,	O	,	_	0	SENT_122	[p7l80t2575r248b2624],
16	Italy	NNP	LOCATION	Italy	appos	2	SENT_122	[p7l281t2553r416b2633],

1	N	NN	O	n	nn	2	SENT_123	[p7l99t2662r155b2716],
2	o	NN	O	o	nn	4	SENT_123	[p7l158t2676r194b2716],
3	potential	JJ	O	potential	amod	4	SENT_123	[p7l220t2656r519b2732],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_123	[p7l545t2656r805b2716],
5	of	IN	O	of	_	0	SENT_123	[p7l828t2656r904b2716],
6	interest	NN	O	interest	prep_of	4	SENT_123	[p7l916t2657r1168b2715],
7	relevant	JJ	O	relevant	amod	6	SENT_123	[p7l1190t2656r1453b2717],
8	to	TO	O	to	_	0	SENT_123	[p7l1476t2669r1537b2716],
9	this	DT	O	this	det	10	SENT_123	[p7l1565t2656r1688b2715],
10	letter	NN	O	letter	prep_to	7	SENT_123	[p7l1715t2656r1889b2715],
11	was	VBD	O	be	auxpass	12	SENT_123	[p7l1909t2676r2034b2717],
12	reported	VBN	O	report	_	0	SENT_123	[p7l2061t2676r2148b2715, p7l13t2753r250b2828],
13	.	.	O	.	_	0	SENT_123	[p7l2061t2676r2148b2715, p7l13t2753r250b2828],

1	1	LS	NUMBER	1	_	0	SENT_124	[p7l17t2864r66b2916],
2	.	.	O	.	_	0	SENT_124	[p7l17t2864r66b2916],

1	Fuster	NNP	O	Fuster	nn	3	SENT_125	[p7l143t2861r348b2916],
2	V.	NNP	O	V.	nn	3	SENT_125	[p7l369t2861r425b2916],
3	Fine	NNP	O	Fine	_	0	SENT_125	[p7l453t2857r846b2933],
4	—	CD	NUMBER	—	num	6	SENT_125	[p7l453t2857r846b2933],
5	tuning	NN	O	tuning	nn	6	SENT_125	[p7l453t2857r846b2933],
6	therapy	NN	O	therapy	dep	3	SENT_125	[p7l868t2856r1116b2932],
7	for	IN	O	for	_	0	SENT_125	[p7l1136t2856r1231b2916],
8	acute	JJ	O	acute	amod	10	SENT_125	[p7l1253t2869r1424b2916],
9	coronary	JJ	O	coronary	amod	10	SENT_125	[p7l1450t2875r1746b2932],
10	syndromes	NNS	O	syndrome	prep_for	6	SENT_125	[p7l1768t2856r2145b2932],
11	.	.	O	.	_	0	SENT_125	[p7l1768t2856r2145b2932],

1	N	NN	O	n	nn	2	SENT_126	[p7l12t2958r69b3013],
2	EnglJ	NN	O	englj	nsubj	3	SENT_126	[p7l93t2953r288b3030],
3	Med	VBD	O	med	_	0	SENT_126	[p7l310t2953r453b3013],
4	2010	CD	DATE	2010	dobj	3	SENT_126	[p7l479t2957r983b3025],
5	;	:	O	;	_	0	SENT_126	[p7l479t2957r983b3025],
6	363:976	CD	NUMBER	363:976	num	7	SENT_126	[p7l479t2957r983b3025],
7	—	NN	O	—	dep	4	SENT_126	[p7l479t2957r983b3025],
8	7	CD	NUMBER	7	dep	7	SENT_126	[p7l479t2957r983b3025],
9	.	.	O	.	_	0	SENT_126	[p7l479t2957r983b3025],

1	2	LS	NUMBER	2	_	0	SENT_127	[p7l13t3058r67b3109],
2	.	.	O	.	_	0	SENT_127	[p7l13t3058r67b3109],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_128	[p7l141t3050r462b3110],
2	JL	NNP	O	JL	_	0	SENT_128	[p7l482t3055r570b3123],
3	,	,	O	,	_	0	SENT_128	[p7l482t3055r570b3123],
4	Adams	NNP	PERSON	Adams	nn	5	SENT_128	[p7l599t3050r828b3110],
5	CD	NNP	O	CD	appos	2	SENT_128	[p7l856t3054r972b3123],
6	,	,	O	,	_	0	SENT_128	[p7l856t3054r972b3123],
7	Antman	NNP	PERSON	Antman	nn	8	SENT_128	[p7l1000t3055r1271b3109],
8	EM	NNP	O	EM	appos	2	SENT_128	[p7l1297t3055r1423b3123],
9	,	,	O	,	_	0	SENT_128	[p7l1297t3055r1423b3123],
10	et	FW	O	et	nn	11	SENT_128	[p7l1455t3063r1514b3109],
11	al.	FW	O	al.	appos	2	SENT_128	[p7l1537t3050r1611b3110],
12	.	.	O	.	_	0	SENT_128	[p7l1537t3050r1611b3110],

1	ACC/AHA	NNP	O	ACC/AHA	nn	3	SENT_129	[p7l1640t3054r1967b3118],
2	2007	CD	DATE	2007	num	3	SENT_129	[p7l1992t3054r2148b3110],
3	guidelines	NNS	O	guideline	_	0	SENT_129	[p7l14t3146r349b3223],
4	for	IN	O	for	_	0	SENT_129	[p7l376t3146r469b3206],
5	the	DT	O	the	det	6	SENT_129	[p7l492t3146r592b3205],
6	management	NN	O	management	prep_for	3	SENT_129	[p7l616t3159r1044b3223],
7	of	IN	O	of	_	0	SENT_129	[p7l1066t3146r1141b3206],
8	patients	NNS	O	patient	prep_of	6	SENT_129	[p7l1151t3147r1409b3222],
9	with	IN	O	with	_	0	SENT_129	[p7l1432t3146r1579b3206],
10	unstable	JJ	O	unstable	amod	12	SENT_129	[p7l1603t3146r1878b3206],
11	angina	NN	O	angina	nn	12	SENT_129	[p7l1902t3147r2148b3223],
12	]	NN	O	]	prep_with	8	SENT_129	[p7l1902t3147r2148b3223],
13	non	JJ	O	non	amod	3	SENT_129	[p7l14t3243r558b3303],
14	.	.	O	.	_	0	SENT_129	[p7l14t3243r558b3303],

1	—	NN	O	—	_	0	SENT_130	[p7l14t3243r558b3303],
2	.	.	O	.	_	0	SENT_130	[p7l14t3243r558b3303],

1	ST	JJ	O	st	_	0	SENT_131	[p7l14t3243r558b3303],
2	.	.	O	.	_	0	SENT_131	[p7l14t3243r558b3303],

1	—	NN	O	—	_	0	SENT_132	[p7l14t3243r558b3303],
2	.	.	O	.	_	0	SENT_132	[p7l14t3243r558b3303],

1	elevation	NN	O	elevation	nn	3	SENT_133	[p7l14t3243r558b3303],
2	myocardial	JJ	O	myocardial	amod	3	SENT_133	[p7l584t3243r946b3318],
3	infarction	NN	O	infarction	_	0	SENT_133	[p7l970t3243r1311b3302],
4	:	:	O	:	_	0	SENT_133	[p7l970t3243r1311b3302],
5	a	DT	O	a	det	6	SENT_133	[p7l1339t3262r1373b3302],
6	report	NN	O	report	nsubj	20	SENT_133	[p7l1397t3256r1598b3318],
7	of	IN	O	of	_	0	SENT_133	[p7l1620t3243r1696b3302],
8	the	DT	O	the	det	10	SENT_133	[p7l1707t3243r1807b3302],
9	American	NNP	ORGANIZATION	American	nn	10	SENT_133	[p7l1830t3244r2149b3302],
10	College	NNP	ORGANIZATION	College	prep_of	6	SENT_133	[p7l14t3340r255b3417],
11	of	IN	ORGANIZATION	of	_	0	SENT_133	[p7l281t3340r356b3400],
12	Cardiology/American	NNP	ORGANIZATION	Cardiology/American	nn	16	SENT_133	[p7l368t3340r1060b3417],
13	Heart	NNP	ORGANIZATION	Heart	nn	16	SENT_133	[p7l1084t3345r1270b3399],
14	Association	NNP	ORGANIZATION	Association	nn	16	SENT_133	[p7l1289t3341r1670b3400],
15	Task	NNP	ORGANIZATION	Task	nn	16	SENT_133	[p7l1692t3340r1847b3400],
16	Force	NNP	ORGANIZATION	Force	prep_of	10	SENT_133	[p7l1868t3345r2043b3400],
17	on	IN	O	on	_	0	SENT_133	[p7l2069t3359r2149b3400],
18	Practice	NNP	O	Practice	nn	19	SENT_133	[p7l13t3438r273b3496],
19	Guidelines	NNS	O	guideline	prep_on	16	SENT_133	[p7l300t3437r656b3497],
20	(	VBP	O	(	dep	3	SENT_133	[p7l687t3438r1077b3506],
21	Committee	NNP	O	Committee	dobj	20	SENT_133	[p7l687t3438r1077b3506],
22	on	IN	O	on	_	0	SENT_133	[p7l1104t3456r1185b3497],
23	the	DT	O	the	det	24	SENT_133	[p7l1212t3437r1314b3496],
24	Management	NN	O	management	prep_on	21	SENT_133	[p7l1338t3442r1775b3514],
25	of	IN	O	of	_	0	SENT_133	[p7l1798t3437r1874b3497],
26	Patients	NNS	O	patient	prep_of	24	SENT_133	[p7l1886t3438r2148b3496],
27	With	IN	O	with	_	0	SENT_133	[p7l11t3534r174b3593],
28	Unstable	JJ	O	unstable	amod	30	SENT_133	[p7l210t3534r501b3594],
29	Angina	NNP	O	Angina	nn	30	SENT_133	[p7l535t3535r818b3611],
30	)	NN	O	)	prep_with	26	SENT_133	[p7l535t3535r818b3611],
31	.	.	O	.	_	0	SENT_133	[p7l535t3535r818b3611],

1	J	NNP	O	J	nn	4	SENT_134	[p7l851t3539r880b3603],
2	Am	NNP	O	Am	nn	4	SENT_134	[p7l912t3539r1028b3593],
3	Coll	NNP	O	Coll	nn	4	SENT_134	[p7l1065t3534r1198b3594],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_134	[p7l1234t3534r1476b3594],
5	2007	CD	DATE	2007	dep	4	SENT_134	[p7l1513t3538r2145b3606],
6	;	:	O	;	_	0	SENT_134	[p7l1513t3538r2145b3606],
7	50	CD	NUMBER	50	number	8	SENT_134	[p7l1513t3538r2145b3606],
8	(	CD	NUMBER	(	dep	4	SENT_134	[p7l1513t3538r2145b3606],
9	7	CD	NUMBER	7	num	10	SENT_134	[p7l1513t3538r2145b3606],
10	)	NN	O	)	dep	8	SENT_134	[p7l1513t3538r2145b3606],
11	:	:	O	:	_	0	SENT_134	[p7l1513t3538r2145b3606],
12	e1	NN	O	e1	dep	4	SENT_134	[p7l1513t3538r2145b3606],
13	—	CD	NUMBER	—	num	14	SENT_134	[p7l1513t3538r2145b3606],
14	e157	NN	O	e157	dep	12	SENT_134	[p7l1513t3538r2145b3606],
15	.	.	O	.	_	0	SENT_134	[p7l1513t3538r2145b3606],

1	[	NN	O	[	nn	2	SENT_135	[p7l21t3635r336b3701],
2	Erratum	NN	O	erratum	nsubj	7	SENT_135	[p7l21t3635r336b3701],
3	,	,	O	,	_	0	SENT_135	[p7l21t3635r336b3701],
4	J	NNP	O	J	appos	2	SENT_135	[p7l358t3635r387b3699],
5	Am	VBP	O	be	cop	7	SENT_135	[p7l409t3635r525b3688],
6	Coll	NNP	O	Coll	nn	7	SENT_135	[p7l551t3630r684b3689],
7	Cardiol	NNP	O	Cardiol	_	0	SENT_135	[p7l710t3630r952b3689],
8	2008	CD	DATE	2008	dep	7	SENT_135	[p7l977t3634r1410b3701],
9	;	:	O	;	_	0	SENT_135	[p7l977t3634r1410b3701],
10	51:974	CD	NUMBER	51:974	dep	8	SENT_135	[p7l977t3634r1410b3701],
11	.	.	O	.	_	0	SENT_135	[p7l977t3634r1410b3701],
12	]	SYM	O	]	dep	7	SENT_135	[p7l977t3634r1410b3701],

1	3	LS	NUMBER	3	_	0	SENT_136	[p7l14t3734r64b3786],
2	.	.	O	.	_	0	SENT_136	[p7l14t3734r64b3786],

1	Bassand	NNP	O	Bassand	nn	2	SENT_137	[p7l143t3727r417b3787],
2	JP	NNP	O	JP	_	0	SENT_137	[p7l431t3732r513b3800],
3	,	,	O	,	_	0	SENT_137	[p7l431t3732r513b3800],
4	Hamm	NNP	ORGANIZATION	Hamm	nn	5	SENT_137	[p7l537t3732r767b3786],
5	CW	NNP	ORGANIZATION	CW	appos	2	SENT_137	[p7l788t3731r918b3800],
6	,	,	O	,	_	0	SENT_137	[p7l788t3731r918b3800],
7	Ardissino	NN	O	ardissino	nn	8	SENT_137	[p7l941t3727r1261b3787],
8	D	NN	O	d	appos	2	SENT_137	[p7l1283t3732r1351b3799],
9	,	,	O	,	_	0	SENT_137	[p7l1283t3732r1351b3799],
10	et	FW	O	et	nn	11	SENT_137	[p7l1377t3740r1436b3786],
11	al.	FW	O	al.	appos	2	SENT_137	[p7l1454t3727r1528b3787],
12	.	.	O	.	_	0	SENT_137	[p7l1454t3727r1528b3787],

1	Guidelines	NNS	O	guideline	_	0	SENT_138	[p7l1554t3727r1909b3787],
2	for	IN	O	for	_	0	SENT_138	[p7l1932t3727r2027b3787],
3	the	DT	O	the	det	4	SENT_138	[p7l2047t3727r2149b3786],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_138	[p8l15t19r331b96],
5	and	CC	O	and	_	0	SENT_138	[p8l358t19r478b79],
6	treatment	NN	O	treatment	prep_for	1	SENT_138	[p8l505t32r831b78],
7	of	IN	O	of	_	0	SENT_138	[p8l853t19r929b79],
8	non	JJ	O	non	prep_of	4	SENT_138	[p8l941t23r1484b96],
9	.	.	O	.	_	0	SENT_138	[p8l941t23r1484b96],

1	—	NN	O	—	_	0	SENT_139	[p8l941t23r1484b96],
2	.	.	O	.	_	0	SENT_139	[p8l941t23r1484b96],

1	ST-segment	JJ	O	st-segment	amod	2	SENT_140	[p8l941t23r1484b96],
2	elevation	NN	O	elevation	_	0	SENT_140	[p8l1506t19r1800b79],
3	acute	JJ	O	acute	amod	5	SENT_140	[p8l1825t32r1996b79],
4	coronary	JJ	O	coronary	amod	5	SENT_140	[p8l2023t38r2148b79, p8l15t134r204b190],
5	syndromes	NNS	O	syndrome	dep	2	SENT_140	[p8l228t115r605b190],
6	.	.	O	.	_	0	SENT_140	[p8l228t115r605b190],

1	Eur	NNP	O	Eur	nn	2	SENT_141	[p8l634t120r749b175],
2	Heart	NNP	O	Heart	_	0	SENT_141	[p8l772t120r1004b184],
3	]	CD	NUMBER	]	num	4	SENT_141	[p8l772t120r1004b184],
4	2007	CD	DATE	2007	dep	2	SENT_141	[p8l1029t119r1631b186],
5	;	:	O	;	_	0	SENT_141	[p8l1029t119r1631b186],
6	28:1598	CD	NUMBER	28:1598	num	7	SENT_141	[p8l1029t119r1631b186],
7	—	NN	O	—	dep	2	SENT_141	[p8l1029t119r1631b186],
8	660	CD	NUMBER	660	dep	7	SENT_141	[p8l1029t119r1631b186],
9	.	.	O	.	_	0	SENT_141	[p8l1029t119r1631b186],

1	4	LS	NUMBER	4	_	0	SENT_142	[p8l12t220r66b272],
2	.	.	O	.	_	0	SENT_142	[p8l12t220r66b272],

1	The	DT	O	the	det	2	SENT_143	[p8l141t212r264b271],
2	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_143	[p8l304t212r691b289],
3	in	IN	O	in	_	0	SENT_143	[p8l729t213r793b271],
4	Unstable	NNP	O	Unstable	nn	5	SENT_143	[p8l832t212r1122b272],
5	Angina	NNP	O	Angina	prep_in	2	SENT_143	[p8l1159t213r1402b289],
6	to	TO	O	to	aux	7	SENT_143	[p8l1441t225r1503b272],
7	Prevent	VB	O	prevent	infmod	2	SENT_143	[p8l1542t217r1788b272],
8	Recurrent	JJ	O	recurrent	amod	9	SENT_143	[p8l1822t217r2153b275],
9	Events	NNS	O	event	nsubj	11	SENT_143	[p8l13t314r216b368],
10	Trial	NNP	O	Trial	nn	11	SENT_143	[p8l234t308r384b367],
11	Investigators	NNS	O	investigator	xcomp	7	SENT_143	[p8l403t309r828b385],
12	.	.	O	.	_	0	SENT_143	[p8l403t309r828b385],

1	Effects	NNS	O	effect	_	0	SENT_144	[p8l851t308r1068b367],
2	of	IN	O	of	_	0	SENT_144	[p8l1090t308r1165b368],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_144	[p8l1171t308r1528b385],
4	in	IN	O	in	_	0	SENT_144	[p8l1546t309r1608b367],
5	addition	NN	O	addition	prep_in	1	SENT_144	[p8l1628t308r1891b368],
6	to	TO	O	to	_	0	SENT_144	[p8l1912t321r1972b368],
7	aspirin	NN	O	aspirin	prep_to	1	SENT_144	[p8l1992t309r2148b384, p8l14t407r108b465],
8	in	IN	O	in	_	0	SENT_144	[p8l139t407r202b465],
9	patients	NNS	O	patient	prep_in	7	SENT_144	[p8l232t407r496b482],
10	with	IN	O	with	_	0	SENT_144	[p8l525t406r675b466],
11	acute	JJ	O	acute	amod	13	SENT_144	[p8l706t419r877b466],
12	coronary	JJ	O	coronary	amod	13	SENT_144	[p8l909t425r1205b482],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_144	[p8l1234t406r1592b482],
14	Without	IN	O	without	_	0	SENT_144	[p8l1621t406r1882b466],
15	ST	JJ	O	st	amod	17	SENT_144	[p8l1912t410r2148b483],
16	—	NN	O	—	nn	17	SENT_144	[p8l1912t410r2148b483],
17	seg	NN	O	seg	prep_without	1	SENT_144	[p8l1912t410r2148b483],
18	—	CD	NUMBER	—	num	20	SENT_144	[p8l1912t410r2148b483],
19	ment	NN	O	ment	nn	20	SENT_144	[p8l14t516r183b562],
20	elevation	NN	O	elevation	dep	17	SENT_144	[p8l206t503r518b563],
21	.	.	O	.	_	0	SENT_144	[p8l206t503r518b563],

1	N	NN	O	n	nn	3	SENT_145	[p8l546t508r603b563],
2	Engl	NNP	O	Engl	nn	3	SENT_145	[p8l627t503r776b580],
3	J	NNP	O	J	nsubj	4	SENT_145	[p8l794t508r822b572],
4	Med	VBD	O	med	_	0	SENT_145	[p8l843t503r986b563],
5	2001	CD	DATE	2001	dobj	4	SENT_145	[p8l1012t507r1614b575],
6	;	:	O	;	_	0	SENT_145	[p8l1012t507r1614b575],
7	345:494	CD	NUMBER	345:494	num	8	SENT_145	[p8l1012t507r1614b575],
8	-502	CD	NUMBER	-502	dep	5	SENT_145	[p8l1012t507r1614b575],
9	.	.	O	.	_	0	SENT_145	[p8l1012t507r1614b575],

1	[	NN	O	[	nsubj	6	SENT_146	[p8l1650t508r1892b575],
2	Errata	NNP	O	Errata	nn	5	SENT_146	[p8l1650t508r1892b575],
3	,	,	O	,	_	0	SENT_146	[p8l1650t508r1892b575],
4	N	NNP	O	N	appos	5	SENT_146	[p8l1921t508r1977b563],
5	Engl	NNP	ORGANIZATION	Engl	dep	1	SENT_146	[p8l2001t503r2149b580],
6	JMed	VBD	O	jmed	_	0	SENT_146	[p8l7t600r199b669],
7	2001	CD	DATE	2001	dobj	6	SENT_146	[p8l226t604r723b673],
8	;	:	O	;	_	0	SENT_146	[p8l226t604r723b673],
9	345:1506	CD	NUMBER	345:1506	dep	7	SENT_146	[p8l226t604r723b673],
10	,	,	O	,	_	0	SENT_146	[p8l226t604r723b673],
11	1706	CD	DATE	1706	dep	9	SENT_146	[p8l756t604r947b669],
12	.	.	O	.	_	0	SENT_146	[p8l756t604r947b669],
13	]	SYM	O	]	dep	7	SENT_146	[p8l756t604r947b669],

1	THE	DT	O	the	det	3	SENT_147	[p8l13t892r178b946],
2	AUTHORS	NNS	O	author	nn	3	SENT_147	[p8l214t891r624b947],
3	REPLY	NN	O	reply	_	0	SENT_147	[p8l667t892r933b947],
4	:	:	O	:	_	0	SENT_147	[p8l667t892r933b947],
5	Padrini	NNP	PERSON	Padrini	nsubj	8	SENT_147	[p8l974t868r1288b947],
6	and	CC	O	and	_	0	SENT_147	[p8l1325t868r1484b947],
7	Pengo	NNP	ORGANIZATION	Pengo	conj_and	5	SENT_147	[p8l1521t875r1782b969],
8	suggest	VBP	O	suggest	dep	3	SENT_147	[p8l1824t885r2153b969],
9	that	IN	O	that	complm	21	SENT_147	[p8l16t996r189b1075],
10	genetic	JJ	O	genetic	amod	11	SENT_147	[p8l216t997r526b1097],
11	factors	NNS	O	factor	nsubj	21	SENT_147	[p8l558t996r850b1075],
12	associated	VBN	O	associate	partmod	11	SENT_147	[p8l883t996r1331b1075],
13	with	IN	O	with	_	0	SENT_147	[p8l1359t996r1555b1076],
14	a	DT	O	a	det	16	SENT_147	[p8l1587t1023r1632b1075],
15	reduced	VBN	O	reduce	amod	16	SENT_147	[p8l1663t996r2001b1075],
16	response	NN	O	response	prep_with	12	SENT_147	[p8l2034t1022r2147b1075, p8l16t1150r301b1225],
17	to	TO	O	to	_	0	SENT_147	[p8l330t1141r409b1203],
18	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_147	[p8l439t1124r902b1225],
19	may	MD	O	may	aux	21	SENT_147	[p8l929t1150r1105b1225],
20	have	VB	O	have	aux	21	SENT_147	[p8l1128t1124r1312b1203],
21	attenuated	VBN	O	attenuate	ccomp	8	SENT_147	[p8l1340t1124r1775b1203],
22	the	DT	O	the	det	23	SENT_147	[p8l1803t1124r1932b1203],
23	benefits	NNS	O	benefit	dobj	21	SENT_147	[p8l1960t1124r2147b1203, p8l16t1252r202b1331],
24	of	IN	O	of	_	0	SENT_147	[p8l240t1252r340b1331],
25	double	JJ	O	double	amod	27	SENT_147	[p8l358t1252r882b1331],
26	—	JJ	O	—	amod	27	SENT_147	[p8l358t1252r882b1331],
27	dose	NN	O	dose	prep_of	23	SENT_147	[p8l358t1252r882b1331],
28	as	IN	O	as	prep	21	SENT_147	[p8l917t1279r1003b1331],
29	compared	VBN	O	compare	_	0	SENT_147	[p8l1042t1252r1470b1353],
30	with	IN	O	with	prepc_compared_with	21	SENT_147	[p8l1502t1252r1698b1331],
31	standarddose	NN	O	standarddose	nn	32	SENT_147	[p8l1735t1252r2147b1331, p8l16t1380r208b1459],
32	clopidogrel	NN	O	clopidogrel	pobj	21	SENT_147	[p8l244t1380r719b1481],
33	in	IN	O	in	_	0	SENT_147	[p8l753t1381r836b1458],
34	the	DT	O	the	det	35	SENT_147	[p8l872t1380r1003b1459],
35	CURRENT	NNP	DATE	CURRENT	prep_in	32	SENT_147	[p8l1039t1386r1818b1464],
36	.	.	O	.	_	0	SENT_147	[p8l1039t1386r1818b1464],

1	—	NN	O	—	_	0	SENT_148	[p8l1039t1386r1818b1464],
2	.	.	O	.	_	0	SENT_148	[p8l1039t1386r1818b1464],

1	OASIS	NN	O	oasis	_	0	SENT_149	[p8l1039t1386r1818b1464],
2	7	CD	NUMBER	7	num	3	SENT_149	[p8l1858t1388r1904b1459],
3	trial	NN	O	trial	dep	1	SENT_149	[p8l1941t1380r2143b1459],
4	.	.	O	.	_	0	SENT_149	[p8l1941t1380r2143b1459],

1	Their	PRP$	O	they	poss	2	SENT_150	[p8l12t1508r244b1587],
2	suggestion	NN	O	suggestion	nsubjpass	4	SENT_150	[p8l273t1509r741b1609],
3	is	VBZ	O	be	auxpass	4	SENT_150	[p8l770t1509r836b1587],
4	based	VBN	O	base	_	0	SENT_150	[p8l869t1508r1115b1587],
5	on	IN	O	on	_	0	SENT_150	[p8l1145t1534r1252b1587],
6	analyses	NNS	O	analysis	prep_on	4	SENT_150	[p8l1281t1508r1642b1609],
7	of	IN	O	of	_	0	SENT_150	[p8l1676t1508r1776b1587],
8	observational	JJ	O	observational	amod	9	SENT_150	[p8l1788t1508r2147b1587, p8l16t1636r266b1715],
9	data	NNS	O	datum	prep_of	6	SENT_150	[p8l294t1636r500b1732],
10	,	,	O	,	_	0	SENT_150	[p8l294t1636r500b1732],
11	which	WDT	O	which	nsubj	12	SENT_150	[p8l528t1636r793b1716],
12	indicate	VBP	O	indicate	rcmod	9	SENT_150	[p8l820t1636r1162b1715],
13	that	IN	O	that	complm	20	SENT_150	[p8l1191t1636r1363b1715],
14	the	DT	O	the	det	15	SENT_150	[p8l1386t1636r1519b1715],
15	rate	NN	O	rate	nsubj	20	SENT_150	[p8l1547t1653r1707b1715],
16	of	IN	O	of	_	0	SENT_150	[p8l1736t1636r1837b1715],
17	thrombotic	JJ	O	thrombotic	amod	18	SENT_150	[p8l1846t1636r2147b1715, p8l16t1765r226b1844],
18	events	NNS	O	event	prep_of	15	SENT_150	[p8l258t1782r517b1844],
19	is	VBZ	O	be	cop	20	SENT_150	[p8l551t1766r616b1844],
20	higher	JJR	O	higher	ccomp	12	SENT_150	[p8l650t1765r927b1866],
21	among	IN	O	among	_	0	SENT_150	[p8l956t1791r1252b1866],
22	patients	NNS	O	patient	prep_among	20	SENT_150	[p8l1280t1766r1615b1866],
23	who	WP	O	who	nsubj	24	SENT_150	[p8l1645t1765r1826b1844],
24	receive	VBP	O	receive	rcmod	22	SENT_150	[p8l1860t1766r2148b1844],
25	clopidogrel	NN	O	clopidogrel	dobj	24	SENT_150	[p8l16t1893r501b1994],
26	and	CC	O	and	_	0	SENT_150	[p8l548t1893r706b1972],
27	who	WP	O	who	nsubj	29	SENT_150	[p8l750t1893r933b1972],
28	are	VBP	O	be	cop	29	SENT_150	[p8l982t1920r1112b1972],
29	carriers	NNS	O	carrier	conj_and	20	SENT_150	[p8l1161t1894r1487b1972],
30	of	IN	O	of	_	0	SENT_150	[p8l1538t1893r1638b1972],
31	a	DT	O	a	det	34	SENT_150	[p8l1668t1920r1712b1972],
32	CYPZC19	NN	O	cypzc19	nn	34	SENT_150	[p8l1759t1899r2148b1972],
33	loss	NN	O	loss	nn	34	SENT_150	[p8l14t2021r688b2100],
34	—	NN	O	—	prep_of	29	SENT_150	[p8l14t2021r688b2100],
35	of	IN	O	of	_	0	SENT_150	[p8l14t2021r688b2100],
36	—	CD	NUMBER	—	num	38	SENT_150	[p8l14t2021r688b2100],
37	function	NN	O	function	nn	38	SENT_150	[p8l14t2021r688b2100],
38	polymorphism	NN	O	polymorphism	prep_of	34	SENT_150	[p8l724t2021r1352b2122],
39	than	IN	O	than	advmod	29	SENT_150	[p8l1389t2021r1584b2100],
40	among	IN	O	among	_	0	SENT_150	[p8l1620t2047r1917b2122],
41	noncarriers	NNS	O	noncarrier	prep_among	39	SENT_150	[p8l1952t2047r2147b2100, p8l16t2150r367b2228],
42	.	.	O	.	_	0	SENT_150	[p8l1952t2047r2147b2100, p8l16t2150r367b2228],

1	However	RB	O	however	advmod	5	SENT_151	[p8l402t2157r799b2245],
2	,	,	O	,	_	0	SENT_151	[p8l402t2157r799b2245],
3	these	DT	O	these	det	4	SENT_151	[p8l836t2149r1060b2228],
4	analyses	NNS	O	analysis	nsubj	5	SENT_151	[p8l1091t2149r1452b2250],
5	have	VBP	O	have	_	0	SENT_151	[p8l1484t2149r1675b2228],
6	the	DT	O	the	det	7	SENT_151	[p8l1707t2149r1839b2228],
7	potential	NN	O	potential	dobj	5	SENT_151	[p8l1869t2166r2147b2250, p8l16t2277r155b2356],
8	for	IN	O	for	_	0	SENT_151	[p8l195t2277r318b2356],
9	confounding	VBG	O	confound	prepc_for	7	SENT_151	[p8l357t2277r916b2378],
10	because	IN	O	because	mark	14	SENT_151	[p8l955t2277r1292b2356],
11	they	PRP	O	they	nsubjpass	14	SENT_151	[p8l1334t2277r1518b2378],
12	are	VBP	O	be	auxpass	14	SENT_151	[p8l1553t2303r1682b2356],
13	not	RB	O	not	neg	14	SENT_151	[p8l1724t2294r1867b2356],
14	based	VBN	O	base	advcl	9	SENT_151	[p8l1903t2277r2149b2356],
15	on	IN	O	on	_	0	SENT_151	[p8l16t2431r121b2484],
16	a	DT	O	a	prep_on	14	SENT_151	[p8l151t2432r195b2484],
17	randomized	VBN	O	randomize	partmod	16	SENT_151	[p8l223t2405r737b2484],
18	comparison	NN	O	comparison	dobj	17	SENT_151	[p8l768t2406r1270b2506],
19	and	CC	O	and	_	0	SENT_151	[p8l1300t2405r1457b2484],
20	do	VBP	O	do	aux	22	SENT_151	[p8l1487t2405r1589b2484],
21	not	RB	O	not	neg	22	SENT_151	[p8l1620t2422r1762b2484],
22	involve	VB	O	involve	advcl	9	SENT_151	[p8l1786t2405r2076b2484],
23	a	DT	O	a	det	27	SENT_151	[p8l2106t2432r2150b2484],
24	placebo	NN	O	placebo	nn	27	SENT_151	[p8l14t2533r696b2634],
25	—	NN	O	—	nn	27	SENT_151	[p8l14t2533r696b2634],
26	control	NN	O	control	nn	27	SENT_151	[p8l14t2533r696b2634],
27	group	NN	O	group	dobj	22	SENT_151	[p8l738t2559r1014b2634],
28	.	.	O	.	_	0	SENT_151	[p8l738t2559r1014b2634],

1	Recent	JJ	O	recent	amod	4	SENT_152	[p8l1061t2540r1357b2617],
2	methodologically	RB	O	methodologically	advmod	3	SENT_152	[p8l1395t2533r2153b2634],
3	rigorous	JJ	O	rigorous	amod	4	SENT_152	[p8l15t2662r368b2762],
4	analyses	NNS	O	analysis	nsubj	15	SENT_152	[p8l399t2661r753b2762],
5	from	IN	O	from	_	0	SENT_152	[p8l785t2661r993b2740],
6	three	CD	NUMBER	three	num	9	SENT_152	[p8l1022t2661r1239b2740],
7	large	JJ	O	large	amod	9	SENT_152	[p8l1268t2661r1745b2762],
8	—	NN	O	—	nn	9	SENT_152	[p8l1268t2661r1745b2762],
9	scale	NN	O	scale	prep_from	4	SENT_152	[p8l1268t2661r1745b2762],
10	,	,	O	,	_	0	SENT_152	[p8l1268t2661r1745b2762],
11	randomized	VBN	O	randomize	partmod	9	SENT_152	[p8l1781t2661r2148b2740, p8l15t2789r216b2885],
12	,	,	O	,	_	0	SENT_152	[p8l1781t2661r2148b2740, p8l15t2789r216b2885],
13	controlled	VBN	O	control	dep	11	SENT_152	[p8l259t2789r698b2868],
14	trials	NNS	O	trial	dobj	11	SENT_152	[p8l734t2789r955b2868],
15	show	VBP	O	show	_	0	SENT_152	[p8l995t2789r1221b2868],
16	no	DT	O	no	det	18	SENT_152	[p8l1253t2815r1358b2868],
17	significant	JJ	O	significant	amod	18	SENT_152	[p8l1397t2789r1868b2890],
18	heterogeneity	NN	O	heterogeneity	dobj	15	SENT_152	[p8l1899t2789r2148b2868, p8l16t2918r375b3018],
19	in	IN	O	in	_	0	SENT_152	[p8l401t2918r483b2995],
20	the	DT	O	the	det	21	SENT_152	[p8l515t2917r646b2996],
21	effects	NNS	O	effect	prep_in	18	SENT_152	[p8l678t2917r954b2996],
22	of	IN	O	of	_	0	SENT_152	[p8l988t2917r1087b2996],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_152	[p8l1101t2917r1575b3018],
24	as	IN	O	as	_	0	SENT_152	[p8l1605t2944r1690b2996],
25	compared	VBN	O	compare	prepc_as	23	SENT_152	[p8l1724t2917r2149b3018],
26	with	IN	O	with	pcomp	25	SENT_152	[p8l11t3045r211b3124],
27	either	CC	O	either	dep	26	SENT_152	[p8l252t3045r505b3124],
28	placebo1	NN	O	placebo1	conj	26	SENT_152	[p8l541t3045r918b3146],
29	or	CC	O	or	_	0	SENT_152	[p8l959t3071r1049b3124],
30	ticagrelorz	NN	O	ticagrelorz	conj	26	SENT_152	[p8l1087t3045r1549b3146],
31	according	VBG	O	accord	_	0	SENT_152	[p8l1589t3045r2026b3146],
32	to	TO	O	to	prepc_according_to	15	SENT_152	[p8l2064t3062r2147b3124],
33	CYPZC19	NN	O	cypzc19	nn	35	SENT_152	[p8l15t3179r404b3252],
34	metabolizer	NN	O	metabolizer	nn	35	SENT_152	[p8l437t3173r958b3252],
35	status	NN	O	status	pobj	15	SENT_152	[p8l989t3190r1266b3252],
36	.	.	O	.	_	0	SENT_152	[p8l989t3190r1266b3252],

1	The	DT	O	the	det	3	SENT_153	[p8l1301t3173r1462b3252],
2	latter	JJ	O	latter	amod	3	SENT_153	[p8l1494t3173r1723b3252],
3	data	NNS	O	datum	nsubj	4	SENT_153	[p8l1753t3173r1937b3252],
4	suggest	VBP	O	suggest	_	0	SENT_153	[p8l1969t3200r2147b3274, p8l15t3318r195b3402],
5	that	IN	O	that	complm	32	SENT_153	[p8l235t3301r412b3380],
6	if	IN	O	if	mark	16	SENT_153	[p8l451t3301r530b3379],
7	CYPZC19	NN	O	cypzc19	nn	9	SENT_153	[p8l556t3307r951b3380],
8	loss	NN	O	loss	nn	9	SENT_153	[p8l996t3301r1703b3380],
9	—	NN	O	—	nsubj	16	SENT_153	[p8l996t3301r1703b3380],
10	of	IN	O	of	_	0	SENT_153	[p8l996t3301r1703b3380],
11	—	CD	NUMBER	—	num	12	SENT_153	[p8l996t3301r1703b3380],
12	function	NN	O	function	npadvmod	13	SENT_153	[p8l996t3301r1703b3380],
13	polymor	JJ	O	polymor	amod	15	SENT_153	[p8l1747t3301r2147b3402],
14	—	NN	O	—	nn	15	SENT_153	[p8l1747t3301r2147b3402],
15	phisms	NNS	O	phism	prep_of	9	SENT_153	[p8l13t3429r327b3530],
16	have	VBP	O	have	advcl	32	SENT_153	[p8l366t3429r556b3508],
17	any	DT	O	any	det	18	SENT_153	[p8l593t3455r744b3530],
18	effect	NN	O	effect	dobj	16	SENT_153	[p8l776t3429r1019b3508],
19	on	IN	O	on	_	0	SENT_153	[p8l1051t3455r1157b3508],
20	the	DT	O	the	det	21	SENT_153	[p8l1195t3429r1327b3508],
21	efficacy	NN	O	efficacy	prep_on	18	SENT_153	[p8l1366t3429r1703b3530],
22	of	IN	O	of	_	0	SENT_153	[p8l1736t3429r1837b3508],
23	clopid	JJ	O	clopid	amod	25	SENT_153	[p8l1855t3429r2147b3530],
24	—	NN	O	—	nn	25	SENT_153	[p8l1855t3429r2147b3530],
25	ogrel	NN	O	ogrel	prep_of	21	SENT_153	[p8l16t3557r258b3658],
26	,	,	O	,	_	0	SENT_153	[p8l16t3557r258b3658],
27	the	DT	O	the	det	28	SENT_153	[p8l299t3557r432b3636],
28	effect	NN	O	effect	nsubj	32	SENT_153	[p8l468t3557r711b3636],
29	is	VBZ	O	be	cop	32	SENT_153	[p8l740t3558r806b3636],
30	at	IN	O	at	advmod	32	SENT_153	[p8l843t3574r922b3636],
31	best	JJS	O	best	pobj	30	SENT_153	[p8l952t3557r1130b3636],
32	modest	JJ	O	modest	ccomp	4	SENT_153	[p8l1160t3557r1501b3636],
33	.	.	O	.	_	0	SENT_153	[p8l1160t3557r1501b3636],

1	A	DT	O	a	det	5	SENT_154	[p8l145t3692r210b3761],
2	much	RB	O	much	advmod	4	SENT_154	[p8l241t3684r475b3763],
3	more	RBR	O	more	advmod	4	SENT_154	[p8l508t3710r724b3762],
4	likely	JJ	O	likely	amod	5	SENT_154	[p8l756t3684r982b3784],
5	explanation	NN	O	explanation	_	0	SENT_154	[p8l1012t3684r1504b3784],
6	for	IN	O	for	_	0	SENT_154	[p8l1538t3684r1658b3762],
7	the	DT	O	the	det	8	SENT_154	[p8l1689t3684r1819b3762],
8	lack	NN	O	lack	prep_for	5	SENT_154	[p8l1852t3684r2024b3763],
9	of	IN	O	of	_	0	SENT_154	[p8l2054t3684r2153b3762],
10	a	DT	O	a	det	13	SENT_154	[p9l20t47r64b98],
11	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_154	[p9l102t20r558b120],
12	treatment	NN	O	treatment	nn	13	SENT_154	[p9l592t37r1006b98],
13	effect	NN	O	effect	prep_of	8	SENT_154	[p9l1040t20r1275b98],
14	of	IN	O	of	_	0	SENT_154	[p9l1310t20r1408b98],
15	double	JJ	O	double	amod	17	SENT_154	[p9l1429t20r1938b99],
16	—	JJ	O	—	amod	17	SENT_154	[p9l1429t20r1938b99],
17	dose	NN	O	dose	prep_of	13	SENT_154	[p9l1429t20r1938b99],
18	clopidogrel	NN	O	clopidogrel	dep	5	SENT_154	[p9l1977t20r2133b98, p9l19t147r376b247],
19	on	IN	O	on	_	0	SENT_154	[p9l413t173r519b225],
20	the	DT	O	the	det	23	SENT_154	[p9l557t147r689b225],
21	primary	JJ	O	primary	amod	23	SENT_154	[p9l725t148r1074b247],
22	efficacy	NN	O	efficacy	nn	23	SENT_154	[p9l1108t147r1443b247],
23	outcome	NN	O	outcome	prep_on	18	SENT_154	[p9l1477t164r1844b226],
24	in	IN	O	in	_	0	SENT_154	[p9l1881t148r1964b224],
25	the	DT	O	the	det	27	SENT_154	[p9l2002t147r2134b225],
26	overall	JJ	O	overall	amod	27	SENT_154	[p9l21t275r312b354],
27	CURRENT	NNP	DATE	CURRENT	prep_in	23	SENT_154	[p9l350t281r1147b359],
28	.	.	O	.	_	0	SENT_154	[p9l350t281r1147b359],

1	—	NN	O	—	_	0	SENT_155	[p9l350t281r1147b359],
2	.	.	O	.	_	0	SENT_155	[p9l350t281r1147b359],

1	OASIS	NN	ORGANIZATION	oasis	nsubj	4	SENT_156	[p9l350t281r1147b359],
2	7	CD	NUMBER	7	num	3	SENT_156	[p9l1190t283r1236b354],
3	trial	NN	O	trial	dep	1	SENT_156	[p9l1275t275r1457b354],
4	is	VBZ	O	be	_	0	SENT_156	[p9l1495t276r1561b354],
5	that	IN	O	that	complm	19	SENT_156	[p9l1603t275r1778b354],
6	5379	CD	DATE	5379	nsubj	19	SENT_156	[p9l1813t281r2012b354],
7	of	IN	O	of	_	0	SENT_156	[p9l2052t275r2152b354],
8	the	DT	O	the	det	10	SENT_156	[p9l21t402r151b480],
9	25,086	CD	NUMBER	25,086	num	10	SENT_156	[p9l183t408r460b497],
10	patients	NNS	O	patient	prep_of	6	SENT_156	[p9l491t403r824b502],
11	who	WP	O	who	nsubjpass	13	SENT_156	[p9l855t402r1034b481],
12	were	VBD	O	be	auxpass	13	SENT_156	[p9l1064t428r1261b481],
13	enrolled	VBN	O	enrol	rcmod	6	SENT_156	[p9l1296t402r1638b480],
14	(	RB	O	(	advmod	13	SENT_156	[p9l1675t407r1900b493],
15	21	CD	PERCENT	21	num	16	SENT_156	[p9l1675t407r1900b493],
16	%	NN	PERCENT	%	dobj	13	SENT_156	[p9l1675t407r1900b493],
17	)	CD	NUMBER	)	dep	6	SENT_156	[p9l1675t407r1900b493],
18	were	VBD	O	be	cop	19	SENT_156	[p9l1933t428r2134b481],
19	unable	JJ	O	unable	ccomp	4	SENT_156	[p9l20t529r305b608],
20	to	TO	O	to	aux	21	SENT_156	[p9l343t545r424b607],
21	benefit	VB	O	benefit	xcomp	19	SENT_156	[p9l463t529r766b607],
22	from	IN	O	from	_	0	SENT_156	[p9l798t529r1007b607],
23	a	DT	O	a	det	25	SENT_156	[p9l1044t556r1088b607],
24	higher	JJR	O	higher	amod	25	SENT_156	[p9l1123t529r1403b629],
25	dose	NN	O	dose	prep_from	21	SENT_156	[p9l1437t529r1630b607],
26	of	IN	O	of	_	0	SENT_156	[p9l1668t529r1768b607],
27	clopido	NN	O	clopido	nn	29	SENT_156	[p9l1787t529r2133b629],
28	—	CD	NUMBER	—	num	29	SENT_156	[p9l1787t529r2133b629],
29	grel	NN	O	grel	prep_of	25	SENT_156	[p9l20t656r187b756],
30	because	IN	O	because	mark	35	SENT_156	[p9l232t656r574b735],
31	they	PRP	O	they	nsubj	35	SENT_156	[p9l619t656r804b756],
32	either	DT	O	either	advmod	35	SENT_156	[p9l845t656r1096b734],
33	did	VBD	O	do	aux	35	SENT_156	[p9l1138t656r1274b734],
34	not	RB	O	not	neg	35	SENT_156	[p9l1319t673r1463b734],
35	have	VB	O	have	advcl	21	SENT_156	[p9l1502t656r1694b735],
36	clinically	RB	O	clinically	advmod	37	SENT_156	[p9l1740t656r2139b756],
37	signiﬁcant	JJ	O	signiﬁcant	amod	40	SENT_156	[p9l21t783r466b883],
38	coronary	JJ	O	coronary	amod	40	SENT_156	[p9l492t809r860b883],
39	artery	NN	O	artery	nn	40	SENT_156	[p9l885t800r1128b883],
40	disease	NN	O	disease	dobj	35	SENT_156	[p9l1154t783r1450b861],
41	or	CC	O	or	_	0	SENT_156	[p9l1481t809r1567b861],
42	they	PRP	O	they	nsubj	43	SENT_156	[p9l1594t783r1770b883],
43	received	VBD	O	receive	conj_or	35	SENT_156	[p9l1795t783r2135b862],
44	only	RB	O	only	advmod	46	SENT_156	[p9l21t910r208b1010],
45	one	CD	NUMBER	one	num	46	SENT_156	[p9l254t936r407b988],
46	dose	NN	O	dose	dobj	43	SENT_156	[p9l458t910r654b988],
47	of	IN	O	of	_	0	SENT_156	[p9l706t910r806b988],
48	study	NN	O	study	nn	49	SENT_156	[p9l840t910r1073b1010],
49	medication	NN	O	medication	prep_of	46	SENT_156	[p9l1119t910r1609b988],
50	because	IN	O	because	_	0	SENT_156	[p9l1660t910r2001b989],
51	of	IN	O	of	_	0	SENT_156	[p9l2053t910r2153b988],
52	planned	VBN	O	plan	amod	54	SENT_156	[p9l19t1037r354b1137],
53	CABG	NN	O	cabg	nn	54	SENT_156	[p9l383t1043r638b1115],
54	surgery	NN	O	surgery	prep_because_of	43	SENT_156	[p9l669t1063r988b1137],
55	.	.	O	.	_	0	SENT_156	[p9l669t1063r988b1137],

1	Among	IN	O	among	_	0	SENT_157	[p9l1018t1045r1329b1137],
2	the	DT	O	the	det	4	SENT_157	[p9l1355t1037r1483b1115],
3	17,263	CD	NUMBER	17,263	num	4	SENT_157	[p9l1515t1043r1766b1132],
4	patients	NNS	O	patient	pobj	1	SENT_157	[p9l1797t1038r2133b1137],
5	who	WP	O	who	nsubj	6	SENT_157	[p9l16t1164r200b1243],
6	underwent	VBD	O	undergo	rcmod	4	SENT_157	[p9l249t1164r720b1243],
7	PCI	NNP	O	PCI	dobj	6	SENT_157	[p9l761t1170r935b1259],
8	,	,	O	,	_	0	SENT_157	[p9l761t1170r935b1259],
9	double	JJ	O	double	amod	11	SENT_157	[p9l989t1164r1519b1243],
10	—	NN	O	—	nn	11	SENT_157	[p9l989t1164r1519b1243],
11	dose	NN	O	dose	appos	7	SENT_157	[p9l989t1164r1519b1243],
12	as	IN	O	as	mark	20	SENT_157	[p9l1566t1191r1652b1242],
13	compared	VBN	O	compare	_	0	SENT_157	[p9l1702t1164r2135b1264],
14	with	IN	O	with	prepc_compared_with	20	SENT_157	[p9l16t1291r214b1370],
15	standard	JJ	O	standard	amod	16	SENT_157	[p9l263t1291r886b1369],
16	—	NN	O	—	pobj	20	SENT_157	[p9l263t1291r886b1369],
17	dose	NN	O	dose	nn	18	SENT_157	[p9l263t1291r886b1369],
18	clopidogrel	NN	O	clopidogrel	nsubjpass	20	SENT_157	[p9l934t1291r1426b1391],
19	was	VBD	O	be	auxpass	20	SENT_157	[p9l1468t1318r1633b1370],
20	associated	VBN	O	associate	dep	11	SENT_157	[p9l1682t1291r2135b1369],
21	with	IN	O	with	_	0	SENT_157	[p9l16t1419r204b1499],
22	a	DT	O	a	det	23	SENT_157	[p9l238t1446r282b1498],
23	reduction	NN	O	reduction	prep_with	20	SENT_157	[p9l314t1419r705b1498],
24	in	IN	O	in	_	0	SENT_157	[p9l738t1420r819b1497],
25	the	DT	O	the	det	26	SENT_157	[p9l854t1419r981b1498],
26	rate	NN	O	rate	prep_in	23	SENT_157	[p9l1016t1436r1169b1498],
27	of	IN	O	of	_	0	SENT_157	[p9l1204t1419r1301b1498],
28	stent	JJ	O	stent	amod	29	SENT_157	[p9l1319t1436r1518b1498],
29	thrombosis	NN	O	thrombosis	prep_of	26	SENT_157	[p9l1548t1419r2018b1498],
30	of	IN	O	of	prep	29	SENT_157	[p9l2055t1419r2153b1498],

1	46	CD	NUMBER	46	number	2	SENT_158	[p9l19t1551r205b1625],
2	°	CD	NUMBER	°	dep	27	SENT_158	[p9l19t1551r205b1625],
3	/	:	O	/	punct	7	SENT_158	[p9l19t1551r205b1625],
4	o	NN	O	o	dep	7	SENT_158	[p9l19t1551r205b1625],
5	(	CD	NUMBER	(	num	6	SENT_158	[p9l241t1552r633b1637],
6	P	NN	O	p	npadvmod	7	SENT_158	[p9l241t1552r633b1637],
7	<	JJR	O	<	dep	2	SENT_158	[p9l241t1552r633b1637],
8	0.001	CD	NUMBER	0.001	num	9	SENT_158	[p9l241t1552r633b1637],
9	)	NN	O	)	dep	2	SENT_158	[p9l241t1552r633b1637],
10	and	CC	O	and	_	0	SENT_158	[p9l669t1546r826b1624],
11	of	IN	O	of	_	0	SENT_158	[p9l858t1546r957b1624],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_158	[p9l971t1546r1595b1625],
13	death	NN	O	death	prep_of	20	SENT_158	[p9l1625t1546r1884b1641],
14	,	,	O	,	_	0	SENT_158	[p9l1625t1546r1884b1641],
15	myocardial	JJ	O	myocardial	amod	16	SENT_158	[p9l1920t1572r2134b1646, p9l21t1673r314b1751],
16	infarction	NN	O	infarction	conj_or	13	SENT_158	[p9l353t1673r802b1768],
17	,	,	O	,	_	0	SENT_158	[p9l353t1673r802b1768],
18	or	CC	O	or	_	0	SENT_158	[p9l847t1699r936b1751],
19	stroke	NN	O	stroke	conj_or	13	SENT_158	[p9l974t1673r1235b1752],
20	of	IN	O	of	dep	27	SENT_158	[p9l1275t1673r1375b1751],
21	14	CD	PERCENT	14	num	22	SENT_158	[p9l1399t1679r1574b1752],
22	%	NN	PERCENT	%	pobj	20	SENT_158	[p9l1399t1679r1574b1752],
23	(	CD	NUMBER	(	num	24	SENT_158	[p9l1618t1679r2055b1764],
24	P	NN	O	p	dep	27	SENT_158	[p9l1618t1679r2055b1764],
25	=	JJ	O	=	amod	27	SENT_158	[p9l1618t1679r2055b1764],
26	O.	NNP	O	O.	nn	27	SENT_158	[p9l1618t1679r2055b1764],
27	O4	NN	O	o4	_	0	SENT_158	[p9l1618t1679r2055b1764],
28	)	CD	NUMBER	)	num	29	SENT_158	[p9l1618t1679r2055b1764],
29	.3	NN	NUMBER	.3	dep	27	SENT_158	[p9l1618t1679r2055b1764],

1	Padrini	NNP	PERSON	Padrini	_	0	SENT_159	[p9l147t1800r466b1878],
2	and	CC	O	and	_	0	SENT_159	[p9l529t1800r688b1878],
3	Pengo	NNP	ORGANIZATION	Pengo	conj_and	1	SENT_159	[p9l751t1807r1015b1900],
4	and	CC	O	and	_	0	SENT_159	[p9l1080t1800r1239b1878],
5	Vassiliou	NNP	PERSON	Vassiliou	nn	6	SENT_159	[p9l1299t1800r1694b1879],
6	question	NN	O	question	conj_and	1	SENT_159	[p9l1758t1801r2134b1900],
7	whether	IN	O	whether	complm	15	SENT_159	[p9l16t1927r369b2006],
8	coadministration	NN	O	coadministration	nsubj	15	SENT_159	[p9l410t1927r1153b2005],
9	of	IN	O	of	_	0	SENT_159	[p9l1197t1927r1296b2005],
10	a	DT	O	a	det	11	SENT_159	[p9l1320t1954r1364b2005],
11	proton	NN	O	proton	prep_of	8	SENT_159	[p9l1405t1944r1975b2027],
12	—	CD	NUMBER	—	num	14	SENT_159	[p9l1405t1944r1975b2027],
13	pump	NN	O	pump	nn	14	SENT_159	[p9l1405t1944r1975b2027],
14	inhibitor	NN	O	inhibitor	dep	11	SENT_159	[p9l2019t1928r2133b2004, p9l20t2055r298b2134],
15	attenuated	VBD	O	attenuate	dep	1	SENT_159	[p9l330t2055r762b2134],
16	the	DT	O	the	det	17	SENT_159	[p9l797t2055r926b2134],
17	beneﬁts	NNS	O	beneﬁts	dobj	15	SENT_159	[p9l962t2055r1290b2134],
18	of	IN	O	of	_	0	SENT_159	[p9l1328t2055r1426b2134],
19	double	JJ	O	double	amod	22	SENT_159	[p9l1443t2055r1941b2134],
20	—	JJ	O	—	amod	22	SENT_159	[p9l1443t2055r1941b2134],
21	dose	NN	O	dose	nn	22	SENT_159	[p9l1443t2055r1941b2134],
22	clopidogrel	NN	O	clopidogrel	prep_of	17	SENT_159	[p9l1978t2055r2133b2134, p9l19t2182r368b2282],

1	as	IN	O	as	_	0	SENT_160	[p9l405t2209r489b2260],
2	compared	VBN	O	compare	_	0	SENT_160	[p9l530t2182r947b2282],
3	with	IN	O	with	prepc_compared_with	1	SENT_160	[p9l981t2182r1171b2261],
4	standard	JJ	O	standard	amod	9	SENT_160	[p9l1211t2182r1809b2260],
5	—	NN	O	—	nn	9	SENT_160	[p9l1211t2182r1809b2260],
6	dose	NN	O	dose	nn	9	SENT_160	[p9l1211t2182r1809b2260],
7	clopid	NN	O	clopid	nn	9	SENT_160	[p9l1847t2182r2133b2282],
8	—	NN	O	—	nn	9	SENT_160	[p9l1847t2182r2133b2282],
9	ogrel	NN	O	ogrel	pobj	1	SENT_160	[p9l21t2309r261b2409],
10	.	.	O	.	_	0	SENT_160	[p9l21t2309r261b2409],

1	The	DT	O	the	det	2	SENT_161	[p9l302t2309r462b2387],
2	analysis	NN	O	analysis	nsubj	13	SENT_161	[p9l500t2309r839b2409],
3	in	IN	O	in	_	0	SENT_161	[p9l879t2310r962b2386],
4	our	PRP$	O	we	poss	5	SENT_161	[p9l1002t2335r1147b2388],
5	article	NN	O	article	prep_in	2	SENT_161	[p9l1182t2309r1448b2387],
6	and	CC	O	and	_	0	SENT_161	[p9l1487t2309r1644b2387],
7	in	IN	O	in	_	0	SENT_161	[p9l1682t2310r1765b2386],
8	another	DT	O	another	det	9	SENT_161	[p9l1803t2309r2138b2387],
9	article	NN	O	article	conj_and	5	SENT_161	[p9l20t2437r292b2516],
10	on	IN	O	on	_	0	SENT_161	[p9l337t2463r443b2516],
11	the	DT	O	the	det	12	SENT_161	[p9l486t2437r621b2516],
12	trial	NN	O	trial	prep_on	9	SENT_161	[p9l665t2437r846b2516],
13	showed	VBD	O	show	_	0	SENT_161	[p9l890t2437r1216b2516],
14	that	IN	O	that	complm	45	SENT_161	[p9l1260t2437r1435b2516],
15	double	JJ	O	double	amod	17	SENT_161	[p9l1473t2437r2004b2516],
16	—	JJ	O	—	amod	17	SENT_161	[p9l1473t2437r2004b2516],
17	dose	NN	O	dose	nsubjpass	45	SENT_161	[p9l1473t2437r2004b2516],
18	as	IN	O	as	mark	26	SENT_161	[p9l2046t2464r2133b2516],
19	compared	VBN	O	compare	_	0	SENT_161	[p9l21t2564r439b2664],
20	with	IN	O	with	prepc_compared_with	26	SENT_161	[p9l467t2564r657b2643],
21	standard	JJ	O	standard	amod	22	SENT_161	[p9l692t2564r1289b2642],
22	—	NN	O	—	pobj	26	SENT_161	[p9l692t2564r1289b2642],
23	dose	NN	O	dose	nn	24	SENT_161	[p9l692t2564r1289b2642],
24	clopidogrel	NN	O	clopidogrel	nsubjpass	26	SENT_161	[p9l1323t2564r1792b2664],
25	was	VBD	O	be	auxpass	26	SENT_161	[p9l1820t2591r1980b2643],
26	associated	VBN	O	associate	dep	17	SENT_161	[p9l2014t2591r2134b2642, p9l22t2691r363b2769],
27	with	IN	O	with	_	0	SENT_161	[p9l404t2691r595b2770],
28	a	DT	O	a	det	31	SENT_161	[p9l639t2718r683b2769],
29	consistent	JJ	O	consistent	amod	31	SENT_161	[p9l728t2692r1155b2769],
30	treatment	NN	O	treatment	nn	31	SENT_161	[p9l1195t2708r1608b2769],
31	effect	NN	O	effect	prep_with	26	SENT_161	[p9l1649t2691r1904b2786],
32	,	,	O	,	_	0	SENT_161	[p9l1649t2691r1904b2786],
33	irrespective	RB	O	irrespective	_	0	SENT_161	[p9l1954t2692r2133b2769, p9l22t2819r367b2918],
34	of	IN	O	of	_	0	SENT_161	[p9l412t2818r512b2896],
35	whether	IN	O	whether	complm	37	SENT_161	[p9l534t2818r894b2897],
36	patients	NNS	O	patient	nsubj	37	SENT_161	[p9l934t2819r1281b2918],
37	received	VBD	O	receive	prepc_irrespective_of	31	SENT_161	[p9l1328t2818r1679b2897],
38	a	DT	O	a	det	41	SENT_161	[p9l1723t2845r1767b2896],
39	protonpump	NN	O	protonpump	nn	41	SENT_161	[p9l1808t2835r2134b2918, p9l19t2971r268b3045],
40	inhibitor	NN	O	inhibitor	nn	41	SENT_161	[p9l314t2945r751b3023],
41	.3	NN	NUMBER	.3	dobj	37	SENT_161	[p9l314t2945r751b3023],
42	These	DT	O	these	det	43	SENT_161	[p9l795t2945r1045b3023],
43	analyses	NNS	O	analysis	dep	31	SENT_161	[p9l1090t2945r1448b3045],
44	were	VBD	O	be	auxpass	45	SENT_161	[p9l1491t2971r1693b3024],
45	based	VBN	O	base	ccomp	13	SENT_161	[p9l1739t2945r1982b3023],
46	on	IN	O	on	_	0	SENT_161	[p9l2029t2971r2134b3023],
47	detailed	JJ	O	detailed	amod	48	SENT_161	[p9l21t3072r362b3150],
48	information	NN	O	information	prep_on	45	SENT_161	[p9l398t3072r918b3150],
49	on	IN	O	on	_	0	SENT_161	[p9l956t3098r1062b3150],
50	the	DT	O	the	det	51	SENT_161	[p9l1099t3072r1232b3150],
51	use	NN	O	use	prep_on	45	SENT_161	[p9l1269t3099r1408b3151],
52	of	IN	O	of	_	0	SENT_161	[p9l1446t3072r1546b3150],
53	proton	NN	O	proton	nn	56	SENT_161	[p9l1563t3089r2133b3172],
54	—	CD	NUMBER	—	num	56	SENT_161	[p9l1563t3089r2133b3172],
55	pump	NN	O	pump	nn	56	SENT_161	[p9l1563t3089r2133b3172],
56	inhibitors	NNS	O	inhibitor	prep_of	51	SENT_161	[p9l20t3199r420b3277],
57	collected	VBN	O	collect	partmod	51	SENT_161	[p9l463t3199r824b3277],
58	in	IN	O	in	_	0	SENT_161	[p9l863t3200r944b3276],
59	the	DT	O	the	det	62	SENT_161	[p9l984t3199r1112b3277],
60	last	JJ	O	last	amod	62	SENT_161	[p9l1150t3199r1297b3277],
61	18,430	CD	NUMBER	18,430	num	62	SENT_161	[p9l1334t3205r1597b3294],
62	patients	NNS	O	patient	prep_in	57	SENT_161	[p9l1636t3200r1962b3299],
63	enrolled	VBN	O	enrol	partmod	62	SENT_161	[p9l2004t3225r2133b3277, p9l20t3326r265b3404],
64	in	IN	O	in	_	0	SENT_161	[p9l306t3327r389b3403],
65	the	DT	O	the	det	66	SENT_161	[p9l430t3326r562b3404],
66	trial	NN	O	trial	prep_in	63	SENT_161	[p9l604t3326r804b3421],
67	,	,	O	,	_	0	SENT_161	[p9l604t3326r804b3421],
68	and	CC	O	and	_	0	SENT_161	[p9l850t3326r1007b3404],
69	they	PRP	O	they	nsubj	70	SENT_161	[p9l1048t3326r1229b3426],
70	provide	VBP	O	provide	conj_and	13	SENT_161	[p9l1265t3326r1581b3426],
71	no	DT	O	no	det	72	SENT_161	[p9l1623t3352r1728b3404],
72	evidence	NN	O	evidence	dobj	70	SENT_161	[p9l1770t3326r2135b3405],
73	of	IN	O	of	_	0	SENT_161	[p9l21t3453r120b3531],
74	a	DT	O	a	det	95	SENT_161	[p9l135t3480r179b3531],
75	statistically	RB	O	statistically	advmod	76	SENT_161	[p9l213t3453r704b3553],
76	significant	JJ	O	significant	amod	95	SENT_161	[p9l734t3453r1201b3553],
77	or	CC	O	or	_	0	SENT_161	[p9l1230t3479r1318b3531],
78	a	DT	O	a	det	83	SENT_161	[p9l1348t3480r1392b3531],
79	clinically	RB	O	clinically	advmod	80	SENT_161	[p9l1425t3453r1815b3553],
80	impor	JJ	O	impor	amod	83	SENT_161	[p9l1843t3454r2133b3553],
81	—	CD	NUMBER	—	npadvmod	82	SENT_161	[p9l1843t3454r2133b3553],
82	tant	JJ	O	tant	amod	83	SENT_161	[p9l21t3597r187b3658],
83	interaction	NN	O	interaction	conj_or	76	SENT_161	[p9l213t3581r657b3658],
84	between	IN	O	between	_	0	SENT_161	[p9l690t3580r1034b3659],
85	the	DT	O	the	det	86	SENT_161	[p9l1066t3580r1193b3658],
86	use	NN	O	use	prep_between	83	SENT_161	[p9l1226t3607r1361b3659],
87	of	IN	O	of	_	0	SENT_161	[p9l1395t3580r1491b3658],
88	a	DT	O	a	det	92	SENT_161	[p9l1505t3607r1549b3658],
89	proton	NN	O	proton	nn	92	SENT_161	[p9l1578t3597r2133b3680],
90	—	CD	NUMBER	—	num	92	SENT_161	[p9l1578t3597r2133b3680],
91	pump	NN	O	pump	nn	92	SENT_161	[p9l1578t3597r2133b3680],
92	inhibitor	NN	O	inhibitor	prep_of	86	SENT_161	[p9l20t3707r400b3785],
93	and	CC	O	and	_	0	SENT_161	[p9l437t3707r594b3785],
94	clopidogrel	NN	O	clopidogrel	prep_of	86	SENT_161	[p9l635t3707r1116b3807],
95	treatment	NN	O	treatment	prep_of	72	SENT_161	[p9l1157t3723r1599b3785],
96	.	.	O	.	_	0	SENT_161	[p9l1157t3723r1599b3785],

1	The	DT	O	the	det	2	SENT_162	[p9l1642t3707r1802b3785],
2	lack	NN	O	lack	nsubj	16	SENT_162	[p9l1842t3707r2017b3786],
3	of	IN	O	of	_	0	SENT_162	[p9l2054t3707r2153b3785],
4	an	DT	O	a	det	5	SENT_162	[p10l20t46r122b98],
5	interaction	NN	O	interaction	prep_of	2	SENT_162	[p10l162t21r628b98],
6	between	IN	O	between	_	0	SENT_162	[p10l669t20r1025b99],
7	a	DT	O	a	det	11	SENT_162	[p10l1064t47r1109b98],
8	proton	NN	O	proton	nn	11	SENT_162	[p10l1146t37r1716b120],
9	—	CD	NUMBER	—	num	11	SENT_162	[p10l1146t37r1716b120],
10	pump	NN	O	pump	nn	11	SENT_162	[p10l1146t37r1716b120],
11	inhibitor	NN	O	inhibitor	prep_between	5	SENT_162	[p10l1757t20r2138b98],
12	and	CC	O	and	_	0	SENT_162	[p10l20t147r177b225],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_162	[p10l217t147r697b247],
14	treatment	NN	O	treatment	conj_and	11	SENT_162	[p10l737t164r1159b225],
15	is	VBZ	O	be	cop	16	SENT_162	[p10l1193t148r1259b225],
16	consistent	JJ	O	consistent	_	0	SENT_162	[p10l1301t148r1738b225],
17	with	IN	O	with	_	0	SENT_162	[p10l1768t147r1963b226],
18	the	DT	O	the	det	19	SENT_162	[p10l2002t147r2135b225],
19	results	NNS	O	result	prep_with	16	SENT_162	[p10l20t274r308b353],
20	of	IN	O	of	_	0	SENT_162	[p10l346t274r447b352],
21	the	DT	O	the	det	22	SENT_162	[p10l464t274r598b352],
22	Clopidogrel	NNP	MISC	Clopidogrel	prep_of	19	SENT_162	[p10l634t274r1144b374],
23	and	CC	O	and	_	0	SENT_162	[p10l1179t274r1338b352],
24	the	DT	O	the	det	25	SENT_162	[p10l1374t274r1508b352],
25	Optimization	NN	O	optimization	conj_and	19	SENT_162	[p10l1544t275r2135b374],
26	of	IN	O	of	_	0	SENT_162	[p10l21t401r120b479],
27	Gastrointestinal	JJ	O	gastrointestinal	amod	28	SENT_162	[p10l143t401r843b479],
28	Events	NNS	O	event	prep_of	25	SENT_162	[p10l883t408r1155b480],
29	Trial	NN	O	trial	nn	32	SENT_162	[p10l1195t401r1396b479],
30	(	CD	NUMBER	(	num	32	SENT_162	[p10l1442t407r2129b496],
31	NCTOO557921	NN	O	nctoo557921	nn	32	SENT_162	[p10l1442t407r2129b496],
32	)	NN	O	)	tmod	28	SENT_162	[p10l1442t407r2129b496],
33	,	,	O	,	_	0	SENT_162	[p10l1442t407r2129b496],
34	which	WDT	O	which	nsubj	35	SENT_162	[p10l16t529r273b609],
35	showed	VBD	O	show	rcmod	32	SENT_162	[p10l309t529r624b609],
36	no	DT	O	no	det	37	SENT_162	[p10l657t555r761b608],
37	difference	NN	O	difference	dobj	35	SENT_162	[p10l797t529r1218b608],
38	in	IN	O	in	_	0	SENT_162	[p10l1251t530r1332b607],
39	the	DT	O	the	det	40	SENT_162	[p10l1366t529r1497b608],
40	rate	NN	O	rate	prep_in	35	SENT_162	[p10l1530t546r1687b608],
41	of	IN	O	of	_	0	SENT_162	[p10l1721t529r1819b608],
42	thrombotic	JJ	O	thrombotic	amod	43	SENT_162	[p10l1834t529r2133b608, p10l21t656r229b734],
43	events	NNS	O	event	prep_of	40	SENT_162	[p10l266t672r524b735],
44	among	IN	O	among	_	0	SENT_162	[p10l562t682r856b756],
45	patients	NNS	O	patient	prep_among	35	SENT_162	[p10l888t657r1220b756],
46	who	WP	O	who	nsubj	47	SENT_162	[p10l1255t656r1435b735],
47	received	VBD	O	receive	rcmod	45	SENT_162	[p10l1473t656r1810b735],
48	clopid	JJ	O	clopid	amod	50	SENT_162	[p10l1847t656r2133b756],
49	—	NN	O	—	nn	50	SENT_162	[p10l1847t656r2133b756],
50	ogrel	NN	O	ogrel	dobj	47	SENT_162	[p10l21t783r244b883],
51	who	WP	O	who	nsubjpass	54	SENT_162	[p10l294t783r479b862],
52	were	VBD	O	be	auxpass	54	SENT_162	[p10l531t809r736b862],
53	randomly	RB	O	randomly	advmod	54	SENT_162	[p10l791t783r1213b883],
54	assigned	VBN	O	assign	rcmod	50	SENT_162	[p10l1263t783r1644b883],
55	to	TO	O	to	aux	56	SENT_162	[p10l1700t799r1782b861],
56	receive	VB	O	receive	xcomp	54	SENT_162	[p10l1838t784r2134b862],
57	omeprazole	NN	O	omeprazole	dobj	56	SENT_162	[p10l21t910r502b1010],
58	or	CC	O	or	_	0	SENT_162	[p10l531t936r618b988],
59	placebo	NN	O	placebo	conj_or	16	SENT_162	[p10l642t910r1018b1010],
60	.4	CD	NUMBER	.4	num	59	SENT_162	[p10l642t910r1018b1010],
61	These	DT	O	these	det	62	SENT_162	[p10l1043t910r1285b988],
62	data	NNS	O	datum	nsubj	63	SENT_162	[p10l1315t910r1490b988],
63	underscore	VBP	O	underscore	rcmod	59	SENT_162	[p10l1517t910r1972b989],
64	the	DT	O	the	det	65	SENT_162	[p10l2002t910r2134b988],
65	importance	NN	O	importance	nsubj	69	SENT_162	[p10l20t1038r495b1137],
66	of	IN	O	of	_	0	SENT_162	[p10l534t1037r632b1115],
67	randomization	NN	O	randomization	prep_of	65	SENT_162	[p10l652t1037r1264b1115],
68	to	TO	O	to	aux	69	SENT_162	[p10l1303t1054r1382b1115],
69	minimize	VB	O	minimize	xcomp	63	SENT_162	[p10l1422t1038r1824b1115],
70	the	DT	O	the	det	73	SENT_162	[p10l1863t1037r1991b1115],
71	ef	NN	O	ef	nn	73	SENT_162	[p10l2031t1037r2133b1115],
72	—	NN	O	—	nn	73	SENT_162	[p10l2031t1037r2133b1115],
73	fects	NNS	O	fect	dobj	69	SENT_162	[p10l20t1164r208b1242],
74	of	IN	O	of	_	0	SENT_162	[p10l239t1164r337b1242],
75	confounding	NN	O	confounding	prep_of	59	SENT_162	[p10l348t1164r881b1264],
76	associated	VBN	O	associate	partmod	75	SENT_162	[p10l905t1164r1329b1242],
77	with	IN	O	with	_	0	SENT_162	[p10l1354t1164r1541b1243],
78	observational	JJ	O	observational	amod	79	SENT_162	[p10l1571t1164r2135b1243],
79	analyses	NNS	O	analysis	prep_with	76	SENT_162	[p10l20t1291r402b1391],
80	.	.	O	.	_	0	SENT_162	[p10l20t1291r402b1391],

1	Shamir	NNP	PERSON	Shamir	nn	3	SENT_163	[p10l22t1502r335b1582],
2	R.	NNP	PERSON	R.	nn	3	SENT_163	[p10l372t1510r442b1582],
3	Mehta	NNP	PERSON	Mehta	_	0	SENT_163	[p10l486t1502r779b1596],
4	,	,	O	,	_	0	SENT_163	[p10l486t1502r779b1596],
5	M.D.	NNP	O	M.D.	nn	10	SENT_163	[p10l824t1510r1029b1582],
6	John	NNP	PERSON	John	nn	10	SENT_163	[p10l7t1631r213b1734],
7	W.	NNP	PERSON	W.	nn	10	SENT_163	[p10l247t1639r358b1711],
8	Eikelboom	NNP	PERSON	Eikelboom	nn	10	SENT_163	[p10l403t1631r879b1725],
9	,	,	O	,	_	0	SENT_163	[p10l403t1631r879b1725],
10	M.D.	NNP	O	M.D.	appos	3	SENT_163	[p10l924t1639r1129b1711],

1	Salim	NNP	PERSON	Salim	nn	2	SENT_164	[p10l22t1791r259b1871],
2	Yusuf	NNP	PERSON	Yusuf	_	0	SENT_164	[p10l294t1791r564b1885],
3	,	,	O	,	_	0	SENT_164	[p10l294t1791r564b1885],
4	M.B.	NNP	LOCATION	M.B.	nn	10	SENT_164	[p10l609t1799r827b1885],
5	,	,	O	,	_	0	SENT_164	[p10l609t1799r827b1885],
6	B.S.	NNP	O	B.S.	appos	10	SENT_164	[p10l872t1798r1053b1885],
7	,	,	O	,	_	0	SENT_164	[p10l872t1798r1053b1885],
8	D.	NNP	O	D.	appos	10	SENT_164	[p10l1098t1791r1377b1871],
9	Phi	NNP	O	Phi	nn	10	SENT_164	[p10l1098t1791r1377b1871],
10	|	NNP	O	|	appos	2	SENT_164	[p10l1098t1791r1377b1871],
11	.	.	O	.	_	0	SENT_164	[p10l1098t1791r1377b1871],

1	McMaster	NNP	ORGANIZATION	McMaster	nn	5	SENT_165	[p10l25t1940r363b1994],
2	University	NNP	ORGANIZATION	University	nn	5	SENT_165	[p10l389t1940r724b2013],
3	Hamilton	NNP	ORGANIZATION	Hamilton	nn	5	SENT_165	[p10l25t2029r354b2100],
4	,	,	O	,	_	0	SENT_165	[p10l25t2029r354b2100],
5	ON	NNP	O	ON	_	0	SENT_165	[p10l383t2034r517b2100],
6	,	,	O	,	_	0	SENT_165	[p10l383t2034r517b2100],
7	Canada	NNP	LOCATION	Canada	nn	8	SENT_165	[p10l545t2029r792b2090],
8	smehta@mcmaster.ca	NN	O	smehta@mcmaster.ca	appos	5	SENT_165	[p10l21t2124r782b2197],

1	Since	IN	O	since	_	0	SENT_166	[p10l106t2230r276b2289],
2	publication	NN	O	publication	prep_since	9	SENT_166	[p10l308t2229r681b2304],
3	of	IN	O	of	_	0	SENT_166	[p10l714t2229r790b2289],
4	their	PRP$	O	they	poss	5	SENT_166	[p10l809t2229r964b2288],
5	article	NN	O	article	prep_of	2	SENT_166	[p10l994t2229r1218b2301],
6	,	,	O	,	_	0	SENT_166	[p10l994t2229r1218b2301],
7	the	DT	O	the	det	8	SENT_166	[p10l1255t2229r1355b2288],
8	authors	NNS	O	author	nsubj	9	SENT_166	[p10l1388t2229r1634b2289],
9	report	VBP	O	report	_	0	SENT_166	[p10l1668t2242r1872b2304],
10	no	DT	O	no	det	13	SENT_166	[p10l1901t2248r1980b2289],
11	further	JJ	O	further	amod	13	SENT_166	[p10l2014t2229r2134b2289, p10l20t2325r151b2384],
12	potential	JJ	O	potential	amod	13	SENT_166	[p10l174t2325r470b2400],
13	conflict	NN	O	conflict	dobj	9	SENT_166	[p10l495t2325r753b2385],
14	of	IN	O	of	_	0	SENT_166	[p10l774t2325r850b2385],
15	interest	NN	O	interest	prep_of	13	SENT_166	[p10l861t2326r1127b2385],
16	.	.	O	.	_	0	SENT_166	[p10l861t2326r1127b2385],

1	1	LS	NUMBER	1	_	0	SENT_167	[p10l22t2436r70b2487],
2	.	.	O	.	_	0	SENT_167	[p10l22t2436r70b2487],

1	Paré	NN	O	paré	nn	2	SENT_168	[p10l147t2426r287b2487],
2	G	NN	O	g	_	0	SENT_168	[p10l317t2432r387b2499],
3	,	,	O	,	_	0	SENT_168	[p10l317t2432r387b2499],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_168	[p10l418t2428r625b2487],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_168	[p10l655t2432r756b2499],
6	,	,	O	,	_	0	SENT_168	[p10l655t2432r756b2499],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_168	[p10l787t2427r983b2488],
8	S	NNP	PERSON	S	appos	2	SENT_168	[p10l1000t2432r1052b2500],
9	,	,	O	,	_	0	SENT_168	[p10l1000t2432r1052b2500],
10	et	FW	O	et	nn	11	SENT_168	[p10l1086t2441r1145b2487],
11	al.	FW	O	al.	appos	2	SENT_168	[p10l1170t2428r1245b2487],
12	.	.	O	.	_	0	SENT_168	[p10l1170t2428r1245b2487],

1	Effects	NNS	O	effect	_	0	SENT_169	[p10l1278t2427r1502b2487],
2	of	IN	O	of	_	0	SENT_169	[p10l1533t2427r1609b2487],
3	CYPZC19	NN	O	cypzc19	nn	4	SENT_169	[p10l1625t2432r1919b2487],
4	genoN	NN	O	genon	prep_of	1	SENT_169	[p10l1950t2448r2134b2503, p10l537t2589r551b2604],

1	ENGLJ	NNP	MISC	ENGLJ	nn	2	SENT_170	[p10l566t2589r644b2611],
2	MED	NNP	MISC	MED	_	0	SENT_170	[p10l658t2589r710b2604],
3	363	CD	NUMBER	363	dep	2	SENT_170	[p10l720t2583r797b2611],
4	;	:	O	;	_	0	SENT_170	[p10l720t2583r797b2611],
5	25	CD	NUMBER	25	num	6	SENT_170	[p10l720t2583r797b2611],
6	NEjM	NNP	O	NEjM	dep	2	SENT_170	[p10l833t2589r957b2611],
7	,	,	O	,	_	0	SENT_170	[p10l833t2589r957b2611],
8	ORG	NNP	O	ORG	nn	9	SENT_170	[p10l833t2589r957b2611],
9	DECEMBER16	NNP	O	DECEMBER16	appos	6	SENT_170	[p10l994t2583r1166b2609],
10	,	,	O	,	_	0	SENT_170	[p10l994t2583r1166b2609],
11	2010	CD	DATE	2010	num	12	SENT_170	[p10l1177t2589r1237b2605],
12	2467	CD	DATE	2467	appos	6	SENT_170	[p10l1939t2578r2016b2601],

1	The	DT	O	the	det	4	SENT_171	[p10l702t2622r753b2646],
2	New	NNP	O	New	nn	4	SENT_171	[p10l762t2623r824b2646],
3	England	NNP	O	England	nn	4	SENT_171	[p10l833t2622r944b2653],
4	Journal	NNP	O	Journal	_	0	SENT_171	[p10l952t2622r1050b2646],
5	of	IN	O	of	_	0	SENT_171	[p10l1059t2622r1088b2646],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_171	[p10l1095t2622r1220b2646],

1	The	DT	O	the	det	4	SENT_172	[p10l673t2810r718b2831],
2	NEW	NNP	O	NEW	nn	4	SENT_172	[p10l737t2812r822b2831],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_172	[p10l841t2812r1029b2831],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_172	[p10l1048t2812r1227b2838],
5	of	IN	O	of	_	0	SENT_172	[p10l1247t2810r1275b2837],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_172	[p10l1287t2812r1486b2831],

1	type	NN	O	type	_	0	SENT_173	[p10l11t3046r150b3110],
2	on	IN	O	on	_	0	SENT_173	[p10l178t3053r260b3093],
3	outcomes	NNS	O	outcome	prep_on	1	SENT_173	[p10l288t3046r604b3094],
4	of	IN	O	of	_	0	SENT_173	[p10l634t3033r711b3093],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_173	[p10l725t3034r1098b3110],
6	treatment	NN	O	treatment	prep_of	1	SENT_173	[p10l1126t3046r1469b3093],
7	.	.	O	.	_	0	SENT_173	[p10l1126t3046r1469b3093],

1	N	NN	O	n	nn	3	SENT_174	[p10l1499t3039r1556b3094],
2	Engl	NNP	O	Engl	nn	3	SENT_174	[p10l1581t3034r1730b3110],
3	J	NNP	O	J	nsubj	4	SENT_174	[p10l1750t3039r1778b3103],
4	Med	VBD	O	med	_	0	SENT_174	[p10l1802t3034r1945b3093],
5	2010	CD	DATE	2010	dobj	4	SENT_174	[p10l1972t3038r2145b3106],
6	;	:	O	;	_	0	SENT_174	[p10l1972t3038r2145b3106],
7	363:1704	CD	NUMBER	363:1704	number	8	SENT_174	[p10l12t3135r423b3190],
8	—	CD	NUMBER	—	dep	5	SENT_174	[p10l12t3135r423b3190],
9	14	CD	NUMBER	14	dep	8	SENT_174	[p10l12t3135r423b3190],
10	.	.	O	.	_	0	SENT_174	[p10l12t3135r423b3190],

1	2	LS	NUMBER	2	_	0	SENT_175	[p10l10t3235r63b3287],
2	.	.	O	.	_	0	SENT_175	[p10l10t3235r63b3287],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_176	[p10l138t3228r450b3287],
2	L	NNP	PERSON	L	_	0	SENT_176	[p10l478t3233r534b3300],
3	,	,	O	,	_	0	SENT_176	[p10l478t3233r534b3300],
4	James	NNP	PERSON	James	nn	5	SENT_176	[p10l559t3233r752b3297],
5	S	NNP	PERSON	S	appos	2	SENT_176	[p10l784t3232r834b3300],
6	,	,	O	,	_	0	SENT_176	[p10l784t3232r834b3300],
7	Storey	NNP	PERSON	Storey	nn	8	SENT_176	[p10l869t3232r1066b3304],
8	RF	NNP	O	RF	appos	2	SENT_176	[p10l1091t3233r1191b3300],
9	,	,	O	,	_	0	SENT_176	[p10l1091t3233r1191b3300],
10	et	FW	O	et	nn	11	SENT_176	[p10l1225t3240r1282b3287],
11	al.	FW	O	al.	appos	2	SENT_176	[p10l1307t3228r1379b3287],
12	.	.	O	.	_	0	SENT_176	[p10l1307t3228r1379b3287],

1	Effect	NN	O	effect	_	0	SENT_177	[p10l1411t3227r1599b3287],
2	of	IN	O	of	_	0	SENT_177	[p10l1624t3227r1699b3287],
3	CYPZC19	NN	O	cypzc19	nn	8	SENT_177	[p10l1714t3232r2002b3287],
4	and	CC	O	and	_	0	SENT_177	[p10l2031t3228r2149b3287],
5	ABCB1	NN	O	abcb1	nn	8	SENT_177	[p10l8t3329r231b3384],
6	single	JJ	O	single	amod	8	SENT_177	[p10l253t3325r439b3401],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_177	[p10l459t3325r787b3385],
8	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_177	[p10l806t3325r1309b3401],
9	on	IN	O	on	_	0	SENT_177	[p10l1331t3344r1410b3384],
10	outcomes	NNS	O	outcome	prep_on	1	SENT_177	[p10l1431t3337r1736b3385],
11	of	IN	O	of	_	0	SENT_177	[p10l1758t3324r1833b3384],
12	treatment	NN	O	treatment	prep_of	10	SENT_177	[p10l1839t3337r2153b3384],
13	with	IN	O	with	_	0	SENT_177	[p10l8t3422r158b3482],
14	ticagrelor	NN	O	ticagrelor	prep_with	12	SENT_177	[p10l180t3422r501b3498],
15	versus	CC	O	versus	prep	14	SENT_177	[p10l518t3442r724b3482],
16	clopidogrel	NN	O	clopidogrel	dep	15	SENT_177	[p10l748t3422r1121b3498],
17	for	IN	O	for	_	0	SENT_177	[p10l1143t3421r1238b3481],
18	acute	JJ	O	acute	amod	20	SENT_177	[p10l1257t3434r1429b3482],
19	coronary	JJ	O	coronary	amod	20	SENT_177	[p10l1452t3441r1748b3498],
20	syndromes	NNS	O	syndrome	prep_for	16	SENT_177	[p10l1769t3422r2145b3498],
21	:	:	O	:	_	0	SENT_177	[p10l1769t3422r2145b3498],
22	a	DT	O	a	det	24	SENT_177	[p10l11t3539r44b3578],
23	genetic	JJ	O	genetic	amod	24	SENT_177	[p10l69t3519r307b3595],
24	substudy	NN	O	substudy	dep	1	SENT_177	[p10l334t3519r629b3595],
25	of	IN	O	of	_	0	SENT_177	[p10l652t3518r729b3578],
26	the	DT	O	the	det	28	SENT_177	[p10l741t3519r843b3578],
27	PLATO	NNP	O	PLATO	nn	28	SENT_177	[p10l868t3523r1097b3578],
28	trial	NN	O	trial	prep_of	24	SENT_177	[p10l1124t3519r1279b3578],
29	.	.	O	.	_	0	SENT_177	[p10l1124t3519r1279b3578],

1	Lancet	NNP	O	Lancet	_	0	SENT_178	[p10l1309t3524r1530b3578],
2	2010	CD	DATE	2010	num	1	SENT_178	[p10l1552t3523r2111b3591],
3	;	:	O	;	_	0	SENT_178	[p10l1552t3523r2111b3591],
4	376:1320	CD	NUMBER	376:1320	number	5	SENT_178	[p10l1552t3523r2111b3591],
5	—	CD	NUMBER	—	dep	1	SENT_178	[p10l1552t3523r2111b3591],
6	8	CD	NUMBER	8	dep	5	SENT_178	[p10l1552t3523r2111b3591],
7	.	.	O	.	_	0	SENT_178	[p10l1552t3523r2111b3591],

1	3	LS	NUMBER	3	_	0	SENT_179	[p10l11t3621r62b3673],
2	.	.	O	.	_	0	SENT_179	[p10l11t3621r62b3673],

1	Mehta	NNP	ORGANIZATION	Mehta	_	0	SENT_180	[p10l138t3615r347b3673],
2	SR	JJ	ORGANIZATION	sr	dep	1	SENT_180	[p10l387t3619r490b3686],
3	,	,	O	,	_	0	SENT_180	[p10l387t3619r490b3686],
4	Tanguay	NNP	PERSON	Tanguay	appos	2	SENT_180	[p10l531t3619r816b3690],
5	IF	IN	O	if	_	0	SENT_180	[p10l845t3620r928b3686],
6	,	,	O	,	_	0	SENT_180	[p10l845t3620r928b3686],
7	Eikelboom	NNP	O	Eikelboom	nn	8	SENT_180	[p10l971t3615r1328b3674],
8	JW	NNP	O	JW	dep	4	SENT_180	[p10l1360t3620r1473b3686],
9	,	,	O	,	_	0	SENT_180	[p10l1360t3620r1473b3686],
10	et	FW	O	et	nn	11	SENT_180	[p10l1518t3627r1577b3673],
11	al.	FW	O	al.	prep_if	4	SENT_180	[p10l1613t3615r1688b3673],
12	.	.	O	.	_	0	SENT_180	[p10l1613t3615r1688b3673],

1	Double-dose	NN	O	double-dose	nsubj	26	SENT_181	[p10l1731t3615r2149b3674],
2	versus	CC	O	versus	prep	1	SENT_181	[p10l7t3730r213b3770],
3	standard	JJ	O	standard	amod	6	SENT_181	[p10l238t3711r711b3769],
4	—	NN	O	—	nn	6	SENT_181	[p10l238t3711r711b3769],
5	dose	NN	O	dose	nn	6	SENT_181	[p10l238t3711r711b3769],
6	clopidogrel	NN	O	clopidogrel	dep	2	SENT_181	[p10l734t3711r1108b3786],
7	and	CC	O	and	_	0	SENT_181	[p10l1130t3711r1250b3769],
8	high	JJ	O	high	amod	10	SENT_181	[p10l1273t3711r1603b3786],
9	—	NN	O	—	nn	10	SENT_181	[p10l1273t3711r1603b3786],
10	dose	NN	O	dose	dep	2	SENT_181	[p10l1273t3711r1603b3786],
11	versus	CC	O	versus	prep	6	SENT_181	[p10l1622t3730r1828b3770],
12	low	JJ	O	low	amod	15	SENT_181	[p10l1852t3711r2149b3770],
13	—	NN	O	—	nn	15	SENT_181	[p10l1852t3711r2149b3770],
14	dose	NN	O	dose	nn	15	SENT_181	[p10l1852t3711r2149b3770],
15	aspirin	NN	O	aspirin	dep	11	SENT_181	[p11l11t17r241b92],
16	in	IN	O	in	_	0	SENT_181	[p11l270t17r334b74],
17	individuals	NNS	O	individual	prep_in	15	SENT_181	[p11l363t17r728b76],
18	undergoing	VBG	O	undergo	partmod	17	SENT_181	[p11l759t17r1144b92],
19	percutaneous	JJ	O	percutaneous	amod	21	SENT_181	[p11l1170t29r1616b92],
20	coronary	JJ	O	coronary	amod	21	SENT_181	[p11l1648t36r1944b92],
21	intervention	NN	O	intervention	dobj	18	SENT_181	[p11l1969t17r2148b75, p11l8t114r254b174],
22	for	IN	O	for	_	0	SENT_181	[p11l300t113r395b173],
23	acute	JJ	O	acute	amod	25	SENT_181	[p11l439t126r611b174],
24	coronary	JJ	O	coronary	amod	25	SENT_181	[p11l659t133r955b190],
25	syndromes	NNS	O	syndrome	prep_for	21	SENT_181	[p11l1000t114r1357b190],
26	(	VBP	O	(	_	0	SENT_181	[p11l1410t118r2015b183],
27	CURRENT-OASIS	NN	O	current-oasis	nn	29	SENT_181	[p11l1410t118r2015b183],
28	7	CD	NUMBER	7	num	29	SENT_181	[p11l2065t119r2145b182],
29	)	NN	O	)	dobj	26	SENT_181	[p11l2065t119r2145b182],
30	:	:	O	:	_	0	SENT_181	[p11l2065t119r2145b182],
31	a	DT	O	a	det	34	SENT_181	[p11l11t231r44b270],
32	randomised	JJ	O	randomised	amod	34	SENT_181	[p11l69t211r464b270],
33	factorial	JJ	O	factorial	amod	34	SENT_181	[p11l491t210r768b270],
34	trial	NN	O	trial	dobj	26	SENT_181	[p11l794t211r948b270],
35	.	.	O	.	_	0	SENT_181	[p11l794t211r948b270],

1	Lancet	NNP	O	Lancet	_	0	SENT_182	[p11l978t216r1199b270],
2	2010	CD	DATE	2010	num	1	SENT_182	[p11l1221t215r1819b283],
3	;	:	O	;	_	0	SENT_182	[p11l1221t215r1819b283],
4	376:1233	CD	NUMBER	376:1233	number	5	SENT_182	[p11l1221t215r1819b283],
5	-43	CD	NUMBER	-43	dep	1	SENT_182	[p11l1221t215r1819b283],
6	.	.	O	.	_	0	SENT_182	[p11l1221t215r1819b283],

1	4	LS	NUMBER	4	_	0	SENT_183	[p11l9t314r63b365],
2	.	.	O	.	_	0	SENT_183	[p11l9t314r63b365],

1	Bhatt	NNP	PERSON	Bhatt	nn	2	SENT_184	[p11l139t307r319b365],
2	DL	NNP	O	DL	_	0	SENT_184	[p11l347t312r459b378],
3	,	,	O	,	_	0	SENT_184	[p11l347t312r459b378],
4	Cryer	NNP	PERSON	Cryer	nn	5	SENT_184	[p11l497t311r674b382],
5	BL	NN	O	bl	appos	2	SENT_184	[p11l704t312r807b378],
6	,	,	O	,	_	0	SENT_184	[p11l704t312r807b378],
7	Contant	NNP	ORGANIZATION	Contant	nn	8	SENT_184	[p11l845t311r1113b365],
8	CF	NN	ORGANIZATION	cf	appos	2	SENT_184	[p11l1143t311r1243b378],
9	,	,	O	,	_	0	SENT_184	[p11l1143t311r1243b378],
10	et	FW	O	et	nn	11	SENT_184	[p11l1281t319r1340b365],
11	al.	FW	O	al.	appos	2	SENT_184	[p11l1369t307r1444b365],
12	.	.	O	.	_	0	SENT_184	[p11l1369t307r1444b365],

1	Clopidogrel	NN	O	clopidogrel	_	0	SENT_185	[p11l1482t307r1869b382],
2	with	IN	O	with	prep	1	SENT_185	[p11l1899t307r2049b366],
3	or	CC	O	or	_	0	SENT_185	[p11l2083t326r2151b365],
4	Without	IN	O	without	prep	1	SENT_185	[p11l7t403r269b462],
5	omeprazole	NN	O	omeprazole	pobj	4	SENT_185	[p11l302t403r688b478],
6	in	IN	O	in	_	0	SENT_185	[p11l724t403r788b460],
7	coronary	JJ	O	coronary	amod	9	SENT_185	[p11l825t422r1121b478],
8	artery	NN	O	artery	nn	9	SENT_185	[p11l1152t415r1350b478],
9	disease	NN	O	disease	prep_in	1	SENT_185	[p11l1382t403r1640b461],
10	.	.	O	.	_	0	SENT_185	[p11l1382t403r1640b461],

1	N	NN	O	n	nn	3	SENT_186	[p11l1679t408r1735b462],
2	Engl	NNP	O	Engl	nn	3	SENT_186	[p11l1769t403r1918b478],
3	J	NNP	O	J	nsubj	4	SENT_186	[p11l1945t408r1974b471],
4	Med	VBD	O	med	_	0	SENT_186	[p11l2006t403r2149b461],
5	2010	CD	DATE	2010	dobj	4	SENT_186	[p11l11t504r600b572],
6	;	:	O	;	_	0	SENT_186	[p11l11t504r600b572],
7	363:1909	CD	NUMBER	363:1909	number	8	SENT_186	[p11l11t504r600b572],
8	—	CD	NUMBER	—	dep	5	SENT_186	[p11l11t504r600b572],
9	17	CD	NUMBER	17	dep	8	SENT_186	[p11l11t504r600b572],
10	.	.	O	.	_	0	SENT_186	[p11l11t504r600b572],

1	THE	DT	O	the	det	2	SENT_187	[p11l10t791r175b845],
2	EDITORIALIST	NN	O	editorialist	nsubj	3	SENT_187	[p11l213t790r795b845],
3	REPLIES	VBZ	O	reply	_	0	SENT_187	[p11l830t790r1184b846],
4	:	:	O	:	_	0	SENT_187	[p11l830t790r1184b846],
5	The	DT	O	the	det	6	SENT_187	[p11l1217t767r1378b846],
6	disagreement	NN	O	disagreement	nsubj	31	SENT_187	[p11l1411t767r2001b868],
7	expressed	VBN	O	express	partmod	6	SENT_187	[p11l2029t794r2147b846, p11l11t895r339b996],
8	by	IN	O	by	_	0	SENT_187	[p11l378t895r476b996],
9	Merella	NNP	PERSON	Merella	agent	7	SENT_187	[p11l508t895r834b974],
10	et	FW	O	et	nn	11	SENT_187	[p11l872t912r950b974],
11	al.	FW	O	al.	dobj	7	SENT_187	[p11l983t895r1080b974],
12	regarding	VBG	O	regard	_	0	SENT_187	[p11l1125t895r1551b996],
13	my	PRP$	O	my	poss	14	SENT_187	[p11l1587t921r1717b996],
14	approach	NN	O	approach	prep_regarding	11	SENT_187	[p11l1750t895r2148b996],
15	involving	VBG	O	involve	partmod	14	SENT_187	[p11l11t1023r421b1124],
16	the	DT	O	the	det	17	SENT_187	[p11l471t1023r607b1102],
17	use	NN	O	use	dobj	15	SENT_187	[p11l660t1050r804b1102],
18	of	IN	O	of	_	0	SENT_187	[p11l859t1023r960b1102],
19	antithrombotic	JJ	O	antithrombotic	amod	20	SENT_187	[p11l995t1023r1673b1102],
20	agents	NNS	O	agent	prep_of	17	SENT_187	[p11l1724t1040r2008b1124],
21	in	IN	O	in	_	0	SENT_187	[p11l2063t1024r2148b1101],
22	medically	RB	O	medically	advmod	23	SENT_187	[p11l12t1151r441b1252],
23	treated	VBN	O	treat	amod	24	SENT_187	[p11l493t1151r800b1230],
24	patients	NNS	O	patient	prep_in	15	SENT_187	[p11l855t1152r1206b1252],
25	presenting	VBG	O	present	partmod	24	SENT_187	[p11l1263t1152r1739b1252],
26	with	IN	O	with	_	0	SENT_187	[p11l1787t1151r1987b1230],
27	an	DT	O	a	det	30	SENT_187	[p11l2043t1177r2148b1230],
28	acute	JJ	O	acute	amod	30	SENT_187	[p11l11t1296r230b1358],
29	coronary	JJ	O	coronary	amod	30	SENT_187	[p11l263t1305r642b1380],
30	syndrome	NN	O	syndrome	prep_with	25	SENT_187	[p11l671t1279r1089b1380],
31	raises	VBZ	O	raise	parataxis	3	SENT_187	[p11l1121t1280r1361b1358],
32	an	DT	O	a	det	34	SENT_187	[p11l1394t1305r1496b1358],
33	important	JJ	O	important	amod	34	SENT_187	[p11l1527t1280r1962b1380],
34	distinction	NN	O	distinction	dobj	31	SENT_187	[p11l1990t1279r2147b1358, p11l12t1408r384b1486],
35	.	.	O	.	_	0	SENT_187	[p11l1990t1279r2147b1358, p11l12t1408r384b1486],

1	I	PRP	O	I	nsubj	2	SENT_188	[p11l440t1415r471b1485],
2	agree	VBP	O	agree	_	0	SENT_188	[p11l521t1433r757b1508],
3	entirely	RB	O	entirely	advmod	2	SENT_188	[p11l810t1407r1142b1508],
4	that	IN	O	that	complm	37	SENT_188	[p11l1190t1407r1366b1486],
5	in	IN	O	in	_	0	SENT_188	[p11l1413t1408r1498b1485],
6	patients	NNS	O	patient	prep_in	37	SENT_188	[p11l1548t1408r1899b1508],
7	with	IN	O	with	_	0	SENT_188	[p11l1948t1407r2148b1486],
8	clinically	RB	O	clinically	advmod	9	SENT_188	[p11l12t1535r406b1636],
9	significant	JJ	O	significant	amod	11	SENT_188	[p11l442t1535r913b1636],
10	coronary	JJ	O	coronary	amod	11	SENT_188	[p11l947t1561r1334b1636],
11	disease	NN	O	disease	prep_with	6	SENT_188	[p11l1369t1535r1681b1614],
12	for	IN	O	for	_	0	SENT_188	[p11l1720t1535r1844b1614],
13	whom	WP	O	whom	dobj	19	SENT_188	[p11l1875t1535r2148b1614],
14	a	DT	O	a	det	17	SENT_188	[p11l11t1690r56b1742],
15	conservative	JJ	O	conservative	amod	17	SENT_188	[p11l92t1664r623b1742],
16	treatment	NN	O	treatment	nn	17	SENT_188	[p11l661t1680r1087b1742],
17	approach	NN	O	approach	nsubjpass	19	SENT_188	[p11l1118t1663r1516b1764],
18	is	VBZ	O	be	auxpass	19	SENT_188	[p11l1553t1664r1618b1742],
19	planned	VBN	O	plan	prepc_for	11	SENT_188	[p11l1657t1663r2032b1764],
20	,	,	O	,	_	0	SENT_188	[p11l1657t1663r2032b1764],
21	at	IN	DURATION	at	quantmod	23	SENT_188	[p11l2074t1680r2153b1742],
22	least	JJS	DURATION	least	mwe	21	SENT_188	[p11l11t1791r211b1870],
23	1	CD	DURATION	1	nsubjpass	37	SENT_188	[p11l242t1797r286b1869],
24	month	NN	NUMBER	month	tmod	23	SENT_188	[p11l320t1791r606b1870],
25	and	CC	O	and	_	0	SENT_188	[p11l638t1791r797b1870],
26	ideally	RB	O	ideally	advmod	23	SENT_188	[p11l829t1791r1112b1892],
27	up	RB	DURATION	up	quantmod	29	SENT_188	[p11l1140t1817r1244b1892],
28	to	TO	DURATION	to	dep	29	SENT_188	[p11l1279t1808r1361b1870],
29	1	CD	DURATION	1	num	30	SENT_188	[p11l1398t1797r1442b1869],
30	year	NN	NUMBER	year	conj_and	23	SENT_188	[p11l1471t1817r1652b1892],
31	of	IN	O	of	_	0	SENT_188	[p11l1682t1791r1782b1870],
32	clopido	NN	O	clopido	nn	35	SENT_188	[p11l1797t1791r2147b1892],
33	—	CD	NUMBER	—	num	35	SENT_188	[p11l1797t1791r2147b1892],
34	grel	NN	O	grel	nn	35	SENT_188	[p11l8t1920r172b2022],
35	administration	NN	O	administration	prep_of	30	SENT_188	[p11l197t1920r835b2000],
36	is	VBZ	O	be	auxpass	37	SENT_188	[p11l861t1921r927b2000],
37	recommended	VBN	O	recommend	ccomp	2	SENT_188	[p11l956t1920r1567b2000],
38	by	IN	O	by	_	0	SENT_188	[p11l1595t1920r1692b2022],
39	the	DT	O	the	det	40	SENT_188	[p11l1715t1920r1847b2000],
40	guidelines	NNS	O	guideline	agent	37	SENT_188	[p11l1874t1920r2149b2022, p11l7t2050r235b2130],
41	.	.	O	.	_	0	SENT_188	[p11l1874t1920r2149b2022, p11l7t2050r235b2130],

1	However	RB	O	however	advmod	8	SENT_189	[p11l284t2058r683b2147],
2	,	,	O	,	_	0	SENT_189	[p11l284t2058r683b2147],
3	the	DT	O	the	det	7	SENT_189	[p11l733t2050r867b2130],
4	editorial	NN	O	editorial	nn	7	SENT_189	[p11l912t2050r1276b2130],
5	and	CC	O	and	_	0	SENT_189	[p11l1319t2050r1478b2130],
6	accompanying	VBG	O	accompany	nn	7	SENT_189	[p11l1521t2051r2154b2152],
7	algorithm	NN	O	algorithm	nsubj	8	SENT_189	[p11l7t2180r441b2282],
8	are	VBP	O	be	_	0	SENT_189	[p11l482t2206r612b2260],
9	about	IN	O	about	_	0	SENT_189	[p11l654t2180r900b2260],
10	patients	NNS	O	patient	prep_about	8	SENT_189	[p11l935t2181r1280b2282],
11	for	IN	O	for	_	0	SENT_189	[p11l1324t2180r1448b2260],
12	whom	WP	O	whom	dobj	17	SENT_189	[p11l1482t2180r1756b2260],
13	an	DT	O	a	det	15	SENT_189	[p11l1797t2206r1901b2260],
14	invasive	JJ	O	invasive	amod	15	SENT_189	[p11l1942t2181r2149b2260, p11l10t2311r164b2390],
15	strategy	NN	O	strategy	nsubjpass	17	SENT_189	[p11l209t2327r557b2412],
16	is	VBZ	O	be	auxpass	17	SENT_189	[p11l594t2311r661b2390],
17	planned	VBN	O	plan	prepc_for	10	SENT_189	[p11l705t2310r1081b2412],
18	.	.	O	.	_	0	SENT_189	[p11l705t2310r1081b2412],

1	In	IN	O	in	_	0	SENT_190	[p11l1129t2318r1218b2389],
2	this	DT	O	this	det	3	SENT_190	[p11l1262t2310r1424b2390],
3	case	NN	O	case	prep_in	12	SENT_190	[p11l1469t2337r1674b2407],
4	,	,	O	,	_	0	SENT_190	[p11l1469t2337r1674b2407],
5	the	DT	O	the	det	7	SENT_190	[p11l1723t2310r1857b2390],
6	medi	NN	O	medus	nn	7	SENT_190	[p11l1901t2310r2149b2390],
7	—	NN	O	—	nsubj	12	SENT_190	[p11l1901t2310r2149b2390],
8	cally	RB	O	cally	advmod	9	SENT_190	[p11l9t2440r209b2542],
9	treated	VBN	O	treat	partmod	7	SENT_190	[p11l239t2440r540b2520],
10	patient	NN	O	patient	dobj	9	SENT_190	[p11l571t2441r876b2542],
11	is	VBZ	O	be	cop	12	SENT_190	[p11l904t2441r971b2520],
12	one	CD	NUMBER	one	_	0	SENT_190	[p11l1007t2466r1159b2520],
13	who	WP	O	who	nsubj	16	SENT_190	[p11l1188t2440r1373b2520],
14	is	VBZ	O	be	cop	16	SENT_190	[p11l1407t2441r1473b2520],
15	not	RB	O	not	neg	16	SENT_190	[p11l1509t2457r1653b2520],
16	eligible	JJ	O	eligible	rcmod	12	SENT_190	[p11l1683t2440r1995b2542],
17	for	IN	O	for	_	0	SENT_190	[p11l2029t2440r2153b2520],
18	a	DT	O	a	det	20	SENT_190	[p11l7t2597r53b2650],
19	revascularization	NN	O	revascularization	nn	20	SENT_190	[p11l79t2570r826b2650],
20	procedure	NN	O	procedure	prep_for	16	SENT_190	[p11l853t2570r1290b2672],
21	largely	RB	O	largely	advmod	16	SENT_190	[p11l1318t2570r1611b2672],
22	on	IN	O	on	_	0	SENT_190	[p11l1636t2596r1743b2650],
23	the	DT	O	the	det	24	SENT_190	[p11l1771t2570r1906b2650],
24	basis	NN	O	basis	prep_on	16	SENT_190	[p11l1935t2570r2148b2650],
25	of	IN	O	of	_	0	SENT_190	[p11l9t2700r110b2780],
26	nonobstructive	JJ	O	nonobstructive	amod	27	SENT_190	[p11l139t2700r790b2780],
27	disease	NN	O	disease	prep_of	24	SENT_190	[p11l838t2700r1151b2780],
28	or	CC	O	or	_	0	SENT_190	[p11l1200t2726r1290b2780],
29	even	RB	O	even	advmod	33	SENT_190	[p11l1335t2726r1525b2780],
30	outright	JJ	O	outright	amod	33	SENT_190	[p11l1574t2700r1930b2802],
31	normal	JJ	O	normal	amod	33	SENT_190	[p11l1973t2726r2149b2780, p11l8t2830r173b2910],
32	coronary	JJ	O	coronary	amod	33	SENT_190	[p11l203t2856r591b2932],
33	arteries	NNS	O	artery	conj_or	24	SENT_190	[p11l615t2831r964b2910],
34	.	.	O	.	_	0	SENT_190	[p11l615t2831r964b2910],

1	In	IN	O	in	_	0	SENT_191	[p11l999t2838r1088b2909],
2	this	DT	O	this	det	3	SENT_191	[p11l1119t2830r1279b2910],
3	case	NN	O	case	prep_in	8	SENT_191	[p11l1313t2857r1517b2927],
4	,	,	O	,	_	0	SENT_191	[p11l1313t2857r1517b2927],
5	the	DT	O	the	det	6	SENT_191	[p11l1553t2830r1687b2910],
6	algorithm	NN	O	algorithm	nsubj	8	SENT_191	[p11l1717t2830r2150b2932],
7	is	VBZ	O	be	cop	8	SENT_191	[p11l7t2961r74b3040],
8	appropriate	JJ	O	appropriate	_	0	SENT_191	[p11l111t2961r611b3062],
9	even	RB	O	even	advmod	13	SENT_191	[p11l648t2986r838b3040],
10	though	IN	O	though	dep	13	SENT_191	[p11l875t2960r1186b3062],
11	some	DT	O	some	nsubj	13	SENT_191	[p11l1224t2986r1450b3040],
12	would	MD	O	would	aux	13	SENT_191	[p11l1481t2960r1749b3040],
13	consider	VB	O	consider	ccomp	8	SENT_191	[p11l1787t2960r2153b3040],
14	the	DT	O	the	det	15	SENT_191	[p11l9t3090r143b3170],
15	use	NN	O	use	dobj	13	SENT_191	[p11l180t3117r322b3170],
16	of	IN	O	of	_	0	SENT_191	[p11l361t3090r462b3170],
17	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_191	[p11l482t3090r968b3192],
18	for	IN	O	for	_	0	SENT_191	[p11l1006t3090r1131b3170],
19	at	IN	DURATION	at	quantmod	21	SENT_191	[p11l1165t3107r1244b3170],
20	least	JJS	DURATION	least	mwe	19	SENT_191	[p11l1276t3090r1477b3170],
21	1	CD	DURATION	1	prep_for	17	SENT_191	[p11l1513t3096r1558b3169],
22	month	NN	NUMBER	month	tmod	13	SENT_191	[p11l1596t3090r1884b3170],
23	as	IN	O	as	_	0	SENT_191	[p11l1921t3117r2007b3170],
24	an	DT	O	a	det	25	SENT_191	[p11l2046t3116r2150b3170],
25	option	NN	O	option	prep_as	13	SENT_191	[p11l9t3221r320b3322],
26	.	.	O	.	_	0	SENT_191	[p11l9t3221r320b3322],

1	This	DT	O	this	nsubj	6	SENT_192	[p11l357t3220r549b3300],
2	then	RB	O	then	advmod	6	SENT_192	[p11l588t3220r783b3300],
3	becomes	VBZ	O	become	cop	6	SENT_192	[p11l818t3220r1201b3300],
4	a	DT	O	a	det	6	SENT_192	[p11l1238t3247r1283b3300],
5	judgment	NN	O	judgment	nn	6	SENT_192	[p11l1302t3220r1739b3322],
6	call	NN	O	call	_	0	SENT_192	[p11l1770t3220r1948b3300],
7	.	.	O	.	_	0	SENT_192	[p11l1770t3220r1948b3300],

1	The	DT	O	the	det	2	SENT_193	[p11l1986t3220r2150b3300],
2	point	NN	O	point	nsubj	3	SENT_193	[p11l7t3351r243b3452],
3	is	VBZ	O	be	_	0	SENT_193	[p11l283t3351r351b3430],
4	that	IN	O	that	complm	24	SENT_193	[p11l399t3350r576b3430],
5	patients	NNS	O	patient	nsubj	24	SENT_193	[p11l616t3351r968b3452],
6	with	IN	O	with	_	0	SENT_193	[p11l1011t3350r1212b3430],
7	acute	JJ	O	acute	amod	9	SENT_193	[p11l1257t3367r1485b3430],
8	coronary	JJ	O	coronary	amod	9	SENT_193	[p11l1533t3376r1928b3452],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_193	[p11l1971t3376r2149b3452, p11l9t3480r325b3560],
10	who	WP	O	who	nsubj	12	SENT_193	[p11l352t3480r535b3560],
11	have	VBP	O	have	aux	12	SENT_193	[p11l567t3480r755b3560],
12	documented	VBN	O	document	rcmod	9	SENT_193	[p11l787t3480r1315b3560],
13	angiographic	JJ	O	angiographic	amod	14	SENT_193	[p11l1344t3480r1908b3582],
14	findings	NNS	O	finding	dobj	12	SENT_193	[p11l1938t3480r2149b3560, p11l7t3611r191b3712],
15	and	CC	O	and	_	0	SENT_193	[p11l245t3610r407b3690],
16	are	VBP	O	be	auxpass	17	SENT_193	[p11l459t3637r591b3690],
17	triaged	VBN	O	triage	conj_and	12	SENT_193	[p11l644t3610r956b3712],
18	to	TO	O	to	_	0	SENT_193	[p11l1009t3627r1092b3690],
19	medical	JJ	O	medical	amod	20	SENT_193	[p11l1146t3610r1496b3690],
20	care	NN	O	care	prep_to	17	SENT_193	[p11l1548t3637r1728b3690],
21	only	RB	O	only	advmod	24	SENT_193	[p11l1782t3610r1971b3712],
22	are	VBP	O	be	cop	24	SENT_193	[p11l2017t3637r2150b3690],
23	completely	RB	O	completely	advmod	24	SENT_193	[p12l9t21r479b123],
24	different	JJ	O	different	ccomp	3	SENT_193	[p12l515t21r895b101],
25	from	IN	O	from	_	0	SENT_193	[p12l930t21r1142b101],
26	those	DT	O	those	prep_from	24	SENT_193	[p12l1183t21r1416b101],
27	who	WP	O	who	nsubjpass	29	SENT_193	[p12l1452t21r1637b101],
28	are	VBP	O	be	auxpass	29	SENT_193	[p12l1679t47r1809b101],
29	treated	VBN	O	treat	rcmod	26	SENT_193	[p12l1850t21r2150b101],
30	conservatively	RB	O	conservatively	advmod	29	SENT_193	[p12l9t151r618b253],
31	from	IN	O	from	_	0	SENT_193	[p12l649t151r860b231],
32	the	DT	O	the	det	33	SENT_193	[p12l896t151r1030b231],
33	onset	NN	O	onset	prep_from	29	SENT_193	[p12l1066t168r1322b231],
34	.	.	O	.	_	0	SENT_193	[p12l1066t168r1322b231],

1	Valentin	NNP	PERSON	Valentin	nn	2	SENT_194	[p12l6t361r367b442],
2	Fuster	NNP	PERSON	Fuster	_	0	SENT_194	[p12l412t369r704b456],
3	,	,	O	,	_	0	SENT_194	[p12l412t369r704b456],
4	M.D.	NNP	O	M.D.	nn	6	SENT_194	[p12l749t369r984b456],
5	,	,	O	,	_	0	SENT_194	[p12l749t369r984b456],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_194	[p12l1029t361r1260b442],
7	.	.	O	.	_	0	SENT_194	[p12l1029t361r1260b442],

1	Mount	NNP	ORGANIZATION	Mount	nn	3	SENT_195	[p12l14t492r235b547],
2	Sinai	NNP	ORGANIZATION	Sinai	nn	3	SENT_195	[p12l260t491r418b547],
3	School	NNP	ORGANIZATION	School	_	0	SENT_195	[p12l446t486r672b547],
4	of	IN	ORGANIZATION	of	_	0	SENT_195	[p12l700t486r773b547],
5	Medicine	NNP	ORGANIZATION	Medicine	nn	7	SENT_195	[p12l791t486r1099b547],
6	New	NNP	LOCATION	New	nn	7	SENT_195	[p12l14t588r161b644],
7	York	NNP	LOCATION	York	prep_of	3	SENT_195	[p12l182t582r348b654],
8	,	,	O	,	_	0	SENT_195	[p12l182t582r348b654],
9	NY	NNP	O	NY	appos	7	SENT_195	[p12l381t588r480b643],

1	Since	IN	O	since	_	0	SENT_196	[p12l96t690r268b749],
2	publication	NN	O	publication	prep_since	9	SENT_196	[p12l293t689r671b765],
3	of	IN	O	of	_	0	SENT_196	[p12l699t689r776b749],
4	his	PRP$	O	he	poss	5	SENT_196	[p12l788t689r885b748],
5	article	NN	O	article	prep_of	2	SENT_196	[p12l912t689r1139b761],
6	,	,	O	,	_	0	SENT_196	[p12l912t689r1139b761],
7	the	DT	O	the	det	8	SENT_196	[p12l1170t689r1272b748],
8	author	NN	O	author	nsubj	9	SENT_196	[p12l1299t689r1516b749],
9	reports	VBZ	O	report	_	0	SENT_196	[p12l1542t702r1778b765],
10	no	DT	O	no	det	13	SENT_196	[p12l1807t708r1887b749],
11	further	JJ	O	further	amod	13	SENT_196	[p12l1916t689r2154b749],
12	potential	JJ	O	potential	amod	13	SENT_196	[p12l6t786r307b862],
13	conﬂict	NN	O	conﬂict	dobj	9	SENT_196	[p12l333t786r593b846],
14	of	IN	O	of	_	0	SENT_196	[p12l615t786r692b846],
15	interest	NN	O	interest	prep_of	13	SENT_196	[p12l703t787r972b846],
16	.	.	O	.	_	0	SENT_196	[p12l703t787r972b846],

1	Trial	NN	O	trial	_	0	SENT_197	[p12l513t938r621b986],
2	of	IN	O	of	_	0	SENT_197	[p12l644t937r703b986],
3	Lorcaserin	NNP	O	Lorcaserin	prep_of	1	SENT_197	[p12l717t939r982b986],
4	for	IN	O	for	_	0	SENT_197	[p12l1004t937r1077b986],
5	Weight	NNP	O	Weight	nn	6	SENT_197	[p12l1094t938r1280b1001],
6	Management	NNP	O	Management	prep_for	1	SENT_197	[p12l1303t942r1647b1001],

1	To	TO	O	to	dep	5	SENT_198	[p12l7t1170r120b1225],
2	THE	DT	O	the	det	3	SENT_198	[p12l160t1171r326b1225],
3	EDITOR	NN	O	editor	pobj	1	SENT_198	[p12l374t1170r712b1226],
4	:	:	O	:	_	0	SENT_198	[p12l374t1170r712b1226],
5	Smith	NNP	PERSON	Smith	_	0	SENT_198	[p12l762t1147r1016b1226],
6	et	FW	O	et	nn	8	SENT_198	[p12l1062t1164r1140b1226],
7	al.	FW	O	al.	nn	8	SENT_198	[p12l1178t1147r1276b1226],
8	(	FW	O	(	rcmod	5	SENT_198	[p12l1331t1147r1525b1248],
9	July	NNP	DATE	July	dep	12	SENT_198	[p12l1331t1147r1525b1248],
10	15	CD	DATE	15	dep	9	SENT_198	[p12l1568t1153r1663b1226],
11	issue	NN	O	issue	nn	12	SENT_198	[p12l1710t1148r1990b1239],
12	)	NN	O	)	dobj	8	SENT_198	[p12l1710t1148r1990b1239],
13	1	CD	NUMBER	1	num	14	SENT_198	[p12l1710t1148r1990b1239],
14	report	NN	O	report	dep	12	SENT_198	[p12l2034t1173r2148b1226, p12l8t1292r194b1376],
15	on	IN	O	on	_	0	SENT_198	[p12l241t1301r348b1354],
16	the	DT	O	the	det	17	SENT_198	[p12l401t1275r534b1354],
17	effects	NNS	O	effect	prep_on	14	SENT_198	[p12l587t1275r871b1354],
18	of	IN	O	of	_	0	SENT_198	[p12l925t1275r1027b1354],
19	lorcaserin	NN	O	lorcaserin	prep_of	17	SENT_198	[p12l1059t1275r1490b1354],
20	together	RB	O	together	_	0	SENT_198	[p12l1543t1275r1908b1376],
21	with	IN	O	with	_	0	SENT_198	[p12l1952t1275r2149b1354],
22	nutritional	JJ	O	nutritional	prep_together_with	8	SENT_198	[p12l10t1403r476b1482],
23	and	CC	O	and	_	0	SENT_198	[p12l533t1403r693b1482],
24	exercise	NN	O	exercise	nn	25	SENT_198	[p12l752t1404r1090b1482],
25	counseling	NN	O	counseling	conj_and	5	SENT_198	[p12l1150t1403r1628b1504],
26	for	IN	O	for	_	0	SENT_198	[p12l1683t1403r1807b1482],
27	weight	NN	O	weight	nn	28	SENT_198	[p12l1859t1403r2154b1504],
28	management	NN	O	management	prep_for	25	SENT_198	[p12l10t1548r602b1632],
29	.	.	O	.	_	0	SENT_198	[p12l10t1548r602b1632],

1	I	PRP	O	I	nsubj	2	SENT_199	[p12l659t1539r690b1609],
2	have	VBP	O	have	_	0	SENT_199	[p12l742t1531r933b1610],
3	concerns	NNS	O	concern	dobj	2	SENT_199	[p12l987t1557r1373b1610],
4	about	IN	O	about	_	0	SENT_199	[p12l1427t1531r1673b1610],
5	the	DT	O	the	det	6	SENT_199	[p12l1721t1531r1855b1610],
6	effectiveness	NN	O	effectiveness	prep_about	3	SENT_199	[p12l1909t1531r2148b1610, p12l10t1660r349b1738],
7	of	IN	O	of	_	0	SENT_199	[p12l394t1659r495b1738],
8	lorcaserin	NN	O	lorcaserin	prep_of	6	SENT_199	[p12l517t1659r948b1738],
9	in	IN	O	in	_	0	SENT_199	[p12l989t1660r1072b1737],
10	clinical	JJ	O	clinical	amod	11	SENT_199	[p12l1115t1659r1430b1738],
11	practice	NN	O	practice	prep_in	8	SENT_199	[p12l1470t1660r1834b1760],
12	.	.	O	.	_	0	SENT_199	[p12l1470t1660r1834b1760],

1	An	DT	O	a	det	3	SENT_200	[p12l1877t1667r2002b1737],
2	effective	JJ	O	effective	amod	3	SENT_200	[p12l2043t1659r2148b1738, p12l10t1787r292b1866],
3	drug	NN	O	drug	nsubj	5	SENT_200	[p12l339t1787r547b1888],
4	should	MD	O	should	aux	5	SENT_200	[p12l590t1787r884b1866],
5	reduce	VB	O	reduce	_	0	SENT_200	[p12l929t1787r1217b1866],
6	weight	NN	O	weight	dobj	5	SENT_200	[p12l1257t1787r1559b1888],
7	by	IN	O	by	_	0	SENT_200	[p12l1599t1787r1698b1888],
8	1.8	CD	NUMBER	1.8	num	9	SENT_200	[p12l1742t1793r1868b1866],
9	kg	NN	O	kg	prep_by	5	SENT_200	[p12l1915t1787r2024b1888],
10	in	IN	O	in	_	0	SENT_200	[p12l2064t1788r2149b1865],
11	4	CD	DURATION	4	num	12	SENT_200	[p12l8t1921r58b1994],
12	weeks	NNS	NUMBER	week	prep_in	9	SENT_200	[p12l92t1915r421b1994],
13	?	.	O	?	_	0	SENT_200	[p12l92t1915r421b1994],

1	At	IN	O	at	_	0	SENT_201	[p12l453t1923r554b1994],
2	4	CD	DURATION	4	num	3	SENT_201	[p12l583t1921r633b1994],
3	weeks	NNS	NUMBER	week	prep_at	6	SENT_201	[p12l664t1915r952b2011],
4	,	,	O	,	_	0	SENT_201	[p12l664t1915r952b2011],
5	there	EX	O	there	expl	6	SENT_201	[p12l994t1915r1212b1994],
6	was	VBD	O	be	_	0	SENT_201	[p12l1244t1942r1408b1994],
7	no	DT	O	no	det	9	SENT_201	[p12l1445t1941r1551b1994],
8	apparent	JJ	O	apparent	amod	9	SENT_201	[p12l1588t1932r1971b2016],
9	difference	NN	O	difference	nsubj	6	SENT_201	[p12l2002t1915r2148b1994, p12l10t2043r320b2122],
10	in	IN	O	in	_	0	SENT_201	[p12l357t2044r442b2121],
11	the	DT	O	the	det	14	SENT_201	[p12l479t2043r613b2122],
12	two	CD	NUMBER	two	num	14	SENT_201	[p12l652t2060r811b2122],
13	study	NN	O	study	nn	14	SENT_201	[p12l852t2043r1083b2144],
14	groups	NNS	O	group	prep_in	9	SENT_201	[p12l1116t2069r1414b2144],
15	in	IN	O	in	_	0	SENT_201	[p12l1453t2044r1538b2121],
16	the	DT	O	the	det	17	SENT_201	[p12l1576t2043r1709b2122],
17	article	NN	O	article	prep_in	14	SENT_201	[p12l1747t2043r2016b2122],
18	by	IN	O	by	_	0	SENT_201	[p12l2056t2043r2154b2144],
19	Smith	NNP	PERSON	Smith	prep_by	6	SENT_201	[p12l12t2171r266b2250],
20	et	FW	O	et	nn	21	SENT_201	[p12l311t2188r390b2250],
21	al.	FW	O	al.	dep	19	SENT_201	[p12l427t2171r525b2250],
22	.	.	O	.	_	0	SENT_201	[p12l427t2171r525b2250],

1	The	DT	O	the	det	4	SENT_202	[p12l571t2171r733b2250],
2	average	JJ	O	average	amod	4	SENT_202	[p12l777t2197r1097b2272],
3	weight	NN	O	weight	nn	4	SENT_202	[p12l1137t2171r1433b2272],
4	loss	NN	O	loss	nsubj	11	SENT_202	[p12l1470t2171r1635b2250],
5	in	IN	O	in	_	0	SENT_202	[p12l1682t2172r1765b2249],
6	the	DT	O	the	det	8	SENT_202	[p12l1809t2171r1943b2250],
7	placebo	NN	O	placebo	nn	8	SENT_202	[p12l1986t2171r2148b2272, p12l10t2299r207b2378],
8	group	NN	O	group	prep_in	4	SENT_202	[p12l240t2325r494b2400],
9	was	VBD	O	be	cop	11	SENT_202	[p12l522t2326r686b2379],
10	2.2	CD	NUMBER	2.2	num	11	SENT_202	[p12l720t2305r848b2378],
11	kg	NN	O	kg	_	0	SENT_202	[p12l881t2299r988b2400],
12	at	IN	O	at	_	0	SENT_202	[p12l1016t2316r1096b2378],
13	1	CD	DURATION	1	num	14	SENT_202	[p12l1125t2305r1170b2377],
14	year	NN	NUMBER	year	prep_at	11	SENT_202	[p12l1197t2325r1396b2400],
15	.	.	O	.	_	0	SENT_202	[p12l1197t2325r1396b2400],

1	In	IN	O	in	_	0	SENT_203	[p12l1432t2307r1521b2377],
2	the	DT	O	the	det	4	SENT_203	[p12l1553t2299r1687b2378],
3	lorcaserin	NN	O	lorcaserin	nn	4	SENT_203	[p12l1717t2299r2149b2378],
4	group	NN	O	group	prep_in	10	SENT_203	[p12l10t2453r281b2528],
5	,	,	O	,	_	0	SENT_203	[p12l10t2453r281b2528],
6	this	DT	O	this	det	7	SENT_203	[p12l314t2427r472b2506],
7	value	NN	O	value	nsubj	10	SENT_203	[p12l497t2427r714b2506],
8	was	VBD	O	be	cop	10	SENT_203	[p12l737t2454r898b2507],
9	5.8	CD	NUMBER	5.8	num	10	SENT_203	[p12l930t2433r1052b2506],
10	kg	NN	O	kg	_	0	SENT_203	[p12l1081t2427r1206b2528],
11	.	.	O	.	_	0	SENT_203	[p12l1081t2427r1206b2528],

1	Assuming	VBG	O	assume	partmod	25	SENT_204	[p12l1236t2428r1673b2528],
2	that	DT	O	that	det	4	SENT_204	[p12l1697t2427r1868b2506],
3	2.2	CD	NUMBER	2.2	num	4	SENT_204	[p12l1890t2433r2016b2506],
4	kg	NN	O	kg	dobj	1	SENT_204	[p12l2045t2427r2153b2528],
5	of	IN	O	of	_	0	SENT_204	[p12l10t2555r111b2634],
6	lorcaserin	NN	O	lorcaserin	nn	7	SENT_204	[p12l140t2555r1057b2634],
7	—	NN	O	—	prep_of	4	SENT_204	[p12l140t2555r1057b2634],
8	associated	VBN	O	associate	partmod	7	SENT_204	[p12l140t2555r1057b2634],
9	weight	NN	O	weight	nn	10	SENT_204	[p12l1101t2555r1396b2656],
10	loss	NN	O	loss	nsubj	12	SENT_204	[p12l1439t2555r1604b2634],
11	was	VBD	O	be	cop	12	SENT_204	[p12l1651t2582r1815b2634],
12	due	JJ	O	due	ccomp	8	SENT_204	[p12l1866t2555r2016b2634],
13	to	TO	O	to	_	0	SENT_204	[p12l2066t2572r2148b2634],
14	counseling	NN	O	counseling	prep_to	12	SENT_204	[p12l10t2683r507b2784],
15	,	,	O	,	_	0	SENT_204	[p12l10t2683r507b2784],
16	the	DT	O	the	det	19	SENT_204	[p12l543t2683r676b2762],
17	net	JJ	O	net	amod	19	SENT_204	[p12l707t2700r842b2762],
18	weight	NN	O	weight	nn	19	SENT_204	[p12l863t2683r1158b2784],
19	loss	NN	O	loss	nsubj	25	SENT_204	[p12l1183t2683r1348b2762],
20	achieved	VBN	O	achieve	partmod	19	SENT_204	[p12l1379t2683r1750b2762],
21	with	IN	O	with	_	0	SENT_204	[p12l1775t2683r1971b2762],
22	lorcaserin	NN	O	lorcaserin	prep_with	20	SENT_204	[p12l2000t2683r2148b2762, p12l10t2812r320b2890],
23	was	VBD	O	be	cop	25	SENT_204	[p12l361t2838r524b2890],
24	3.6	CD	NUMBER	3.6	num	25	SENT_204	[p12l572t2817r698b2890],
25	kg	NN	O	kg	_	0	SENT_204	[p12l744t2811r852b2912],
26	at	IN	O	at	_	0	SENT_204	[p12l893t2828r972b2890],
27	1	CD	DURATION	1	num	28	SENT_204	[p12l1016t2817r1061b2889],
28	year	NN	NUMBER	year	prep_at	25	SENT_204	[p12l1102t2837r1301b2912],
29	.	.	O	.	_	0	SENT_204	[p12l1102t2837r1301b2912],

1	This	DT	O	this	det	2	SENT_205	[p12l1348t2811r1537b2890],
2	finding	NN	O	finding	nsubj	3	SENT_205	[p12l1584t2811r1911b2912],
3	is	VBZ	O	be	_	0	SENT_205	[p12l1952t2812r2018b2890],
4	in	IN	O	in	_	0	SENT_205	[p12l2065t2812r2149b2889],
5	line	NN	O	line	prep_in	3	SENT_205	[p12l8t2939r169b3018],
6	with	IN	O	with	_	0	SENT_205	[p12l209t2939r405b3018],
7	that	DT	O	that	prep_with	5	SENT_205	[p12l450t2939r624b3018],
8	of	IN	O	of	_	0	SENT_205	[p12l664t2939r764b3018],
9	an	DT	O	a	det	11	SENT_205	[p12l789t2965r893b3018],
10	earlier	JJR	O	earlier	amod	11	SENT_205	[p12l938t2939r1214b3018],
11	study	NN	O	study	prep_of	7	SENT_205	[p12l1257t2939r1488b3040],
12	of	IN	O	of	_	0	SENT_205	[p12l1528t2939r1629b3018],
13	lorcaserin	NN	O	lorcaserin	prep_of	11	SENT_205	[p12l1653t2939r2148b3018],
14	.	.	O	.	_	0	SENT_205	[p12l1653t2939r2148b3018],

1	-	:	O	-	_	0	SENT_206	[p12l1653t2939r2148b3018],
2	"	``	O	"	punct	9	SENT_206	[p12l1653t2939r2148b3018],
3	’	CD	NUMBER	’	nsubj	9	SENT_206	[p12l1653t2939r2148b3018],
4	This	DT	O	this	det	6	SENT_206	[p12l6t3067r195b3146],
5	weight	NN	O	weight	nn	6	SENT_206	[p12l240t3067r536b3168],
6	loss	NN	O	loss	dep	3	SENT_206	[p12l577t3067r742b3146],
7	is	VBZ	O	be	cop	9	SENT_206	[p12l791t3068r858b3146],
8	rather	RB	O	rather	advmod	9	SENT_206	[p12l907t3067r1168b3146],
9	small	JJ	O	small	_	0	SENT_206	[p12l1214t3067r1473b3163],
10	,	,	O	,	_	0	SENT_206	[p12l1214t3067r1473b3163],
11	given	VBN	O	give	dep	9	SENT_206	[p12l1525t3068r1754b3168],
12	that	IN	O	that	complm	14	SENT_206	[p12l1801t3067r1975b3146],
13	patients	NNS	O	patient	nsubj	14	SENT_206	[p12l2016t3093r2148b3168, p12l10t3196r248b3274],
14	weighed	VBD	O	weigh	pcomp	11	SENT_206	[p12l279t3195r642b3296],
15	approximately	RB	O	approximately	quantmod	16	SENT_206	[p12l674t3195r1296b3296],
16	100	CD	NUMBER	100	num	17	SENT_206	[p12l1327t3201r1476b3274],
17	kg	NN	O	kg	dobj	14	SENT_206	[p12l1510t3195r1618b3296],
18	at	IN	O	at	_	0	SENT_206	[p12l1647t3212r1727b3274],
19	study	NN	O	study	prep_at	14	SENT_206	[p12l1756t3195r1988b3296],
20	en	IN	O	en	_	0	SENT_206	[p12l2017t3221r2148b3274],
21	—	CD	NUMBER	—	num	22	SENT_206	[p12l2017t3221r2148b3274],
22	try	NN	O	try	prep_en	14	SENT_206	[p12l10t3340r144b3424],
23	.	.	O	.	_	0	SENT_206	[p12l10t3340r144b3424],

1	I	PRP	O	I	nsubj	2	SENT_207	[p12l198t3331r229b3401],
2	assume	VBP	O	assume	_	0	SENT_207	[p12l277t3349r600b3402],
3	that	IN	O	that	complm	7	SENT_207	[p12l651t3323r824b3402],
4	more	JJR	O	more	nsubjpass	7	SENT_207	[p12l869t3349r1090b3402],
5	can	MD	O	can	aux	7	SENT_207	[p12l1141t3349r1291b3402],
6	be	VB	O	be	auxpass	7	SENT_207	[p12l1341t3323r1439b3402],
7	achieved	VBN	O	achieve	ccomp	2	SENT_207	[p12l1488t3323r1859b3402],
8	if	IN	O	if	mark	10	SENT_207	[p12l1908t3323r1985b3401],
9	patients	NNS	O	patient	nsubj	10	SENT_207	[p12l2016t3349r2148b3424, p12l10t3452r248b3530],
10	switch	VBP	O	switch	advcl	7	SENT_207	[p12l281t3451r560b3531],
11	from	IN	O	from	_	0	SENT_207	[p12l590t3451r802b3530],
12	soft	JJ	O	soft	amod	13	SENT_207	[p12l833t3451r998b3530],
13	drinks	NNS	O	drink	prep_from	10	SENT_207	[p12l1024t3451r1302b3531],
14	to	TO	O	to	_	0	SENT_207	[p12l1335t3468r1417b3530],
15	sparkling	JJ	O	sparkling	amod	16	SENT_207	[p12l1449t3451r1862b3552],
16	water	NN	O	water	prep_to	10	SENT_207	[p12l1883t3468r2144b3531],
17	.	.	O	.	_	0	SENT_207	[p12l1883t3468r2144b3531],

1	Since	IN	O	since	mark	3	SENT_208	[p12l12t3580r235b3658],
2	lorcaserin	NN	O	lorcaserin	nsubj	3	SENT_208	[p12l270t3579r701b3658],
3	had	VBD	O	have	advcl	10	SENT_208	[p12l735t3579r893b3658],
4	minimal	JJ	O	minimal	amod	6	SENT_208	[p12l928t3579r1302b3658],
5	side	JJ	O	side	amod	6	SENT_208	[p12l1337t3579r1503b3658],
6	effects	NNS	O	effect	dobj	3	SENT_208	[p12l1539t3579r1846b3675],
7	,	,	O	,	_	0	SENT_208	[p12l1539t3579r1846b3675],
8	it	PRP	O	it	nsubj	10	SENT_208	[p12l1886t3580r1946b3658],
9	also	RB	O	also	advmod	10	SENT_208	[p12l1974t3579r2147b3658],
10	concerns	VBZ	O	concern	_	0	SENT_208	[p12l10t3734r396b3787],
11	me	PRP	O	I	dobj	10	SENT_208	[p12l464t3734r593b3787],
12	that	IN	O	that	complm	16	SENT_208	[p12l659t3708r833b3787],
13	half	PDT	O	half	predet	15	SENT_208	[p12l894t3708r1080b3787],
14	the	DT	O	the	det	15	SENT_208	[p12l1128t3708r1262b3787],
15	patients	NNS	O	patient	nsubj	16	SENT_208	[p12l1327t3709r1671b3809],
16	withdrew	VBD	O	withdraw	ccomp	10	SENT_208	[p12l1734t3708r2153b3787],
17	from	IN	O	from	_	0	SENT_208	[p13l10t21r222b100],
18	the	DT	O	the	det	19	SENT_208	[p13l252t21r386b100],
19	study	NN	O	study	prep_from	16	SENT_208	[p13l417t21r661b122],
20	.	.	O	.	_	0	SENT_208	[p13l417t21r661b122],

1	Were	VBD	O	be	cop	3	SENT_209	[p13l693t29r911b100],
2	these	DT	O	these	nsubj	3	SENT_209	[p13l942t21r1167b100],
3	patients	NNS	O	patient	_	0	SENT_209	[p13l1195t22r1539b122],
4	simply	RB	O	simply	advmod	5	SENT_209	[p13l1573t21r1858b122],
5	disap	VBP	O	disap	dep	3	SENT_209	[p13l1884t21r2148b122],
6	—	CD	NUMBER	—	npadvmod	7	SENT_209	[p13l1884t21r2148b122],
7	pointed	JJ	O	pointed	acomp	5	SENT_209	[p13l8t149r340b250],
8	because	IN	O	because	mark	12	SENT_209	[p13l387t149r725b228],
9	the	DT	O	the	det	10	SENT_209	[p13l772t149r906b228],
10	medication	NN	O	medication	nsubj	12	SENT_209	[p13l951t149r1438b228],
11	had	VBD	O	have	aux	12	SENT_209	[p13l1484t149r1642b228],
12	limited	VBN	O	limit	ccomp	7	SENT_209	[p13l1686t149r1997b228],
13	effectiveness	NN	O	effectiveness	dobj	12	SENT_209	[p13l2043t149r2148b228, p13l10t275r516b357],
14	?	.	O	?	_	0	SENT_209	[p13l2043t149r2148b228, p13l10t275r516b357],

1	Stephan	NNP	PERSON	Stephan	nn	3	SENT_210	[p13l14t413r366b518],
2	von	NNP	PERSON	von	nn	3	SENT_210	[p13l401t442r554b493],
3	Haehling	NNP	PERSON	Haehling	_	0	SENT_210	[p13l600t413r1015b519],
4	,	,	O	,	_	0	SENT_210	[p13l600t413r1015b519],
5	M.D.	NNP	O	M.D.	nn	7	SENT_210	[p13l1059t421r1291b507],
6	,	,	O	,	_	0	SENT_210	[p13l1059t421r1291b507],
7	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_210	[p13l1336t413r1565b493],
8	.	.	O	.	_	0	SENT_210	[p13l1336t413r1565b493],

1	Charité	NNP	ORGANIZATION	Charité	nn	4	SENT_211	[p13l11t556r250b617],
2	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_211	[p13l281t556r538b617],
3	School	NNP	ORGANIZATION	School	nn	4	SENT_211	[p13l567t556r790b617],
4	Berlin	NNP	LOCATION	Berlin	_	0	SENT_211	[p13l16t652r224b723],
5	,	,	O	,	_	0	SENT_211	[p13l16t652r224b723],
6	Germany	NNP	LOCATION	Germany	nn	7	SENT_211	[p13l252t657r558b731],
7	stephan	NN	O	stephan	appos	4	SENT_211	[p13l12t748r1154b828],
8	.	.	O	.	_	0	SENT_211	[p13l12t748r1154b828],

1	von	NN	O	von	_	0	SENT_212	[p13l12t748r1154b828],
2	.	.	O	.	_	0	SENT_212	[p13l12t748r1154b828],

1	haeh	NN	O	haeh	_	0	SENT_213	[p13l12t748r1154b828],
2	|	NN	O	|	nn	3	SENT_213	[p13l12t748r1154b828],
3	ing@charite.de	NN	O	ing@charite.de	dep	1	SENT_213	[p13l12t748r1154b828],

1	No	DT	O	no	det	3	SENT_214	[p13l95t857r189b911],
2	potential	JJ	O	potential	amod	3	SENT_214	[p13l215t852r512b927],
3	conflict	NN	O	conflict	nsubjpass	11	SENT_214	[p13l539t851r797b911],
4	of	IN	O	of	_	0	SENT_214	[p13l820t851r895b911],
5	interest	NN	O	interest	prep_of	3	SENT_214	[p13l907t853r1158b911],
6	relevant	JJ	O	relevant	amod	5	SENT_214	[p13l1180t852r1442b911],
7	to	TO	O	to	_	0	SENT_214	[p13l1464t864r1526b911],
8	this	DT	O	this	det	9	SENT_214	[p13l1553t852r1676b910],
9	letter	NN	O	letter	prep_to	6	SENT_214	[p13l1702t852r1875b911],
10	was	VBD	O	be	auxpass	11	SENT_214	[p13l1896t871r2019b912],
11	reported	VBN	O	report	_	0	SENT_214	[p13l2047t871r2134b911, p13l9t948r245b1023],
12	.	.	O	.	_	0	SENT_214	[p13l2047t871r2134b911, p13l9t948r245b1023],

1	1	LS	NUMBER	1	_	0	SENT_215	[p13l12t1059r62b1110],
2	.	.	O	.	_	0	SENT_215	[p13l12t1059r62b1110],

1	Smith	NNP	ORGANIZATION	Smith	nn	5	SENT_216	[p13l141t1052r334b1110],
2	SR	JJ	ORGANIZATION	sr	amod	5	SENT_216	[p13l370t1056r471b1123],
3	,	,	O	,	_	0	SENT_216	[p13l370t1056r471b1123],
4	Weissman	NNP	ORGANIZATION	Weissman	dep	5	SENT_216	[p13l507t1053r846b1110],
5	NJ	NNP	ORGANIZATION	NJ	_	0	SENT_216	[p13l879t1057r976b1123],
6	,	,	O	,	_	0	SENT_216	[p13l879t1057r976b1123],
7	Anderson	NNP	PERSON	Anderson	nn	8	SENT_216	[p13l1012t1052r1331b1111],
8	CM	NN	O	cm	appos	5	SENT_216	[p13l1366t1056r1495b1123],
9	,	,	O	,	_	0	SENT_216	[p13l1366t1056r1495b1123],
10	et	FW	O	et	nn	11	SENT_216	[p13l1534t1064r1593b1110],
11	al.	FW	O	al.	appos	8	SENT_216	[p13l1622t1052r1696b1110],
12	.	.	O	.	_	0	SENT_216	[p13l1622t1052r1696b1110],

1	Multicenter	NNP	O	Multicenter	_	0	SENT_217	[p13l1732t1052r2130b1123],
2	,	,	O	,	_	0	SENT_217	[p13l1732t1052r2130b1123],
3	placebo	NN	O	placebo	nn	4	SENT_217	[p13l9t1148r644b1223],
4	—	NN	O	—	appos	1	SENT_217	[p13l9t1148r644b1223],
5	controlled	VBN	O	control	partmod	4	SENT_217	[p13l9t1148r644b1223],
6	trial	NN	O	trial	dobj	5	SENT_217	[p13l673t1148r813b1206],
7	of	IN	O	of	_	0	SENT_217	[p13l842t1147r920b1207],
8	lorcaserin	NN	O	lorcaserin	prep_of	6	SENT_217	[p13l934t1148r1270b1207],
9	for	IN	O	for	_	0	SENT_217	[p13l1299t1147r1395b1207],
10	weight	NN	O	weight	nn	11	SENT_217	[p13l1419t1148r1648b1223],
11	management	NN	O	management	prep_for	5	SENT_217	[p13l1673t1160r2130b1223],
12	.	.	O	.	_	0	SENT_217	[p13l1673t1160r2130b1223],

1	N	NN	O	n	nn	2	SENT_218	[p13l8t1249r64b1303],
2	EnglJ	NN	O	englj	nsubj	3	SENT_218	[p13l90t1244r284b1319],
3	Med	VBD	O	med	_	0	SENT_218	[p13l306t1244r448b1303],
4	2010	CD	DATE	2010	dobj	3	SENT_218	[p13l474t1248r1027b1315],
5	;	:	O	;	_	0	SENT_218	[p13l474t1248r1027b1315],
6	363:245	CD	NUMBER	363:245	number	7	SENT_218	[p13l474t1248r1027b1315],
7	—	CD	NUMBER	—	dep	4	SENT_218	[p13l474t1248r1027b1315],
8	56	CD	NUMBER	56	dep	7	SENT_218	[p13l474t1248r1027b1315],
9	.	.	O	.	_	0	SENT_218	[p13l474t1248r1027b1315],

1	2	LS	NUMBER	2	_	0	SENT_219	[p13l9t1348r63b1399],
2	.	.	O	.	_	0	SENT_219	[p13l9t1348r63b1399],

1	Kaplan	NNP	PERSON	Kaplan	nn	2	SENT_220	[p13l139t1340r371b1415],
2	LM	NNP	O	LM	_	0	SENT_220	[p13l399t1345r522b1399],
3	.	.	O	.	_	0	SENT_220	[p13l399t1345r522b1399],

1	Pharmacologic	JJ	MISC	pharmacologic	amod	2	SENT_221	[p13l554t1340r1048b1415],
2	therapies	NNS	O	therapy	_	0	SENT_221	[p13l1077t1340r1376b1415],
3	for	IN	O	for	_	0	SENT_221	[p13l1407t1339r1501b1399],
4	obesity	NN	O	obesity	prep_for	2	SENT_221	[p13l1528t1340r1774b1415],
5	.	.	O	.	_	0	SENT_221	[p13l1528t1340r1774b1415],

1	Gastroen	JJ	O	gastroen	amod	5	SENT_222	[p13l1807t1344r2134b1399],
2	—	NN	O	—	nn	5	SENT_222	[p13l1807t1344r2134b1399],
3	terol	NN	O	terol	nn	5	SENT_222	[p13l10t1436r160b1494],
4	Clin	NNP	O	Clin	nn	5	SENT_222	[p13l185t1436r320b1494],
5	North	NNP	O	North	nsubj	7	SENT_222	[p13l344t1436r542b1495],
6	Am	VBP	O	be	cop	7	SENT_222	[p13l565t1441r681b1494],
7	2010	CD	DATE	2010	_	0	SENT_222	[p13l706t1440r1178b1507],
8	;	:	O	;	_	0	SENT_222	[p13l706t1440r1178b1507],
9	39:69	CD	NUMBER	39:69	number	10	SENT_222	[p13l706t1440r1178b1507],
10	—	CD	NUMBER	—	dep	7	SENT_222	[p13l706t1440r1178b1507],
11	79	CD	NUMBER	79	dep	10	SENT_222	[p13l706t1440r1178b1507],
12	.	.	O	.	_	0	SENT_222	[p13l706t1440r1178b1507],

1	3	LS	NUMBER	3	_	0	SENT_223	[p13l10t1539r60b1590],
2	.	.	O	.	_	0	SENT_223	[p13l10t1539r60b1590],

1	Smith	NNP	ORGANIZATION	Smith	_	0	SENT_224	[p13l141t1532r334b1591],
2	SR	JJ	ORGANIZATION	sr	dep	1	SENT_224	[p13l363t1536r465b1603],
3	,	,	O	,	_	0	SENT_224	[p13l363t1536r465b1603],
4	Prosser	NNP	ORGANIZATION	Prosser	nn	5	SENT_224	[p13l497t1537r741b1591],
5	WA	NNP	ORGANIZATION	WA	appos	2	SENT_224	[p13l765t1537r896b1603],
6	,	,	O	,	_	0	SENT_224	[p13l765t1537r896b1603],
7	Donahue	NNP	PERSON	Donahue	nn	8	SENT_224	[p13l928t1532r1225b1592],
8	DJ	NNP	O	DJ	appos	2	SENT_224	[p13l1252t1537r1343b1603],
9	,	,	O	,	_	0	SENT_224	[p13l1252t1537r1343b1603],
10	Morgan	NNP	ORGANIZATION	Morgan	nn	11	SENT_224	[p13l1373t1537r1632b1607],
11	ME	NNP	ORGANIZATION	ME	appos	2	SENT_224	[p13l1658t1537r1785b1603],
12	,	,	O	,	_	0	SENT_224	[p13l1658t1537r1785b1603],
13	Anderson	NNP	PERSON	Anderson	nn	14	SENT_224	[p13l1815t1532r2135b1591],
14	CM	NN	O	cm	appos	2	SENT_224	[p13l10t1632r139b1699],
15	,	,	O	,	_	0	SENT_224	[p13l10t1632r139b1699],
16	Shanahan	NNP	PERSON	Shanahan	nn	17	SENT_224	[p13l178t1628r504b1687],
17	WR	NNP	O	WR	appos	2	SENT_224	[p13l535t1633r676b1690],
18	.	.	O	.	_	0	SENT_224	[p13l535t1633r676b1690],

1	Lorcaserin	NNP	O	Lorcaserin	_	0	SENT_225	[p13l713t1629r1062b1687],
2	(	CD	NUMBER	(	num	4	SENT_225	[p13l1099t1632r1418b1699],
3	APD356	NN	O	apd356	nn	4	SENT_225	[p13l1099t1632r1418b1699],
4	)	NN	O	)	dep	1	SENT_225	[p13l1099t1632r1418b1699],
5	,	,	O	,	_	0	SENT_225	[p13l1099t1632r1418b1699],
6	a	DT	O	a	det	8	SENT_225	[p13l1455t1647r1488b1686],
7	selective	JJ	O	selective	amod	8	SENT_225	[p13l1522t1628r1795b1687],
8	5	CD	NUMBER	5	appos	4	SENT_225	[p13l1830t1632r2131b1696],
9	.	.	O	.	_	0	SENT_225	[p13l1830t1632r2131b1696],

1	—	NN	O	—	_	0	SENT_226	[p13l1830t1632r2131b1696],
2	.	.	O	.	_	0	SENT_226	[p13l1830t1632r2131b1696],

1	HT	JJ	O	ht	amod	3	SENT_227	[p13l1830t1632r2131b1696],
2	(	NN	O	(	nn	3	SENT_227	[p13l1830t1632r2131b1696],
3	2C	NN	O	2c	nsubj	7	SENT_227	[p13l1830t1632r2131b1696],
4	)	CD	NUMBER	)	num	5	SENT_227	[p13l1830t1632r2131b1696],
5	agonist	NN	O	agonist	dep	3	SENT_227	[p13l10t1725r270b1799],
6	,	,	O	,	_	0	SENT_227	[p13l10t1725r270b1799],
7	reduces	VBZ	O	reduce	_	0	SENT_227	[p13l299t1724r546b1784],
8	body	NN	O	body	nn	9	SENT_227	[p13l573t1724r733b1799],
9	weight	NN	O	weight	dobj	7	SENT_227	[p13l750t1724r975b1799],
10	in	IN	O	in	_	0	SENT_227	[p13l995t1724r1059b1782],
11	obese	JJ	O	obese	amod	12	SENT_227	[p13l1085t1724r1268b1783],
12	men	NNS	O	man	prep_in	9	SENT_227	[p13l1293t1743r1435b1782],
13	and	CC	O	and	_	0	SENT_227	[p13l1459t1724r1579b1783],
14	women	NNS	O	woman	conj_and	12	SENT_227	[p13l1600t1743r1859b1784],
15	.	.	O	.	_	0	SENT_227	[p13l1600t1743r1859b1784],

1	Obesity	NN	O	obesity	nn	4	SENT_228	[p13l1888t1724r2138b1799],
2	(	CD	NUMBER	(	num	4	SENT_228	[p13l14t1820r213b1888],
3	Silver	NN	O	silver	nn	4	SENT_228	[p13l14t1820r213b1888],
4	Spring	NN	DATE	spring	_	0	SENT_228	[p13l238t1820r475b1895],
5	)	CD	DATE	)	num	6	SENT_228	[p13l238t1820r475b1895],
6	2009	CD	DATE	2009	dep	4	SENT_228	[p13l505t1824r1059b1891],
7	;	:	O	;	_	0	SENT_228	[p13l505t1824r1059b1891],
8	17:494	CD	NUMBER	17:494	num	9	SENT_228	[p13l505t1824r1059b1891],
9	-503	CD	NUMBER	-503	dep	4	SENT_228	[p13l505t1824r1059b1891],
10	.	.	O	.	_	0	SENT_228	[p13l505t1824r1059b1891],

1	To	TO	O	to	dep	16	SENT_229	[p13l9t2112r121b2167],
2	THE	DT	O	the	det	3	SENT_229	[p13l152t2113r316b2167],
3	EDITOR	NN	O	editor	pobj	1	SENT_229	[p13l355t2112r691b2168],
4	:	:	O	:	_	0	SENT_229	[p13l355t2112r691b2168],
5	In	IN	O	in	_	0	SENT_229	[p13l726t2097r815b2167],
6	the	DT	O	the	det	7	SENT_229	[p13l849t2089r982b2168],
7	article	NN	O	article	prep_in	16	SENT_229	[p13l1015t2089r1282b2168],
8	by	IN	O	by	_	0	SENT_229	[p13l1317t2089r1414b2190],
9	Smith	NNP	PERSON	Smith	prep_by	7	SENT_229	[p13l1446t2089r1699b2168],
10	et	FW	O	et	nn	11	SENT_229	[p13l1733t2106r1810b2168],
11	al.	FW	O	al.	dep	9	SENT_229	[p13l1838t2089r1961b2185],
12	,	,	O	,	_	0	SENT_229	[p13l1838t2089r1961b2185],
13	the	DT	O	the	det	15	SENT_229	[p13l2001t2089r2134b2168],
14	eligibility	NN	O	eligibility	nn	15	SENT_229	[p13l11t2217r399b2318],
15	criteria	NNS	O	criterion	nsubj	16	SENT_229	[p13l421t2218r709b2296],
16	included	VBD	O	include	_	0	SENT_229	[p13l732t2217r1085b2296],
17	a	DT	O	a	det	21	SENT_229	[p13l1109t2244r1153b2296],
18	body	NN	O	body	nn	21	SENT_229	[p13l1177t2217r1619b2318],
19	—	CD	NUMBER	—	num	21	SENT_229	[p13l1177t2217r1619b2318],
20	mass	NN	O	mass	nn	21	SENT_229	[p13l1177t2217r1619b2318],
21	index	NN	O	index	nsubj	22	SENT_229	[p13l1645t2217r1872b2296],
22	(	VBD	O	(	ccomp	16	SENT_229	[p13l1899t2224r2129b2313],
23	BMI	NNP	O	BMI	nsubj	38	SENT_229	[p13l1899t2224r2129b2313],
24	,	,	O	,	_	0	SENT_229	[p13l1899t2224r2129b2313],
25	the	DT	O	the	det	26	SENT_229	[p13l11t2345r144b2424],
26	weight	NN	O	weight	appos	23	SENT_229	[p13l175t2345r468b2446],
27	in	IN	O	in	_	0	SENT_229	[p13l497t2346r581b2423],
28	kilograms	NNS	O	kilogram	prep_in	26	SENT_229	[p13l615t2345r1054b2446],
29	divided	VBN	O	divide	partmod	28	SENT_229	[p13l1091t2345r1402b2424],
30	by	IN	O	by	_	0	SENT_229	[p13l1438t2345r1535b2446],
31	the	DT	O	the	det	32	SENT_229	[p13l1566t2345r1698b2424],
32	square	NN	O	square	agent	29	SENT_229	[p13l1735t2371r2016b2446],
33	of	IN	O	of	_	0	SENT_229	[p13l2053t2345r2153b2424],
34	the	DT	O	the	det	35	SENT_229	[p13l11t2473r144b2552],
35	height	NN	O	height	prep_of	32	SENT_229	[p13l183t2473r457b2574],
36	in	IN	O	in	_	0	SENT_229	[p13l490t2474r573b2551],
37	meters	NNS	O	meter	prep_in	35	SENT_229	[p13l611t2480r926b2565],
38	)	VBP	O	)	ccomp	22	SENT_229	[p13l611t2480r926b2565],
39	“	NN	O	“	dobj	38	SENT_229	[p13l973t2473r1113b2552],
40	of	IN	O	of	_	0	SENT_229	[p13l973t2473r1113b2552],
41	30	CD	NUMBER	30	prep_of	39	SENT_229	[p13l1135t2479r1233b2552],
42	to	TO	O	to	_	0	SENT_229	[p13l1274t2490r1355b2552],
43	45	CD	NUMBER	45	prep_to	38	SENT_229	[p13l1393t2479r1489b2552],
44	or	CC	O	or	_	0	SENT_229	[p13l1531t2499r1620b2552],
45	of	IN	O	of	_	0	SENT_229	[p13l1657t2473r1757b2552],
46	27	CD	NUMBER	27	number	48	SENT_229	[p13l1776t2479r1875b2552],
47	to	TO	O	to	dep	48	SENT_229	[p13l1914t2490r1996b2552],
48	45	CD	NUMBER	45	prep_of	38	SENT_229	[p13l2034t2479r2130b2552],
49	with	IN	O	with	_	0	SENT_229	[p13l6t2601r198b2680],
50	at	IN	O	at	quantmod	52	SENT_229	[p13l227t2618r305b2680],
51	least	JJS	O	least	mwe	50	SENT_229	[p13l328t2601r523b2680],
52	1	CD	NUMBER	1	prep_with	48	SENT_229	[p13l551t2607r596b2679],
53	coexisting	VBG	O	coexist	partmod	48	SENT_229	[p13l626t2602r1062b2702],
54	condition	NN	O	condition	nn	56	SENT_229	[p13l1088t2601r1490b2680],
55	(	NN	O	(	nn	56	SENT_229	[p13l1524t2601r2129b2702],
56	hypertension	NN	O	hypertension	dobj	53	SENT_229	[p13l1524t2601r2129b2702],
57	,	,	O	,	_	0	SENT_229	[p13l1524t2601r2129b2702],
58	dyslipidemia	NN	O	dyslipidemia	dobj	53	SENT_229	[p13l11t2729r566b2830],
59	,	,	O	,	_	0	SENT_229	[p13l11t2729r566b2830],
60	[	CD	NUMBER	[	dobj	53	SENT_229	[p13l610t2736r741b2820],
61	or	CC	O	or	_	0	SENT_229	[p13l610t2736r741b2820],
62	]	CD	NUMBER	]	num	65	SENT_229	[p13l610t2736r741b2820],
63	cardiovascular	JJ	O	cardiovascular	amod	65	SENT_229	[p13l780t2729r1394b2809],
64	disease	NN	O	disease	nn	65	SENT_229	[p13l1420t2729r1810b2825],
65	)	NN	O	)	dobj	53	SENT_229	[p13l1420t2729r1810b2825],
66	,	,	O	,	_	0	SENT_229	[p13l1420t2729r1810b2825],
67	”	CD	NUMBER	”	conj_or	48	SENT_229	[p13l1420t2729r1810b2825],
68	Where	WRB	O	where	advmod	73	SENT_229	[p13l1838t2729r2132b2808],
69	—	RB	O	—	amod	72	SENT_229	[p13l1838t2729r2132b2808],
70	as	IN	O	as	_	0	SENT_229	[p13l10t2884r97b2936],
71	exclusion	NN	O	exclusion	prep_as	69	SENT_229	[p13l147t2857r553b2936],
72	criteria	NNS	O	criterion	nsubj	73	SENT_229	[p13l602t2858r913b2936],
73	included	VBD	O	include	rcmod	67	SENT_229	[p13l958t2857r1332b2936],
74	“	CD	NUMBER	“	dobj	73	SENT_229	[p13l1384t2862r1469b2936],
75	a	DT	O	a	det	78	SENT_229	[p13l1384t2862r1469b2936],
76	systolic	JJ	O	systolic	amod	78	SENT_229	[p13l1516t2857r1840b2958],
77	blood	NN	O	blood	nn	78	SENT_229	[p13l1887t2857r2134b2936],
78	pressure	NN	O	pressure	dep	73	SENT_229	[p13l10t3011r358b3086],
79	exceeding	VBG	O	exceed	partmod	78	SENT_229	[p13l386t2985r797b3086],
80	140	CD	NUMBER	140	num	82	SENT_229	[p13l824t2991r965b3064],
81	mm	NN	O	mm	nn	82	SENT_229	[p13l993t3011r1162b3063],
82	Hg	NN	O	hg	dobj	79	SENT_229	[p13l1188t2993r1315b3086],
83	or	CC	O	or	_	0	SENT_229	[p13l1339t3011r1425b3064],
84	a	DT	O	a	det	87	SENT_229	[p13l1447t3012r1492b3064],
85	diastolic	JJ	O	diastolic	amod	87	SENT_229	[p13l1518t2985r1864b3064],
86	blood	NN	O	blood	nn	87	SENT_229	[p13l1891t2985r2134b3064],
87	pressure	NN	O	pressure	conj_or	48	SENT_229	[p13l10t3139r358b3214],
88	exceeding	VBG	O	exceed	partmod	87	SENT_229	[p13l385t3113r797b3214],
89	90	CD	NUMBER	90	num	91	SENT_229	[p13l820t3119r919b3192],
90	mm	NN	O	mm	nn	91	SENT_229	[p13l946t3139r1116b3191],
91	Hg	NN	O	hg	dobj	88	SENT_229	[p13l1141t3119r1322b3214],
92	.	.	O	.	_	0	SENT_229	[p13l1141t3119r1322b3214],

1	”	NN	O	”	ccomp	5	SENT_230	[p13l1141t3119r1322b3214],
2	Thus	RB	O	thus	advmod	1	SENT_230	[p13l1349t3113r1576b3209],
3	,	,	O	,	_	0	SENT_230	[p13l1349t3113r1576b3209],
4	it	PRP	O	it	nsubj	5	SENT_230	[p13l1607t3114r1664b3192],
5	seems	VBZ	O	seem	_	0	SENT_230	[p13l1687t3139r1938b3192],
6	that	IN	O	that	_	0	SENT_230	[p13l1967t3113r2139b3192],
7	the	DT	O	the	det	10	SENT_230	[p13l11t3241r144b3320],
8	two	CD	NUMBER	two	num	10	SENT_230	[p13l179t3258r337b3320],
9	criteria	NNS	O	criterion	nn	10	SENT_230	[p13l374t3242r677b3320],
10	conflict	NN	O	conflict	prep_that	5	SENT_230	[p13l711t3241r1068b3320],
11	.	.	O	.	_	0	SENT_230	[p13l711t3241r1068b3320],

1	2463	CD	DATE	2463	num	4	SENT_231	[p13l149t3396r225b3419],
2	N	NN	O	n	nn	4	SENT_231	[p13l930t3407r944b3422],
3	ENGLJ	NN	O	englj	nn	4	SENT_231	[p13l958t3407r1036b3429],
4	MED	NN	O	med	_	0	SENT_231	[p13l1051t3407r1103b3422],
5	36	CD	NUMBER	36	dep	4	SENT_231	[p13l1113t3401r1141b3429],
6	;	:	O	;	_	0	SENT_231	[p13l1158t3407r1177b3427],
7	2	CD	NUMBER	2	num	9	SENT_231	[p13l1158t3407r1177b3427],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_231	[p13l1226t3407r1350b3429],
9	DECEMBER	NN	DATE	december	dep	5	SENT_231	[p13l1386t3407r1515b3422],
10	16	CD	DATE	16	dep	9	SENT_231	[p13l1526t3401r1558b3427],
11	,	,	DATE	,	_	0	SENT_231	[p13l1526t3401r1558b3427],
12	2010	CD	DATE	2010	appos	10	SENT_231	[p13l1570t3407r1630b3423],

1	The	DT	O	the	det	4	SENT_232	[p13l936t3440r987b3464],
2	New	NNP	O	New	nn	4	SENT_232	[p13l996t3441r1058b3464],
3	Englan	NNP	O	Englan	nn	4	SENT_232	[p13l1067t3440r1161b3471],
4	ournal	NN	O	ournal	_	0	SENT_232	[p13l1200t3440r1284b3464],
5	of	IN	O	of	_	0	SENT_232	[p13l1294t3440r1323b3464],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_232	[p13l1330t3440r1455b3464],

